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STRUCTURE AND COMPOSITION OF POSTSYNAPTIC DENSITIES 
Madeline Marie Farley, Ph.D. 
Supervisory Professor: M. Neal Waxham, Ph.D. 
Abstract 
Communication between neurons within the brain occurs at chemical synapses 
and is fundamental for all brain functions.  Modulation of the strength of communication 
is controlled by both presynaptic and postsynaptic mechanisms and is termed synaptic 
plasticity.  One postsynaptic structure postulated to regulate synaptic strength is the 
postsynaptic density (PSD), a large electron dense protein complex located just below 
the synaptic membrane.  The PSD, which is composed of signaling, scaffold and 
cytoskeletal proteins, supports and organizes neurotransmitter receptors within the 
synaptic membrane in addition to bridging signaling with the actin cytoskeletal network.  
The protein composition and structure of PSDs is known to change in response to 
synaptic activity and several PSD proteins are implicated in neurological conditions 
characterized by synaptic dysfunction.  However, there is a lack of information 
regarding the variability of PSD structure and composition from individual PSDs across 
the brain.  In order to address this deficiency, PSDs were isolated from adult rat 
cerebella, hippocampi and cerebral cortices three brain regions with unique neuronal 
populations.  The structure and composition of morphologically identified PSDs from 
these regions was then compared through immunogold analysis and electron 
tomography.  Tomographic reconstructions revealed that while the majority of PSDs 
shared a similar dense protein organization, there were cerebellar PSDs which 
displayed a latticelike protein organization.  PSDs from cortices and cerebellar were 
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also approximately twice as thick as hippocampal PSDs and thicker than previously 
reported measurements.  This suggests that the PSD extends further into the 
postsynaptic spine than previously appreciated, presumably facilitating interactions with 
the spine cytoskeletal network.  Immunogold analysis of PSD scaffold proteins 
suggested that the underlying PSD scaffold is quite variable across the brain, and even 
within brain regions.  Additionally, an immunogold analysis of two key molecules 
documented to play roles in synaptic plasticity, CaMKII and the proteasome, supported 
their potential role in structural modifications of the PSD.  Together, these results 
indicate that PSDs exhibit remarkable diversity in their composition and morphology, 
presumably as a reflection of the unique functional demands placed on different 
synapses. 
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Chapter 1. Introduction 
1.1. Chemical Synapses 
The mammalian brain is composed of billions of neurons which communicate at 
synapses, the site of contact between two neurons where information is physically 
passed from one neuron to another in the form of chemicals or electrical charge.  
Synapses were directly visualized by electron microscopy in the mid-twentieth century 
and this work established the basic ultrastructure of chemical synapses (Palay, 1956, 
Gray, 1959b).  These studies revealed that presynaptic processes are frequently found 
in close opposition to postsynaptic membranes of dendritic spines.  These early studies 
describe dendritic spine heads as approximately 2 μm long with the dendritic neck as 
narrow as 100 nm and often containing a spine apparatus (Gray, 1959b).  The 
presynaptic process, which often contained mitochondria (Palay, 1956, Gray, 1959b) 
and vesicles between 20-65 nm (Palay, 1956), has been described as approximately 1 
μm in diameter with the presynaptic neck between 200 nm and 300 nm in diameter 
(Gray, 1959b).  Figure 1.1 is a micrograph of thin sectioned neuronal tissue in which 
dendritic spines are evident; several presynaptic terminals, filled with synaptic vesicles, 
can be seen in close opposition to postsynaptic spines and the area between the 
presynaptic and postsynaptic membranes, termed synaptic cleft, is visible.  The 
synaptic cleft is approximately 20-30 nm in width and electron dense material sits 
between the two synaptic membranes (Palay, 1956, Gray, 1959b).  Just below the 
postsynaptic membrane is a larger electron dense band termed the postsynaptic 
density (PSD) (Gray, 1959b), also evident in Figure 1.1, which on average extends 
approximately 46 nm into the postsynaptic spine and is believed to be present in the 
majority of excitatory chemical synapses (Gray, 1959a). 
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Chemical synapses are categorized as either excitatory or inhibitory depending 
on the type of neurotransmitters released.  The majority of synapses, and the synapses 
focused on in this work, release the excitatory neurotransmitter glutamate (Sheng and 
Hoogenraad, 2007).  During synaptic transmission, illustrated in Figure 1.2, presynaptic 
action potentials result in an influx of calcium (Ca2+) into the presynaptic terminal, which 
results in the fusion of synaptic vesicles with the plasma membrane and release of 
glutamate into the synaptic cleft (Sheng and Hoogenraad, 2007).  Glutamate can then 
bind glutamate receptors on the postsynaptic membrane, including α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptors (AMPARs) and N-methyl-D-aspartic acid 
receptors (NMDARs), resulting in a postsynaptic influx of sodium ions that depolarize 
the postsynaptic cell (Figure 1.2) (Sheng and Hoogenraad, 2007).  Depolarization 
above a specific voltage threshold results in a significant increase in postsynaptic Ca2+ 
through NMDARs, which triggers a cascade of postsynaptic signaling resulting in long-
term potentiation (LTP) or long-term depression (LTD), two models of learning which 
represent the long lasting changes associated with learning and memory (Sheng and 
Kim, 2002).  The strength of synaptic transmission is important for brain function 
including learning and memory (Malenka and Bear, 2004, Sheng and Hoogenraad, 
2007).  Activity-dependent alterations in the strength of communication between 
neurons is the basis of information storage, and the strength of neuronal 
communication depends on the number of synapses and strength of synaptic 
transmission (Chklovskii et al., 2004, Sheng and Hoogenraad, 2007), that can be 
modulated by both presynaptic and postsynaptic mechanisms, termed synaptic 
plasticity (Sheng and Kim, 2002). 
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Figure 1.1. Synapses in Thin Sectioned Neuronal Tissue. 
Cross-section through dendritic spines from a micrograph of thin sectioned neuronal 
tissue.  Included in this micrograph are several examples of presynaptic terminals and 
postsynaptic densities (PSD).  Adapted with permission from: Synapse Web, Kristen M. 
Harris, PI, http://synapses.clm.utexas.edu/.  Micrograph by J. Spacek.  Scale bar = 500 
nm. 
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Figure 1.2. Overview of Chemical Transmission. 
Action potentials in the presynaptic cell drive Ca2+ ions into the presynaptic 
compartment, which results in the fusion of synaptic vesicles with the plasma 
membrane and release of neurotransmitter glutamate into the synaptic cleft.  Once in 
the synaptic cleft, glutamate can bind and activate AMPARs and NMDARs on the 
postsynaptic membrane, increasing postsynaptic sodium levels.  
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1.2. The Postsynaptic Density 
PSDs were first described as electron-dense synaptic specializations present at 
all mature glutamatergic synapses (Palay, 1956, Gray, 1959b, Cotman et al., 1974), as 
discussed above and shown in Figure 1.1 and in Figure 1.2 as the gray postsynaptic 
oval structure.  PSDs are approximately 100-500 nm in diameter, 40-60 nm thick, have 
an average mass of 1 GDa and are composed of hundreds of proteins including 
signaling, scaffolding and cytoskeletal proteins, as well as neurotransmitter receptors 
(Cotman et al., 1974, Chen et al., 2005, Collins et al., 2006, Dosemeci et al., 2007).  
PSDs function to support and organize the neurotransmitter receptors located in the 
synaptic plasma membrane and to form functional protein modules bridging 
neurotransmitter receptors with cytoplasmic signaling proteins that are crucial for 
synaptic transmission and are implicated in disorders of neurologic dysfunction (Kim 
and Sheng, 2004, Sheng and Kim, 2011).    
 
1.2.1. Major Proteins of The Postsynaptic Density 
Proteomic analyses of postsynaptic density fractions have identified a long list of 
proteins that are associated with PSDs (Jordan et al., 2004, Li et al., 2004, Peng et al., 
2004, Yoshimura et al., 2004, Collins et al., 2005, Cheng et al., 2006, Dosemeci et al., 
2006, Dosemeci et al., 2007) with a consensus of approximately 400 proteins including 
a variety of signaling, cytoskeletal and scaffolding molecules as well as an array of 
receptors and channels (Collins et al., 2005).  Semiquantitative measurements of 
protein complexes from PSD fractions that were affinity-purified for the major PSD 
scaffold protein PSD-95, revealed 288 PSD proteins (Dosemeci et al., 2007). Included 
in the 50 most abundant were, in order; Ca2+/calmodulin-dependent protein kinase II 
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(CaMKII), PSD-95, actin, Shank3, Homer, Shank1, Shank2, NMDAR subunit NR2b, 
SAP102, NMDAR subunit NR1, and α-actinin (Dosemeci et al., 2007).  The proposed 
functions, protein-protein interactions and implications in neurologic dysfunction for 
these PSD proteins are discussed below.  Table 1.1 summarizes the molecular weight 
(kDa), relevant protein interactions and the estimated number of each protein within an 
average PSD for these PSD proteins, while Figure 1.3 illustrates the relevant protein 
interactions in a stick model and Figure 1.4 models a possible organization for these 
proteins within PSDs.  (For reviews on PSD proteins see (Kennedy, 2000, Okabe, 
2007, Sheng and Hoogenraad, 2007)).   
 
1.2.1.1. CaMKII 
The major PSD protein CaMKII (Kennedy et al., 1983), which is estimated to 
represent 2-6% of the total mass of the PSD (Chen et al., 2005), is a holoenzyme 
composed of 12 subunits of varying ratios of αCaMKII and βCaMKII, two isoforms of 
CaMKII, organized into two stacked rings of 6 subunits each (Kolodziej et al., 2000, 
Gaertner et al., 2004a, Swulius and Waxham, 2008).  CaMKII is postulated to be a 
crucial element in NMDAR-dependent LTP, a form of synaptic plasticity (Malenka et al., 
1989, Fink and Meyer, 2002, Lisman et al., 2002, Colbran and Brown, 2004, Lisman et 
al., 2012), and in structurally organizing the PSD (Lin and Redmond, 2009, Hell, 2014).  
CaMKII translocates to PSDs in animal models of ischemia (Aronowski et al., 1992, 
Kolb et al., 1995) and in response to NMDAR activation (Strack et al., 1997, Shen and 
Meyer, 1999) and high levels of potassium (Dosemeci et al., 2001).  CaMKII can self-
associate (Hudmon et al., 2005) and αCaMKII directly binds NMDAR subunits, 
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transmembrane protein densin-180, actin binding protein α-actinin, synGAP (Colbran, 
2004) and the proteasome (Bingol et al., 2010, Djakovic et al., 2012), while βCaMKII 
can bind α-actinin and actin (Colbran, 2004).  Immunogold labeling experiments on 
isolated PSDs determined that within PSDs, CaMKII is typically located 25 nm 
underneath the synaptic face clustering toward the cytoplasmic edge (Petersen et al., 
2003), and although there are variable concentrations of CaMKII within PSDs 
(Petersen et al., 2003), it is approximated that 80 holoenzymes exist within each PSD 
(Chen et al., 2005).  Imaging of isolated PSDs by electron tomography has allowed 
visual identification of the holoenzymes (Fera et al., 2012), which are barrel shaped 
and approximately 20 nm in diameter and height (Kolodziej et al., 2000), within 
individual PSD structures.    
After activation of CaMKII by Ca2+-bound calmodulin, CaMKII can 
autophosphorylate and remain activate until dephosphorylated (Miller and Kennedy, 
1986, Swulius and Waxham, 2008).  The αCaMKII and βCaMKII isoforms have 
differential affinities for Ca2+/CaM (Gaertner et al., 2004b) and effects on synaptic 
transmission (Thiagarajan et al., 2002).  The active kinase can phosphorylate many 
PSD proteins (Dosemeci and Jaffe, Yoshimura et al., 2002), including the proteasome 
(Djakovic et al., 2012), synGAP, a Ras GTPase-activating protein (Oh et al., 2004), the 
NR2 subunits of the NMDAR (Omkumar et al., 1996, Strack and Colbran, 1998), 
AMPAR subunits, and scaffolds PSD-95, Homer (Yoshimura et al., 2002), GKAP and 
Shank (Dosemeci and Jaffe), often significantly increasing their activity level.  In 
response to NMDAR activation, βCaMKII, which binds monomeric and filamentous 
actin, modifies the synaptic actin network by regulating actin polymerization and 
structure (Okamoto et al., 2007, Sanabria et al., 2009, Hoffman et al., 2013), 
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suggesting a role for βCaMKII in synaptic maturation by regulating synaptic 
cytoskeletal structure (Fink et al., 2003).  In further support of CaMKII’s importance in 
synaptic function, inhibitory phosphorylation of CaMKII blocks LTP (Elgersma et al., 
2002, Lisman et al., 2012), a form of synaptic plasticity and CaMKII has been 
implicated in several neurological diseases characterized by synaptic dysfunction 
including Angelman syndrome (Weeber et al., 2003, van Woerden et al., 2007) and 
Parkinson’s disease (Picconi et al., 2004).  For a review of CaMKII’s role in PSDs see 
(Hell, 2014). 
 
1.2.1.2. PSD-95 
PSD-95 is a scaffold protein, which contains a PDZ domain allowing self-
association and formation of multiprotein complexes.  Other scaffolds within the PSD-
95 family include PSD-93, SAP102, and SAP97.  PSD-95 is believed to organize the 
postsynaptic density by bridging signaling molecules with receptors at the synaptic 
membrane, including both AMPARs and NMDARs.  PSD-95 can interact with a variety 
of proteins through its PDZ domain including NMDAR subunits, potassium channels, 
synGAP, neuroligin a trans-synaptic protein which helps align the presynaptic and 
postsynaptic membranes, and stargazin proteins which bind AMPARs at the synaptic 
membrane.  PSD-95 can also bind GKAP, another PSD scaffold protein that bridges 
PSD-95 and Shank, due to a SH3 domain (Kim and Sheng, 2004, Zheng et al., 2011).  
Proteomic analysis by mass spectrometry measured PSD-95 to be three times more 
abundant than scaffolds GKAP and Shank combined (Peng et al., 2004), while another 
study estimates that PSD-95 comprises 2.3% of total PSD mass, with approximately 
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300 copies of PSD-95 per PSD (Chen et al., 2005), further confirming PSD-95’s status 
as the major PSD scaffold.   
Within PSDs, PSD-95 is located approximately 10-20 nm underneath the 
synaptic membrane as determined by immunogold labeling experiments on thin 
sectioned neuronal tissue (Valtschanoff and Weinberg, 2001) and by tomography of 
isolated PSDs (Petersen et al., 2003, DeGiorgis et al., 2006, Chen et al., 2008, Chen et 
al., 2011).  When present in PSDs the scaffold is in an extended conformation forming 
a layer of vertical filaments approximately 10-20 nm from the postsynaptic membrane 
(Chen et al., 2008), presumably bridging glutamate receptors with proteins further 
inside the PSD (Chen et al., 2011).  Additionally PSD-95 levels within PSDs increase 
throughout development (Swulius et al., 2010) appearing to replace the PDZ scaffold 
SAP102 (Sans et al., 2000, Petralia et al., 2005).   
Mice lacking PSD-95 have alterations in spatial learning and both LTP and LTD, 
two NMDAR-dependent forms of plasticity (Migaud et al., 1998).  Overexpression of 
PSD-95 resulted in increased number of AMAPRs, dependent on palmitoylation of 
PSD-95, and enhanced AMPAR signaling (El-Husseini et al., 2000).  Palmitoylation of 
PSD-95, the addition of a palmitate moiety, is crucial for accumulation of PSD-95 in 
synapses (Craven et al., 1999), and depalmitoylation of PSD-95 is required for 
glutamate driven endocytosis of AMPARs (El-Husseini Ael et al., 2002).  PSD-95 is 
also degraded by the ubiquitin proteasome system in response to activation of 
NMDARs, and results in the internalization of AMPARs (Colledge et al., 2003).  
Additionally, soluble amyloid beta (Aβ), implicated in Alzheimer’s disease as a cause of 
synaptic dysfunction, has been shown to induce PSD-95 degradation through activation 
of NMDARs (Roselli et al., 2005).  While the exact functions of PSD-95 are not entirely 
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clear, there is overwhelming evidence that PSD-95 is crucial for organization of 
glutamate receptors and synaptic transmission, by influencing synaptic size and 
strength. 
 
1.2.1.3. SAP102 
SAP102, as mentioned above, is also a scaffold in the PDZ domain containing 
PSD-95 family (Kim and Sheng, 2004, Zheng et al., 2011).  SAP102 is highly abundant 
early in development, decreasing in concentration as PSD-95 increases significantly 
throughout postnatal development in both hippocampal tissue (Sans et al., 2000) and 
PSDs (Petralia et al., 2005).  The developmental switch between SAP102 and PSD-95 
mimics a switch in NMDAR subunits from NR2b in early postnatal hippocampal tissue 
to NR2a (Sans et al., 2000, Petralia et al., 2005), suggesting preferred binding between 
SAP102 and NR2b, and PSD-95 and NR2a.  These results are supported by co-
immunoprecipitation experiments in adult hippocampal tissue (Sans et al., 2000).  
SAP102 is composed of three PDZ domains, a SH3 and a GK domain, same as PSD-
95, allowing SAP102 to interact with NMDAR subunits, potassium channels, synGAP, 
neuroligin, stargazin, and GKAP (Kim and Sheng, 2004, Zheng et al., 2011).  SAP102 
helps establish early postsynaptic organization through interactions with NR2b and 
GKAP which forms a complex with scaffolds SAP102, Shank and Homer (Petralia et 
al., 2005, Zheng et al., 2011).  SAP102 is more mobile than PSD-95 in PSDs and this 
was attributed to association with the highly mobile actin network through the SH3 or 
GK domains (Zheng et al., 2010), presumably trough interactions with GKAP.  
Additionally SAP102 and PSD-95 appear to differentially interact with and regulate 
glutamate receptors; overexpression of PSD-95 leads to increases in functional 
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synaptic AMPARs (El-Husseini et al., 2000).  In contrast, functional increases in 
NMDARs result from overexpression of SAP102 (Zheng et al., 2011). 
 
1.2.1.4. Shank Proteins 
The Shank family of proteins, comprised of Shank1, Shank2 and Shank3, are 
also believed to function as PSD scaffolds, containing a SH3 domain and a PDZ 
domain among others (Sheng and Kim, 2000).  The Shank family interacts with PSD 
scaffolds GKAP and Homer through their PDZ and SH3 domains (Sheng and Kim, 
2000, Kim and Sheng, 2004).  All three scaffolds are expressed in the brain with 
varying abundance and expression patterns (Boeckers et al., 1999a, Boeckers et al., 
1999b, Sheng and Kim, 2000) and are enriched in PSDs (Lim et al., 1999, Naisbitt et 
al., 1999).  It is estimated that the ratio of PSD-95: GKAP: Shank: Homer is 
approximately 6: 2: 2: 1 in forebrain PSDs, with Shank2 as the most abundant Shank in 
forebrain PSDs and Shank1 the least abundant (Cheng et al., 2006).  In addition to 
interacting with PSD scaffolds GKAP and Homer, Shank proteins can also directly bind 
some metabotropic glutamate receptors (mGluRs) (Tu et al., 1999), several actin 
binding proteins including cortactin which binds F-actin (Du et al., 1998), other Shank 
proteins (Sheng and Kim, 2000), and GRIP which interacts with AMPARs (Sheng and 
Kim, 2000).  Through interactions with PSD-95, Homer and GRIP, Shank can indirectly 
form protein complexes with NMDARs, mGluRs, and AMPARs and presumably bridge 
together these protein modules through Shank-Shank interactions (Sheng and Kim, 
2000), which are hypothesized to form the core structural framework of the PSD (Baron 
et al., 2006). Similar to scaffolds PSD-95 (Colledge et al., 2003) and GKAP, Shanks 
are also targeted and degraded by the ubiquitin proteasome system (Ehlers, 2003).  
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Shank can also indirectly interact with the actin network through cortactin, further 
supporting the notion that Shanks form the PSD core bridging receptor protein modules 
to the cytoskeletal network.  Immunogold labeling experiments on thin sectioned 
neuronal tissue determined Shank to be located within PSDs approximately 24 nm 
underneath the synaptic membrane (Valtschanoff and Weinberg, 2001) and 
significantly more Shank is detected by immunogold labeling on the cytoplasmic face 
compared to the synaptic face (Petersen et al., 2003).  Overexpression of Shank alters 
spine morphology and induces recruitment of F-actin to spines further suggesting that 
Shank functionally connects synaptic activity to the spine cytoskeleton (Sala et al., 
2001). 
The importance of Shank in synaptic function is highlighted by several studies 
which have implicated Shank in neurological disorders and diseases such as autism 
spectrum disorders (Durand et al., 2007, Moessner et al., 2007, Gauthier et al., 2009, 
Berkel et al., 2010, Arons et al., 2012, Sato et al., 2012) and Alzheimer’s disease 
(Gong et al., 2009, Roselli et al., 2009, Pham et al., 2010, Grabrucker et al., 2011b, 
Grabrucker et al., 2011d).  Mutations in each of the three Shank proteins have been 
associated with autism spectrum disorders (Durand et al., 2007, Moessner et al., 2007, 
Gauthier et al., 2009, Kumar and Christian, 2009, Berkel et al., 2010, Grabrucker et al., 
2011c, Sato et al., 2012).  Autism spectrum disorder related mutations in Shank1 and 
Shank2 are believed to caused synaptic dysfunction through their influence on spine 
morphology and glutamate receptor signaling, while mutations in Shank3 disrupt 
transsynaptic singling via neuroligin (Arons et al., 2012).  Shank protein-protein 
interaction are also heavily regulated by synaptic zinc levels and zinc is required for 
Shank to associate with PSDs (Baron et al., 2006, Grabrucker et al., 2011a).  
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Intriguingly zinc deficiencies in the brain have been associated with problems in 
learning and memory (Takeda, 2000) and many other neurological disorders including 
Parkinson’s disease and Down’s syndrome (Grabrucker et al., 2011b).  Alzheimer’s 
disease associated Aβ can sequester synaptic zinc and application of soluble Aβ has 
been shown to decrease synaptic levels of Shank (Roselli et al., 2009, Grabrucker et 
al., 2011d) and Homer, and is associated with a reduction of PSD size (Roselli et al., 
2009).  This is an interesting finding given the reductions in synaptic zinc (Suh et al., 
2000) and Shank (Pham et al., 2010) in the hippocampi of human Alzheimer’s disease 
patients.   
 
1.2.1.5. Homer 
Homer, the binding partner of Shank proteins, is enriched in the brain and in 
PSDs (Xiao et al., 1998).  Homer can bind the PSD scaffold Shank, mGluRs, IP3 
receptors, and other Homer molecules forming multimers (Tu et al., 1998, Xiao et al., 
1998).  In fact, the mesh-like structure formed by Homer-Shank interactions is believed 
to form the core scaffold of the PSD (Hayashi et al., 2009).  Homer is believed to assist 
in regulating synaptic Ca2+, spine morphology and synaptic transmission through 
interactions with mGluRs (Foa and Gasperini, 2009).  Interestingly, the effects of Shank 
overexpression on spine morphology and F-actin translocation, described previously, 
are dependent upon Homer, presumably mediated by the ability of Homer to regulate 
intracellular Ca2+ levels through direct interactions with mGluRs and IP3 receptors 
(Sala et al., 2001).  Homer knockout mice are deficient in formation of fear memories 
(Inoue et al., 2009) and Homer has also been implicated in Fragile X and Alzheimer’s 
disease, among other pathologic conditions (Foa and Gasperini, 2009).  Within 
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forebrain PSDs, it is estimated that for every two Shank molecules there is one Homer 
molecule (Cheng et al., 2006) and Homer, like Shank, lies closer to the cytoplasmic 
PSD face (Petralia et al., 2005).   
 
1.2.1.6. NMDA-type Glutamate Receptors 
NMDARs are glutamate receptors that allow Ca2+ to enter the postsynaptic 
compartment in response to synaptic depolarization.  Activation of NMDARs can trigger 
LTP or LTD, two forms of long lasting changes in synaptic plasticity associated with 
learning and memory (Sheng and Kim, 2002).  The receptors are composed of four 
subunits, two NR1subunits and two NR2 subunits all of which are enriched in PSDs (Al-
Hallaq et al., 2001, Lee et al., 2001, Okabe, 2007, Sorokina et al., 2011).  The NR2 
subunits NR2a and NR2b, which accounts for approximately 1% of the total PSD 
protein (Okabe, 2007), can directly bind PDZ proteins in the PSD-95 family (Sorokina et 
al., 2011).  NR2 subunits also bind CaMKII, situating the Ca2+-dependent kinase in a 
favorable position to receive Ca2+ flowing through open NMDAR channels (Strack and 
Colbran, 1998, Kennedy, 2000).  NR1 subunits can also bind calmodulin, the Ca2+ 
binding protein required for activation of CaMKII, further highlighting the connection 
between NMDARs and the CaMKII pathway.  NR1 and NR2b subunits can also directly 
bind α-actinin, bridging NMDARs to the actin network as α-actinin binds actin 
(Wyszynski et al., 1997).  Intriguingly, NMDAR knockout mice had no observable defect 
in either synaptic morphology or protein composition (Okabe, 2007), although activation 
of NMDAR results in phosphorlyation of over 100 PSD proteins (Coba et al., 2009, 
Sheng and Kim, 2011).  Immunogold studies on synapses (Racca et al., 2000) and 
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proteomic analysis of PSD fractions (Cheng et al., 2006) suggest that approximately 10 
NMDARs are present in individual synapses. 
 
1.2.1.7. Actin and α-Actinin 
Actin is highly enriched in spines and is thought to contribute to spine size and 
morphology, molecular transport, and anchoring of the PSD and neurotransmitter 
receptors (Cingolani and Goda, 2008, Schoenenberger et al., 2011).  Actin directly 
binds βCaMKII, α-actinin and cortactin (Okabe, 2007); α-actinin bridges actin to 
NMDARs (Wyszynski et al., 1997), αCaMKII and βCaMKII (Okabe, 2007), while 
cortactin links actin to the Shank/GKAP/PSD-95 scaffold complex through Shank (Du et 
al., 1998, Naisbitt et al., 1999, Kim and Sheng, 2004, Okabe, 2007).  Actin exists in a 
monomeric form, G-actin, and a filamentous form, F-actin, both of which interact with 
βCaMKII which in turn regulates actin polymerization and F-actin bundling in an 
activity-dependent manner (Okamoto et al., 2007, Sanabria et al., 2009, Hoffman et al., 
2013).  Treadmilling of PSD associated actin is believed to organize the internal PSD 
structure which is highly dynamic (Blanpied et al., 2008, Kerr and Blanpied, 2012); 
depolymerization of F-actin reduced synaptic NMDARs and AMPARs (Allison et al., 
1998) as well as the mobility of PSD scaffolds PSD-95, GKAP, Shank and Homer 
(Kuriu et al., 2006).  Given that βCaMKII modulates actin binding and F-actin structure 
in response to calcium influxes through NMDARs (Okamoto et al., 2007, Sanabria et 
al., 2009, Hoffman et al., 2013), presumably the internal organization of the PSDs is 
also regulated by CaMKII in an activity-dependent manner. 
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Type of PSD 
Protein 
Molecular 
Weight 
Relevant Binding 
Partners 
Estimated Copies within 
PSD 
αCaMKII Signaling 55 kDa 
NR2 
≈ 80 Mixed Holoenzymes 
α‐actinin 
proteasome 
αCaMKII 
βCaMKII Signaling 60 kDa 
G-actin 
F‐actin 
α‐actinin 
PSD-95 Scaffold 95 kDa 
GKAP                 
≈ 300 NR2 
stargazin 
SAP102 Scaffold 105 kDa 
neuroligin 
x PSD-95 
SAP102 
Shank1 Scaffold 120-240 kDa 
GKAP 
≈ 150  
Homer 
Shank2 Scaffold 160 kDa 
cortactin 
Shank 
Shank3 Scaffold 190 kDa 
mGluRs 
neuroligin 
Homer Scaffold 45 kDa 
mGluRs 
≈ 50 Shank 
Homer 
Actin Scaffold 42 kDa 
βCaMKII 
x α‐actinin 
cortactin 
α-actinin Scaffold 100 kDa 
actin 
x 
αCaMKII 
βCaMKII 
NR1 
NR2 
NR1 Receptor 105 kDa 
α-actinin 
≈10 - 20 NMDARs 
CaM 
NR2b Receptor 166 kDa 
αCaMKII 
PSD‐95 
SAP102 
α‐actinin 
Table 1.1. Major PSD Proteins. 
For review of PSD protein interactions see (Sheng and Kim, 2000, Kim and Sheng, 
2004, Okabe, 2007, Sheng and Hoogenraad, 2007, Foa and Gasperini, 2009) and for 
estimated copies within PSDs see (Cheng et al., 2006, Okabe, 2007, Sheng and 
Hoogenraad, 2007).   
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Figure 1.3. Summary of Major PSD Protein Interactions. 
Summary of the major protein interactions for the PSD proteins described in this 
chapter and referenced through this dissertation.  Solid lines indicate direct 
interactions, while dashed lines indicate indirect interactions.  The double line just 
below the NMDAR and AMPAR represents the synaptic plasma membrane.  For review 
of PSD protein interactions see (Sheng and Kim, 2000, Kim and Sheng, 2004, Okabe, 
2007, Sheng and Hoogenraad, 2007, Foa and Gasperini, 2009).  
  
 18 
 
 
Figure 1.4. Organization of Major PSD Proteins. 
Possible organization of key PSD proteins based on protein interactions and estimated 
location within PSDs (Sheng and Kim, 2011). 
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1.2.2. PSD Morphology and Structural Organization 
PSD morphology has been described from thin sectioned neuronal tissue 
(Palay, 1956, Gray, 1959b, a, 1961, Cohen and Siekevitz, 1978, Harris et al., 1992) as 
well as from biochemically isolated PSDs, which are morphologically consistent with 
PSDs in the native synaptic environment (Cotman et al., 1974, Cohen et al., 1977, 
Matus and Taff-Jones, 1978, Carlin et al., 1980, Petersen et al., 2003).  Historically 
PSDs have been described as dense cup-shaped structures between 0.2-1 μm in 
diameter and approximately 60 nm thick composed of smaller but poorly resolved 
particles (Cotman et al., 1974, Cohen et al., 1977, Cohen and Siekevitz, 1978), with a 
distinct cleft and cytoplasmic faces (Petersen et al., 2003).  More recently, through the 
use of cryo and stain electron tomography, protein substructures of filamentous and 
globular proteins have been resolved (Swulius et al., Chen et al., 2008, Fera et al., 
2012, Swulius et al., 2012).  Isolated PSDs have also been treated with various 
detergents (Matus and Taff-Jones, 1978) and reducing agents (Blomberg et al., 1977) 
to strip away proteins in order to describe the underlying lattice presumed to be the 
core scaffold of the PSD. 
The morphologic changes in PSDs during synaptic maturation have also been 
described; early in development PSDs appear to be thin lattices of protein and through 
development proteins are recruited to the PSD (Swulius et al., 2010), significantly 
increases the density of the PSD structure (Swulius et al., 2012).  Similarly PSD 
morphology (Dosemeci et al., 2001) and PSD protein composition (Ehlers, 2003) 
change in response to synaptic activity.  PSD composition is dynamically regulated by 
protein phosphorlyation (Dosemeci and Jaffe, Yoshimura et al., 2002, Cheng et al., 
2006), palmitoylation (El-Husseini Ael et al., 2002), reorganization (Kuriu et al., 2006, 
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Blanpied et al., 2008, Tao-Cheng et al., 2010, Zheng et al., 2010, Yang et al., 2011, 
Kerr and Blanpied, 2012), degradation (Ehlers, 2003, Yi and Ehlers, 2005), synthesis 
(Steward and Schuman, 2003, Schuman et al., 2006) and recruitment (Strack et al., 
1997, Djakovic et al., 2009).  These changes in PSD composition and protein 
organization are hypothesized to modulate synaptic transmission and therefore 
contribute to learning and memory (Kennedy, 2000).  To better understand the PSD 
composition and eventually how it is dynamically regulated, numerous proteomic 
studies have been targeted at defining the PSD proteome (Jordan et al., 2004, Li et al., 
2004, Peng et al., 2004, Yoshimura et al., 2004, Collins et al., 2005, Cheng et al., 2006, 
Dosemeci et al., 2007).  Compositional changes in PSDs throughout development 
(Sans et al., 2000, Petralia et al., 2005, Swulius et al., 2010) and in response to activity 
(Ehlers, 2003) have also been investigated and several groups have also employed 
immunogold labeling to assess PSD protein organization (Valtschanoff and Weinberg, 
2001, Petersen et al., 2003, DeGiorgis et al., 2006, Chen et al., 2008, Swulius et al., 
2010), indentifying several PSD proteins which redistributed within PSDs in response to 
activity (Tao-Cheng et al., 2010, Yang et al., 2011).  For reviews on PSD structure see 
(Okabe, 2007, Sheng and Hoogenraad, 2007, Sheng and Kim, 2011). 
However, there is a lack of information regarding the variability of PSD 
morphology and protein composition across the brain.  It is hypothesized that different 
areas of the brain place unique demands on the process of synaptic transmission and 
that the PSD protein composition, and therefore PSD structure, likely change across 
the brain to support these unique demands.  Gross differences in morphology have 
been described between PSDs isolated from cerebral cortices and cerebella from post-
mortem canine brains (Carlin et al., 1980); cortical PSDs were thicker while cerebellar 
 21 
 
PSDs appeared to be more latticelike in structure (Carlin et al., 1980).  Additionally a 
proteomics study measured 43 PSD proteins which statistically differed in 
concentration between cortical and cerebellar derived PSD including neurotransmitter 
receptors, signaling and scaffold molecules (Cheng et al., 2006).  However PSDs are 
heterogeneous, each one is compositionally and structurally unique based on the 
activation history of that particular synapse. Therefore while proteomic approaches 
provide valuable information regarding the bulk composition of PSD fractions, a more 
direct comparison of PSD morphology and protein composition of individual PSDs from 
across the brain is still needed and is the focus of this dissertation.   
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Chapter 2: Methodology  
2.1. Isolation of Postsynaptic Densities from Cerebella, Hippocampi, and Cerebral 
Cortices 
PSDs were isolated following a previously reported protocol (Swulius et al., 
2010, Swulius et al., 2012), which was adapted from a widely used PSD enrichment 
procedure (Cohen et al., 1977), in order to remove PSDs from the crowded 
environment of synapses for morphological and compositional analyses.  For a single 
preparation, brains were removed within 30 seconds of decapitation from nine adult 
male Sprague-Dawley rats (176-200 g) and placed in an ice-cold isotonic sucrose 
solution (buffer A) of 0.5 mM HEPES/KOH pH 7.4, 0.32 M sucrose, 1 mM MgCl2, 0.5 
mM CaCl2 and 1 μg/ml leupeptin.  The cerebella, hippocampi, and cortices were 
immediately dissected, as shown in Figure 2.1, and separately homogenized in a total 
volume of 45 ml buffer A with a motor-driven glass/Teflon homogenizer (0.2 mm 
clearance).  All steps of the following protocol were accomplished at 4˚C.  For each 
region, homogenates were spun at 1,400 x g for 10 minutes in a JA20 rotor. 
Supernatants were saved and pellets were resuspended in 12.5 ml buffer A (2 pellets 
from cortical tissue and 1 pellet each from cerebellar and hippocampal tissue) and spun 
again at 1,400 x g for 10 minutes.  The supernatants were combined and pelleted at 
13,800 x g for 10 minutes.  The resulting pellets were resuspended and hand 
homogenized in a second sucrose solution, buffer B, (0.5 mM HEPES/KOH pH 7.4, 
0.32 M sucrose and 1 μg/ml leupeptin), applied to sucrose gradients (<12 ml sample in 
buffer B, 12 ml 1.0 M sucrose, 13 ml 1.4 M sucrose) and spun at 112,000 x g for 120 
minutes in a SW32 rotor.  The synaptosomal fraction, at the 1.0/1.4 M interface, was 
collected, diluted in an equal volume of buffer B, and then an equal volume of triton 
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extraction buffer (5 mM HEPES/KOH pH 7.4, 0.32 M sucrose, 1% TX-100) was added.  
The sample was homogenized and continuously mixed on a rotator for 15 minutes 
before being spun at 32,800 x g for 20 minutes.  The resulting pellet was suspended in 
buffer B, applied to a second sucrose gradient (2 ml of sample in buffer B, 2 ml 1.0 M 
sucrose, 4 ml 1.5 M sucrose, 2 ml 2.1 M sucrose) and spun for 120 minutes at 271,000 
x g in a SW41 rotor.  The synaptic junction fraction, the interface between the 1.5 M 
and 2.1 M sucrose, was then brought to 3 ml with 5 mM HEPES/KOH, pH 7.4, before 
the addition of an equal volume of a triton extraction buffer and rotated for 30 minutes.  
To produce the PSD fraction, the material was then added to the final sucrose gradient 
(6 ml sample, 4 ml 1.5 M sucrose, 2 ml 2.1 M sucrose) and spun at 210,000 x g for 20 
minutes.  The postsynaptic density material at the 1.5/2.1 M interface was then diluted 
to 5 ml with 5 mM HEPES/KOH pH 7.4, pelleted at 48,500 x g for 15 minutes in a 
SW55 rotor, resuspended in 300-500 μl 20% glycerol in 5 mM HEPES/KOH pH 7.4, 
and stored as aliquots at -80˚C.  All spins were performed in either the Avanti® J-E 
Centrifuge or Optima XPN-80 Ultracentrifuge, both from Beckman Coulter.  Gradients 
were spun with acceleration and deceleration program 1, resulting in a 2 minute 
acceleration to and deceleration from 170 RPM, respectively.  The isolation protocol is 
summarized in Figure 2.2.  
The data described in this dissertation, regarding PSDs from different brain 
regions, were produced from two independent PSD preparations that each contained 
the three isolated brain regions from nine rats.  It is important to acknowledge that the 
process of isolating the PSD from the brain has the potential to alter its structure and 
composition. This limitation should be kept in mind when attempting to place the 
findings in this dissertation in the context of PSD structure and function in vivo. 
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Figure 2.1. Dissection of Adult Rat Cerebellum, Hippocampi and Cortices. 
First, the cerebellum was dissected out by cutting along the plane of the line marked 1, 
isolating it away from the rest of the forebrain.  The two hemispheres of the cortex were 
then separated by cutting along the plane of the line marked 2 in order to isolate the 
two hippocampi from the rest of the cerebral cortex.   
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Figure 2.2. Isolation of PSDs from Cortices, Hippocampi, and Cerebella. 
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2.2. Protein Assays, SDS Page and Western Blotting  
Protein concentrations were determined in triplicate and averaged using either 
the Bio-Rad Protein Assay (BIORAD, #500-006) or Pierce BCA Protein Assay Kit 
(Pierce, #23225), with serial dilutions of BSA standards in buffers matching that of the 
unknown sample.  The Bio-Rad assay is not compatible with detergents, while the 
Pierce assay is not compatible with glycerol concentrations above 10%.    
For protein staining, 3-5 μg of total protein from PSD fractions were separated 
by SDS-PAGE with 10% polyacrylamide gels. Gels were incubated for 1 hr in excess 
fixation solution (30% methanol, 7.5% acetic acid) before staining with Amersham 
Deep Purple Total Protein Stain (GE Healthcare) diluted 1 part stain to 200 parts 100 
mM sodium borate, pH 10.5 for 1 hr.  After staining, gels were washed for 30 min in 
wash solution (30% methanol) and then 30 min in fixation solution.  After a 5 min rinse 
in fixation solution, gels were imaged on the Typhoon scanner, using the green laser 
(532 nm) at 500 PMT and 10 μm resolution; ImageQuant was used to estimate the 
molecular weight and intensity of each band.  All incubations were performed at room 
temperature on an orbital shaker. 
For Western blotting, 5-10 μg of total protein from homogenate, synaptosome, 
synaptic junction, or PSD fractions from cerebella, hippocampi, cortices, and forebrains 
were separated by SDS-PAGE with 8%, 10%, or 15% polyacrylamide gels, in running 
buffer (25 mM Tris Base, 192 mM Glycine, 0.1% SDS).  Separated proteins were 
transferred (transfer buffer: 25 mM Tris Base, 192 mM Glycine, 0.02% SDS, 30% 
methanol) to nitrocellulose membranes at 4˚C for 2 hours at 80 volts and membranes 
were then incubated in blocking buffer (5% dry milk in wash buffer (10 mM Tris, pH 8.0, 
150 mM NaCl, and 0.05% NP40)).  Membranes were then incubated in primary 
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antibodies including α-actinin (mouse, Sigma, A5044, 1:2500), actin (rabbit, Sigma, 
A2066, 1:500), PSD-95 (mouse, Thermo-Scientific, MA1-046, 1:2000-5000), Homer 
(mouse, Santa Cruz, sc-17842, 1:1000), SAP102 (mouse, Neuromab, 75-058, 1:2500), 
Shank1 (mouse, Neuromab, 75-064, 1:1000), Shank2 (mouse, Neuromab, 75-088, 
1:1000), Shank3 (mouse, Neuromab, 75-109, 1:1000), αCaMKII (mouse, produced in 
house, 1:2000), βCaMKII (mouse, Invitrogen 13-9800, 1:2000), CaM (mouse, Upstate 
05-173, 1:1000), NR1 (mouse, Millipore, MAB363, 1:2500), NR2b (mouse, Millipore, 
MAB5778, 1:2500), RPT6 (mouse, Enzo Life Science, PW9265, 1:2500) and SV2 
(mouse, Developmental Studies Hybridoma Bank, AB 2315387, 1:1000) diluted in 
blocking buffer, for 1 hour.  Primary antibody information is summarized in Table 2.1.  
Blots were then rinsed twice in wash buffer before a 1 hour incubation in secondary 
antibodies.  Secondary antibodies included HRP anti-mouse (goat, Pierce, 31430, 
1:1250-5000), HRP anti-rabbit (goat, Pierce, 31460, 1:2000), or Alexa 488 anti-mouse 
(goat, Molecular Probes, A-11029, 1:5000).  Secondary antibody information is 
included in Table 2.2.  After incubation with secondary antibodies, membranes were 
rinsed twice with wash buffer prior to imaging on a Typhoon Trio+ scanner (GE 
Healthcare), with the green laser (532 nm), a PMT value ranging between 400-550 and 
a resolution between of at least 50 μm.  The Pierce® ECL 2 system (Thermo Scientific) 
was used for developing blots incubated with either HRP secondary antibody.  This 
included replacing the wash buffer with 0.1% TWEEN in phosphate buffered saline 
throughout blot development and a 5 minute incubation in substrate working solution, 
which contains the substrate to be oxidized by HRP, prior to imaging on a Typhoon 
Trio+ scanner (GE Healthcare), with the blue laser (488 nm), a PMT value ranging 
between 400-550 and a resolution between of at least 50 μm. 
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Western blots were performed for each primary antibody to test specificity on 
adult forebrain PSD fractions.  Each antibody stained the appropriate molecular weight 
band on the gel and these bands are shown in Figure 2.3.  As expected, single bands 
for α-actinin, actin, PSD-95, Homer, SAP102, Shank1, Shank2, Shank3, αCaMKII, 
βCaMKII, NR1, NR2b, RPT6, and SV2 were detected at 100 kDa, 42 kDa, 95 kDa, 45 
kDa, 105 kDa, 205 kDa, 160 kDa, 190 kDa, 55 kDa, 60 kDa, 110 kDa, 170 kDa, 48 
kDa, and 95 kDa, respectively. 
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Figure 2.3.  Western Blots against PSD Proteins. 
 
Lanes were loaded with between 5 and 10 ug of adult forebrain PSDs and blots were 
developed using HRP secondary antibodies and the Pierce® ECL 2 system.  The SV2 
blot was loaded with 8 μg of cortical homogenate, as SV2 is a presynaptic protein not 
detected in PSD fractions, and was developed with the Alexa 488 goat anti-mouse 
secondary. 
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2.3. Immunogold Labeling of Isolated Postsynaptic Densities 
Five microliters of PSDs, approximately 0.7 μg, were added to freshly glow-
discharged formvar/carbon coated copper grids (Ted Pella) for 5 minutes.  All steps 
were performed at room temperature in a humidified chamber.  After blotting excess 
liquid, grids were floated upside down on 35 µL drops of blocking buffer (5% BSA in 
HEPES Buffered Saline: 20 mM HEPES, 150 mM KCL, pH 7.4) for 10 minutes.  After 
blotting, grids were then placed on top of 25 µL drops of primary antibody for 30 
minutes.  Primary and secondary antibodies were diluted to working concentration in 
blocking buffer.  Primary antibodies, summarized in Table 2.1, included those to: α-
actinin (mouse, Sigma, A5044, 1:20), actin (rabbit, Sigma, A2066, 1:20), PSD-95 
(mouse, Thermo-Scientific, MA1-046, 1:20), Homer (mouse, Santa Cruz, sc-17842, 
1:50), SAP102 (mouse, Neuromab, 75-058, 1:10), Shank1 (mouse, Neuromab, 75-064, 
1:20), Shank2 (mouse, Neuromab, 75-088, 1:50), Shank3 (mouse, Neuromab, 75-109, 
1:10), αCaMKII (mouse, produced in house, 1:20), βCaMKII (mouse, Invitrogen 13-
9800, 1:100), CaM (mouse, Upstate 05-173, 1:5), NR1 (mouse, Millipore, MAB363, 
1:5), NR2b (mouse, Millipore, MAB5778, 1:20), RPT6 (mouse, Enzo Life Science, 
PW9265, 1:10).  After incubation with the primary antibody, grids were rinsed three 
times by floating on top of 35 µL drops of blocking buffer, blotting in between.  Grids 
were then placed on 25 µL drops of gold conjugated secondary antibody, diluted in 
blocking buffer, for 30 minutes.  Secondary antibodies, summarized in Table 2.2, 
included 12nm Colloidal Gold-AffiniPure anti-mouse (goat, Jackson Immunoresearch, 
115-205-068, 1:5) or 12nm Colloidal Gold-AffiniPure anti-rabbit (goat, Jackson 
Immunoresearch, 111-205-144, 1:5).  Afterwards, grids were placed on a final 35 µL 
drop of blocking buffer.  Each grid was then negatively stained by rinsing twice with 5 
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µL of MilliQ water, once briefly with 5 µL NanoW (Nanoprobes) and afterwards with 5 
µL of NanoW for 30 seconds.   
Grids were allowed to dry at room temperature for at least 30 minutes and then 
imaged on a JEOL 1400 electron microscope operated at 120 kV.  Images were 
collected on an Orius camera (Gatan) at 32-64kx magnifications at the image plane.  
Labeling density was calculated as the total number of gold particles contained within 
the surface area of the PSD as measured in ImageJ (NIH).  A representative 
immunogold labeled PSD is shown in Figure 2.4, alongside cross-sections through a 
final cryotomographic reconstruction of a representative immunogold labeled PSD 
illustrating gold labeling throughout the z-dimension of the PSD.  The average labeling 
density was calculated by averaging 20 individual immunogold labeled PSDs for each 
region and antibody.  Titrations for every primary and secondary antibody were done to 
ensure asymptotic labeling for a given target protein and Western blots were performed 
for each primary antibody to test specificity.  Negative controls (no primary antibody) 
were run in each experiment and the number of background gold/surface area was 
subtracted from the average labeling density.  Statistical significance was defined as a 
p-value < 0.05, as determined through two-tailed t tests in Excel.  
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Antibody Species Manufacturer Catalog Number WB Dilution IG Dilution 
α-actinin mouse Sigma A5044 1:2500 1:20 
actin rabbit Sigma A2066 1:500 1:20 
PSD-95 mouse Thermo-Scientific MA1-046 1:2000-5000 1:20 
Homer mouse Santa Cruz sc-17842 1:1000 1:50 
SAP102 mouse Neuromab 75-058 1:2500 1:10 
Shank1 mouse Neuromab 75-064 1:1000 1:20 
Shank2 mouse Neuromab 75-088 1:1000 1:50 
Shank3 mouse Neuromab 75-109 1:1000 1:10 
αCaMKII mouse Waxham Lab -- 1:2000 1:20 
βCaMKII mouse Invitrogen 13-9800 1:2000 1:100 
CaM mouse Upstate 05-173 1:1000 1:5 
NR1 mouse Millipore MAB363 1:2500 1:5 
NR2b mouse Millipore MAB5778 1:2500 1:20 
RPT6 mouse Enzo Life Science PW9265 1:2500 1:10 
SV2 mouse Developmental Studies Hybridoma Bank AB 2315387 1:1000 -- 
 
Table 2.1. Antibody Information for all Primary Antibodies Used. 
Information includes: the species in which antibody was raised, manufacturer, catalog 
number, Western blot dilution and immunogold labeling dilution. 
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Antibody Species Manufacturer Catalog Number WB Dilution IG Dilution 
HRP anti-mouse goat Pierce 31430 1:1250-5000 -- 
HRP anti-rabbit goat Pierce 31460 1:2000 -- 
Alexa 488 goat Molecular Probes A-11029 1:5000 -- 
12 nm Gold anti-
mouse goat 
Jackson 
Immunoresearch 115-205-068 -- 1:5 
12 nm Gold anti-
rabbit goat 
Jackson 
Immunoresearch 111-205-144 -- 1:5 
 
Table 2.2. Antibody Information for all Secondary Antibodies Used. 
Information includes: the species in which antibody was raised, manufacturer, catalog 
number, Western blot dilution and immunogold labeling dilution.  
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Figure 2.4. Immunogold Labeling. 
A) Electron micrograph of cortical PSD immunogold labeled for βCaMKII.  Labeling 
density is calculated as the number of gold divided by surface area.  Surface area is 
calculated in ImageJ by measuring the number of pixels within a boundary freely drawn 
around the PSD, similar to left panel, and multiplying by the pixel size, which is 
reported by the Gatan software when imaging.  Labeling density can also be reported 
as the number of gold per PSD.  B) Ten-nanometer cross-sections through a final 
cryotomographic reconstruction of a representative hippocampal PSD immunogold 
labeled for the proteasome (6 nm gold) and βCaMKII (12 nm gold).  The cross-sections 
illustrate gold labeling throughout the entire z-dimension of the PSD, suggesting that 
PSDs are permeable to gold conjugated secondary antibodies.  C) Side views of the 
same immunogold labeled PSD, from B, illustrating gold labeling through the x-
dimension (yz view).  Scale bars = 100 nm. 
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2.4. Spatial Analysis of Immunogold Labeling 
For 2D spatial analysis of gold labeling, I employed a Ripley’s K-function based 
analysis to determine whether the gold distribution for a given PSD deviated from 
spatial randomness, as previously described (Swulius et al., 2010).  Briefly, coordinates 
representing the boundary of the PSD and gold were recorded and a MATLAB 
(MathWorks) model was generated.  The 2D spatial distribution of the gold was then 
compared to 1000 simulations of complete spatial randomness, within the same 
boundary given the same number of gold particles.  This procedure was accomplished 
for every PSD where spatial analysis was employed.  
For each immunogold labeled PSD, like the example shown in Figure 2.5.A, 
Photoshop (Adobe) was used to create a binary image of points outlining the PSD 
boundary and depicting gold distribution.  To achieve this, a new layer was created for 
each image and the PSD border was defined in points using the paintbrush function at 
15 pt and 100% hardness in as few points as needed to define the boundary.  On the 
same layer, a point was created for each gold particle within the PSD boundary using 
the paintbrush function at 9 pt and 50% hardness.  The layer was then saved as a 
grayscale image and opened in ImageJ.  In ImageJ, the threshold function was used to 
select all of the points in the binary image.  Using the analyze particles function, set to 
measure center of mass, the coordinates of each point were reported.  For boundary 
points, the size entered into the analyze particle interface was 60-infinity, while for gold 
coordinates 1-50 was entered as the size.  A text file was created for each image with 
boundary point coordinates ordered clockwise starting with the point closest to the top 
of the image and gold coordinates were listed below.  All boundary coordinates were 
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denoted with a 1 before the x and y coordinates, while gold coordinates were denoted 
with a 2 prior to the x and y coordinates.   
MATLAB (MathWorks) was then used to create coordinate models, like the 
example shown in Figure 2.5.B, for each PSD using the text files.  The coordinate 
models were then used to create 1000 examples of complete spatial randomness 
(CSR) in MATLAB using the same boundary and same number of gold particles as the 
coordinate model.  To determine whether the gold particle distribution deviates from 
random, the gold distribution was compared to the 1000 examples of CSR, using 
Ripley’s K-function (Ripley, 1976, 1977, Kiskowski et al., 2009).  Ripley’s K-function 
uses concentric circles of various radii to calculate the average number of gold particles 
over distance from the center of each particle (Ripley, 1976, 1977).  For example, 
Ripley’s K-function analysis of clustered gold would show an increased number of gold 
particles at small radii as compared to examples of CSR.  The example shown in 
Figure 2.4 C shows the H-function variant of Ripley’s K-function, which is normalized so 
that the expected function is 0 (Loosmore and Ford, 2006).  In the example shown in 
Figure 2.5, the experimental data from Figure 2.5.B is shown as a red line in Figure 
2.5.C and CSR is the black line at 0.  If the experimental data, red line, moves outside 
of the upper or lower envelopes, dashed lines, the data is said to deviate from random.  
In this example the data deviates at smaller radii from the upper envelope, indicating 
clustering and at larger radii drops below the envelope, indicating dispersion at larger 
distances (Figure 2.5).               
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Figure 2.5. Example Ripley’s K-Function Analysis. 
Ripley’s K-function analysis of a cerebellar PSD immunogold labeled for PSD-95.  A) 
Negative stain electron micrograph of a PSD from cerebella immunogold labeled for 
PSD-95.  B) Coordinate model for the PSD in A.  The boundary is defined by red 
points, while the gold is represented in black points.  C) H-function for example PSD.  
Simulated complete spatial randomness (black solid line) was normalized to zero and 
the Ripley’s K-function of the experimental data is shown as a red line. Non-random 
distribution was determined by whether the red line crossed either the maximum and 
minimum envelopes (dashed lines), defined by 1000 simulations of complete spatial 
randomness.  Scale bar = 100 nm. 
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2.5. Electron Tomography 
Fiducial markers were prepared by adding 125 μL of 5% BSA in HBS to 200 μL 
of 10 nm colloidal gold for 5 min at RT.  The gold was then spun at 14,000 x g for 18 
min and resuspended in 5 mM HEPES, pH 7.4.  PSDs were thawed, diluted in 5 mM 
HEPES, pH 7.4, spun down at 14,000 x g for 18 min, and resuspended in 5 mM 
HEPES buffer, pH 7.4 containing BSA coated colloidal gold as fiducial markers.  For 
negative stain tomography, 5 μL of PSDs with gold were applied to freshly glow-
discharged formvar/carbon coated copper grids (Ted Pella) for 5 min.  Grids were 
blotted, rinsed twice with 5 μL MilliQ water and stained twice with 5 μL NanoW 
(Nanoprobes), a 2% solution of methylamine tungstate.  For electron cryotomography, 
5 μL of PSDs with gold were applied to 200 mesh copper 2/2 Quantifoil grids (EMS).  
Grids were blotted by hand and plunged into liquid ethane cooled with liquid nitrogen.  
The resulting grid preparations are modeled in Figure 2.6 in order to illustrate the 
differences between dehydrated negatively stained PSD samples and the non-stained 
hydrated cryo-preserved PSD samples.  For all tomography, grids were imaged on a 
Technai F30 Polara, using FEI’s Batch Tomography software at 2x binning with a Tietz 
4K x 4K CCD.  Negatively stained PSDs were imaged at 1˚ tilt angles from -60˚ to 60˚ 
at ~10 μm defocus with a total dose less than 300 e-/Å2 and a final pixel size of 0.9215 
nm/pixel.  For cryotomography, PSDs were imaged every 2˚ from -60˚ to 60˚ between 
10 and 15 μm defocus with a total dose less than 180 e-/Å2 and a final pixel size of 
1.193 nm/pixel.  Individual PSDs were selected for tilt series collection based on gross 
morphologic criteria including diameter.   
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2.6. Tomographic Reconstruction and Image Processing 
The resulting image stacks were aligned to create three-dimensional 
reconstructions in ETomo within the IMOD suite of programs (Mastronarde, 1997) 
http://bio3d.colorado.edu/imod/.  When aligning a new tomogram in ETomo, the file 
was selected, axis defined and header scanned for information.  Missing header 
information was supplied, such as fiducial diameter, and com scripts were created.  For 
pre-processing, a fixed stack was created and viewed.  The cross correlation was then 
calculated for the fixed stack and a coarse aligned stack was created and viewed.  Next 
the fiducial model was generated, at least 10 fiducial markers around the subject of 
interest were selected, and the seed model was tracked.  Gaps in tracking were 
corrected and tracking was rerun.  The alignment was then computed and if the 
residual error mean or standard deviation were above 0.5 and 0.3, respectively, 
residual vectors were examined, corrected and alignment recomputed.  A 3x binned 
sample tomogram was created for positioning of the tomogram.  The sample tomogram 
was opened, the X and Y dimensions flipped and 3 parallel lines created to define the 
orientation of the PSD throughout the Z dimension.  Once the orientation was 
determined for the PSD, the final alignment could be created.  Then, the default cubic 
interpolation was employed for negative stain tomography, while linear interpolation 
was selected for cryotomography, to reduce noise.  The file was then binned to 1k and 
gold was erased.  Low pass two-dimensional filtering was employed for cryotomograms 
to further reduce noise; cutoff and sigma values were 0.1 and 0.05, respectively.  Once 
the full aligned stack was created, the full tomogram was generated, trimmed, pixels 
scaled and rotated around the x-axis.   
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Additional filtering steps were employed when reconstructing cryotomograms to 
increase the signal to noise ratio.  Cryotomograms are inherently noisier than negative 
stain tomography and were collected at approximately half the dose, reducing the total 
signal.  Increasing the signal to noise ratio was important for increasing the range 
between pixel intensities for buffer and protein in cryotomograms in order to calculate 
the protein-to-volume ratio of cryo-preserved PSDs.  Figure 2.6 illustrates how 
additional filtering of the same cryotomogram can significantly increase visual contrast, 
although, at the cost of losing finer detail.  Table 2.3 summarizes the average pixel 
intensity for buffer and for protein for each of the examples shown in Figure 2.6.  The 
range between the average pixel intensities for buffer and for protein significantly 
increases with additional filtering, most intensely with the addition of low pass two-
dimensional filtering (Table 2.3).  For reconstruction of cryotomograms, linear 
interpolation and low pass two-dimensional filtering with a cutoff value of 0.1 was 
selected to be a part of the standard protocol, as this provided improved signal to noise 
ratio, while still maintaining finer detail.  A description of the filtering options and 
suggested filtering conditions for tomographic reconstruction can be found online   
(http://bio3d.colorado.edu/imod/doc/tomoguide.html#Filtering2D).  
To accomplish the protein-to-volume analysis, only PSDs that were centered 
within the holes of the quantifoil grids could be used to allow for the distinction between 
protein density and surrounding buffer.  Because the PSDs had a tendency to attach to 
the carbon surface, the number of reconstructed images fitting this criterion was limited 
to 12 per group.  Amira (v 5.3.3; Visage Imaging Inc. San Diego, CA) was used to 
calculate the protein-to-volume ratios of cryo-preserved PSDs from the final 
tomographic reconstructions using the following steps.  For each individual tomogram, 
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the PSD boundary was defined in the XY dimensions every 5th slice through the z-
dimension, enclosing the voxels representing both protein and open space within the 
PSD complex, and then the program interpolated the boundary enclosing the whole 
PSD volume.  A pixel intensity threshold was then determined for each tomogram in 
order to distinguish between pixels representing protein and pixels representing buffer 
enclosed in the PSD volume.  The threshold was set as the mid-point between the 
mean buffer and mean protein pixel intensities, as determined by calculating the 
statistical mean pixel intensity for 10x10x10 voxel cubes of only buffer and of PSD 
protein material, determined through the clip stats command in 3DMOD (IMOD).  Using 
the threshold value, the voxels representing protein within the PSD boundary were 
segmented, quantified and the protein-to-volume ratio determined.  Values are reported 
as the total number of voxels above the threshold value divided by the total number of 
voxels enclosed within the PSD boundary. 
PSD thickness was determined by multiplying the number of tomographic slices 
that contained PSD protein density in the Z-dimension, determined in 3DMOD, by the 
pixel sizes of the reconstructions.  Surface areas were determined by multiplying pixel 
size by the total number of pixels within the X-Y boundary of each PSD.  The 
boundaries were set manually in ImageJ using the full projections of the tomograms 
created in 3DMOD.  Differences were considered significant if P < 0.05 in a 2-tailed t 
test. 
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Figure 2.6. Grid Preparation and Differential Filtering of a Tomographic 
Reconstruction. 
Shown for comparison in A) are cartoon models including a top down view of an EM 
grid as well as side views of both a dehydrated negatively stained PSD grid and a 
hydrated cryo-preserved PSD grid.  Included in B-D) are 10 nm cross-sections through 
the same tomographic reconstruction of a cryo-preserved cortical PSD with differential 
filtering conditions employed throughout the reconstruction process.  The 
reconstructions were identical until the creation of the final aligned stack.  The example 
in B) was filtered only with the default cubic interpolation, while C) was filtered by linear 
interpolation.  Examples D-E) were filtered by linear interpolation and low pass 2D 
filtering.  The cutoff value for 2D filtering in D) was the default value, 0.1, while the 
value employed for E) was 0.05.  Scale bar = 100 nm. 
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Image Filtering Conditions Pixel Intensity for Buffer 
Pixel Intensity 
for Protein Range 
A Default 150.3 130.4 20.7 
B Linear Interpolation 148.5 124.0 25.2 
C Linear + 2D filtering (0.1 cutoff) 147.6 106.2 41.6 
D Linear + 2D filtering (0.05 cutoff) 146.6 92.1 54.0 
 
Table 2.3.  Differential Filtering of a Tomographic Reconstruction. 
The average pixel intensity for buffer and for protein was calculated for each 
reconstruction shown in Figure 2.5, to test the effect on differential filtering on the pixel 
intensity range between protein and buffer.  This table lists the average pixel intensity 
for buffer, the average pixel intensity for protein and the difference between the two, 
termed range, for each example from Figure 2.5.  Average pixel intensity was 
determined by measuring the mean pixel intensity for the same 10x10x10 voxel cubes 
of only buffer and of mostly protein for each reconstruction.  
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Chapter 3. Isolation of Postsynaptic Densities from Adult Rat Cerebral Cortices, 
Hippocampi, and Cerebella 
3.1. Enrichment of PSDs from Brain Tissue 
PSDs have been successfully biochemically isolated from synapses for decades 
(Cotman et al., 1974, Cohen et al., 1977), providing the ability to study the three-
dimensional gross morphology of the synaptic organelle through electron microscopy 
(Cotman et al., 1974, Cohen et al., 1977, Carlin et al., 1980, Swulius et al., 2010, Fera 
et al., 2012, Swulius et al., 2012), and its protein composition through SDS-page 
(Blomberg et al., 1977, Carlin et al., 1980, Swulius et al., 2010), Western blotting 
(Petralia et al., 2005, DeGiorgis et al., 2006), immunogold labeling (Petersen et al., 
2003, DeGiorgis et al., 2006, Swulius et al., 2010) and more recently through proteomic 
approaches (Jordan et al., 2004, Li et al., 2004, Peng et al., 2004, Yoshimura et al., 
2004, Cheng et al., 2006, Dosemeci et al., 2006, Dosemeci et al., 2007).  However, 
there has not been a comprehensive comparison of morphologic structure and protein 
composition for PSDs from different brain regions.  The work presented in this 
dissertation is the first use of negative stain and cryo electron tomography to directly 
compare the three-dimensional structure of PSDs isolated from cerebella, hippocampi, 
and cerebral cortices.  It is also the first application of immunogold labeling to 
determine how the PSD protein composition and organization differs between individual 
morphologically identified PSDs from these brain regions. 
PSDs were isolated from cerebral cortices, hippocampi, and cerebella, three 
brain areas amenable to straightforward isolation with unique population of neuronal 
cells.  PSDs were isolated as described in the experimental procedures, adapted from 
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an established and widely used protocol (Cohen et al., 1977), similar to previously 
published protocols from the Waxham lab (Swulius et al., 2010, Swulius et al., 2012), 
and as briefly illustrated in Figure 3.1.  Cerebella, hippocampi, and cortices from whole 
adult rat brains were rapidly dissected and separately homogenized.  The homogenate 
fraction was refined through two low-speed centrifugations, prior to a medium-speed 
centrifugation, which produced a pellet enriched with pinched off nerve endings 
(synaptosomes) that were purified on a discontinuous sucrose gradient.  Detergent 
treatment with TX-100 and centrifugation of synaptosomes lysed the pre- and 
postsynaptic elements, leaving synaptic junctions, which are composed of the PSD and 
residual presynaptic and postsynaptic plasma membranes.  A high-speed 
centrifugation of a discontinuous sucrose gradient further refined the synaptic junction 
fraction.  A second detergent treatment with TX-100 and centrifugation removed the 
remaining synaptic membranes providing the PSD fraction, which was purified with a 
final high-speed centrifugation of a discontinuous sucrose gradient. 
Enrichment for PSDs through the steps of the isolation was monitored by 
Western blot (Figure 3.2).  Eight total micrograms of the homogenate, synaptosome, 
synaptic junction and PSD fractions from each brain region were separated by SDS-
PAGE and probed using antibodies against PSD-95 and SV2 (Figure 3.2).  PSD-95 is a 
PSD scaffold protein, which served as a marker for PSDs, while SV2 is a synaptic 
vesicle protein, which served as a presynaptic marker. As anticipated, PSD-95 
undergoes significant enrichment moving from the homogenate fraction (Hom.) to the 
PSD fraction, with a major enrichment coming at the step of synaptic junction (Syn. J.) 
enrichment (Figure 3.2).  In contrast, SV2 becomes undetectable when synaptosomes 
(Syn.) are lysed with detergent to create the synaptic junction fraction (Figure 3.2), as 
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soluble presynaptic elements have been removed.  Overall the enrichment and loss 
patterns of PSD-95 and SV2, respectively, were similar amongst the fractions from 
cerebella, hippocampi and cortices (Figure 3.2), confirming enrichment for PSD-95 rich 
material absent of presynaptic elements. 
Representative electron micrographs of negatively stained synaptic junctions 
and PSDs from cerebella, hippocampi and cortices are shown in Figure 3.3.  Negative 
stained synaptic junction fractions were lipid heavy, as expected since synaptic 
junctions are composed of the PSD and both presynaptic and postsynaptic 
membranes, and comparable to negative stain micrographs of isolated synaptic 
junctional complexes (Cotman et al., 1974, Matus and Taff-Jones, 1978) and isolated 
synaptosomal membrane fractions (Cohen et al., 1977).  Most of the protein material 
appeared to bind directly to the grid with the lipid material resting on top, as shown in 
the left column of Figure 3.3.  Synaptic junctions were circularly shaped, similar to 
isolated PSDs (right column Figure 3.3), with well-defined boundaries and diameters 
ranging from several hundred nanometers to well over a micron.  The negative stained 
PSDs appeared to attach to the carbon surface with either their cytoplasmic or synaptic 
faces, giving them a general disc shape with irregular yet well-defined boundaries like 
the examples shown in the right column of Figure 3.3.  PSDs were quite variable with 
respect to their diameters, which were typically several hundred nanometers, and 
displayed wide ranges of surface topology or texture like the examples in Figure 3.3. 
To further characterize the enrichment of PSDs from cortices, hippocampi, and 
cerebella, the protein profiles for the homogenate, synaptic junction and PSD fractions 
were compared for each brain region (Figure 3.4).  Three micrograms of total protein 
from each fraction were separated by SDS-PAGE and stained with deep purple stain; 
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the major bands in each lane are indicated with asterisks (Figure 3.4).  For all regions, 
the protein profile is similar between the homogenate and synaptic junction fractions, 
while the profile differs for the PSD fraction (Figure 3.4), similar to previous 
comparisons of SDS-PAGE protein profiles between homogenates, synaptosomes and 
PSDs from adult rat forebrain PSDs (Swulius et al., 2010) and between synaptic 
membrane fractions and PSDs from canine cortices (Blomberg et al., 1977).  The 
protein profiles are almost identical between cortical homogenate and synaptic junction 
fractions, as well as between hippocampal homogenate and synaptic junction fractions 
(Figure 3.4).  The cerebellar synaptic junction fraction contains many but not all of the 
major bands present in the cerebellar homogenate fraction (Figure 3.4).  For all brain 
regions, several of the protein bands are present in all fractions, but PSD fractions 
contain unique bands enriched from both the synaptic junction and homogenate 
fractions (Figure 3.4).  Additionally, the intensity of some of the higher molecular weight 
bands is increased in the PSD fractions; these bands may represent PSD scaffolds like 
Shank proteins, which are enriched in the PSD fraction (Tao-Cheng et al., 2010).  The 
protein patterns for the individual fractions are also similar when compared across the 
different regions, although there is some variety in the profiles of the PSD fractions 
(Figure 3.4), suggesting that PSDs from cerebella, hippocampi, and cortices have 
unique protein compositions which is consistent with previous SDS-PAGE protein 
profiles comparing cerebellar and cortical PSD fractions (Carlin et al., 1980, Cheng et 
al., 2006). 
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Figure 3.1. Isolation of Postsynaptic Densities. 
Synapses are separated from homogenized whole brain tissue through centrifugation.  
Further homogenization and centrifugation produces fractions enriched for 
synaptosomes, which when solubilized with TX-100 produces synaptic junctions, 
composed of the presynaptic and postsynaptic plasma membranes and the PSD.  
Treatment of synaptic junctions with TX-100 further solubilizes the remaining synaptic 
membranes isolated PSDs.   
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Figure 3.2. Loss of Presynaptic Elements and Enrichment of Postsynaptic Elements. 
Western blots illustrating loss of synaptic vesicle protein, SV2, and enrichment of PSD 
scaffold, PSD-95, through the isolation of PSDs from cerebella, hippocampi, and 
cortices.  SV2 loss is seen in synaptic junction (Syn. J) and PSD fractions in 
comparison to brain homogenate (Hom) and synaptosome (Syn) fractions. PSD-95 
increases significantly from homogenate to PSD fraction.  Eight micrograms of total 
protein were loaded into each lane and the secondary antibody was Alexa 488 goat 
anti-mouse (Molecular Probes). 
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Figure 3.3. Electron Micrographs of Synaptic Junctions and PSDs. 
Representative negative stain electron micrographs of synaptic junction material and 
isolated PSDs from cerebella, hippocampi, and cortices.  Scale bars = 100 nm. 
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Figure 3.4. Protein Profiles of Homogenate, Synaptosome and PSD fractions. 
Comparison of homogenate (Hom.), synaptosome (Syn,) and PSD protein profiles for 
cortical, hippocampal and cerebellar fractions, through deep purple staining of SDS-
PAGE-separated proteins. Three micrograms of total protein were loaded into each 
lane.  The major bands in each lane are indicated with asterisks.  Molecular weights 
(kDa) are indicated to the left of the gel.  Major bands were defined as bands whose 
intensities were at least twice the average band intensity within each sample as 
measured in ImageQuant. 
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3.2. Gross Morphology of Isolated PSDs from Negative Stain Micrographs 
For initial morphologic descriptions, isolated PSDs from each region were 
loaded onto glow discharged carbon formvar copper grids, stained with methylamine 
tungstate and then electron micrographs were collected.  Low magnification 
micrographs shown in Figures 3.5-3.7 are representative fields of isolated PSDs from 
each region.  Figure 3.5 is a low magnification micrograph of a typical field of negatively 
stained isolated cortical PSDs and three cortical PSDs, which are highlighted with 
arrows.  Cortical preparations typically produced the best yield of isolated PSDs and 
this is well represented in Figure 3.5, as there is a high density of PSDs relative to the 
other regions.  Detergent resistant lipids, described in more detail in Chapter 4, are also 
visible in the micrograph and the variability in PSD size is evident (Figure 3.5).  Figure 
3.6 is a low magnification micrograph of a field of negatively stained isolated 
hippocampal PSDs.  The density of hippocampal PSDs is not as high as cortical PSDs, 
but this is representative of typical hippocampal PSD yields.  Two well-defined 
hippocampal PSDs are highlighted with arrows (Figure 3.6).  The filament in the top left 
of Figure 3.6 should be noted, as filaments are often seen in the PSD enriched fraction; 
it is likely the filament is composed of neurofilament proteins, which are known 
contaminants in PSD enriched fractions (Peng et al., 2004, Cheng et al., 2006, 
Dosemeci et al., 2006).  Figure 3.7 is a low magnification micrograph of a field of 
isolated and negatively stained cerebellar PSDs.  The density of cerebellar PSDs is 
more comparable to that of hippocampal PSDs and three well-defined cerebellar PSDs 
are highlighted with arrows (Figure 3.7). 
Figures 3.5-3.7 also highlight the range of negative staining that naturally results 
from the staining protocol.  The high density of material on the cortical PSD grid 
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plausibly helped to pool the stain providing sufficient and fairly even contrast between 
protein and the carbon background (Figure 3.5).  The image in Figure 3.6, which has 
less PSD material on the grid, has areas of thicker stain around lipid and protein 
materials, like the highlighted hippocampal PSDs.  Figure 3.7 is an example more 
similar to positive staining, where the protein is stained as opposed to the background, 
leaving the PSDs darker, or more electron dense, than the carbon surface. 
Individual micrographs were collected of well-stained isolated PSDs from each 
region to assess the gross morphology of the different PSDs.  Representative 
examples of individual PSDs from each region, imaged at high magnification, are 
shown in Figures 3.8-3.10.  Figure 3.8 includes nine examples of cortical PSDs, and 
Figures 3.9 and 3.10 each include nine examples of hippocampal and cerebellar PSDs, 
respectively.  From the negative stain micrographs collected and analyzed, cortical 
PSDs can be described as enormous protein complexes that are roughly disc-shaped.  
They had well-defined edges that were typically irregular in shape as seen in Figure 
3.8.  Cortical PSDs also varied greatly in diameter, as seen in Figure 3.8, where PSD 
diameters ranged from approximately 400 nm to a micron.  Lipids were also often seen 
on and around individual PSDs and appeared attached to the protein density.  Three 
PSDs in Figure 3.8 have intact detergent resistant lipid membranes clearly visible and 
the other PSDs appear to have remnants of lipid material.  Texturally cortical PSDs 
were very similar amongst each other, composed of finely packed proteins forming a 
topology of ridges and valleys; ridges of lightly stained protein and dark valleys lacking 
in protein density, where stain has pooled. 
Hippocampal PSDs were morphologically similar to cortical PSDs.  Hippocampal 
PSDs, like the representative examples in Figure 3.9, were generally disc-shaped, with 
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irregular boundaries, some better defined than others.  The hippocampal PSD in the 
middle of the bottom row and the example in the bottom right corner of Figure 3.9 have 
boundaries that are not as well-defined as the other examples.  The example in the 
bottom right corner also has filaments near the upper left edge of the PSD, although it’s 
unclear whether the filaments are interacting with the PSD from this example as they 
could have separately bound to the carbon surface of the grid.  The diameter of 
hippocampal PSDs also greatly varied and the examples in Figure 3.9 range from 
approximately 400 nm to over a micron, similar to the cortical PSDs in Figure 3.8.  
Hippocampal PSDs also appear to have lipid membranes attached to the protein 
density and Figure 3.9 includes several PSDs with large lipid membranes, several with 
smaller lipid structures and two examples of what seems to be lipid remnants.  
Texturally hippocampal PSDs were also similar to cortical PSDs in that they appeared 
to be composed of finely compacted proteins organized into ridges of protein and 
valleys absent of protein where stain pooled, however, some of the material within 
hippocampal PSDs was not as crisp or finely resolved as in cortical PSDs.  This could 
be due to the particular staining of the grids or perhaps some hippocampal PSDs have 
more lipid within their structure, which does not image as crisp as protein. 
The texture of cerebellar PSDs ranged significantly; some cerebellar PSDs were 
composed of finely packed and crisply defined protein organized into ridges and 
valleys, although the areas absent of protein appeared smaller on average in cerebellar 
PSDs, like the representative cerebellar PSDs in the middle position of the top row and 
the left and right columns of the middle row in Figure 3.10.  Some cerebellar PSDs, like 
the examples in left column of the top and bottom rows and the right column of the 
bottom row of Figure 3.10, were more cloudy in appearance, or not as crisp as others 
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and these structures appeared to have larger valleys or areas lacking in protein 
density, than the finer pack and more crisply imaged cerebellar PSDs, which more 
closely resembled hippocampal and cortical PSDs.  Cerebellar PSDs were still 
generally describable as disc-shaped protein densities with irregularly shaped 
boundaries, which appeared to not be as well-defined as and more irregular than both 
hippocampal and cortical PSDs.  Similar to hippocampal and cortical PSDs, lipids were 
often seen bound to cerebellar PSDs and the diameter of cerebellar PSDs was also 
quite variable, with the examples in Figure 3.10 ranging from 400 nm to over a micron. 
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Figure 3.5. Low Magnification Micrograph of Negatively Stained Cortical PSDs. 
Low magnification micrograph showing a typical field of isolated negatively stained 
cortical PSDs.  Three well-defined cortical PSDs are highlighted with arrows.  Scale bar 
= 1 μm. 
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Figure 3.6. Low Magnification Micrograph of Negatively Stained Hippocampal PSDs. 
Low magnification micrograph showing a typical field of isolated negatively stained 
hippocampal PSDs.  Two well-defined hippocampal PSDs are highlighted with arrows.  
Scale bar = 1 μm. 
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Figure 3.7. Low Magnification Micrograph of Negatively Stained Cerebellar PSDs. 
Low magnification micrograph showing a typical field of isolated negatively stained 
cerebellar PSDs.  Three well-defined cortical PSDs are highlighted with arrows.  Scale 
bar = 1 μm. 
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Figure 3.8. High Magnification Micrographs of Negatively Stained Cortical PSDs. 
High magnification negative stain micrographs of representative isolated cortical PSDs.  
Scale bar = 100 nm. 
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Figure 3.9. High Magnification Micrographs of Negatively Stained Hippocampal PSDs. 
High magnification negative stain micrographs of representative isolated hippocampal 
PSDs.  Scale bar = 100 nm. 
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Figure 3.10. High Magnification Micrographs of Negatively Stained Cerebellar PSDs. 
High magnification negative stain micrographs of representative isolated cerebellar 
PSDs.  Scale bar = 100 nm. 
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3.3. Surface Area of Isolated PSDs from Negative Stain Micrographs 
Qualitative similarities and differences in gross morphologic characteristics were 
observed across PSDs from cortices, hippocampi, and cerebella, as well as within each 
PSD group.  Most notable was the less densely packed protein arrangement in some 
cerebellar PSDs relative to those from either hippocampi or cortices (Figures 3.8-3.10). 
The detailed morphological characteristics as determined by electron tomography are 
described in Chapter 4, but a quantitative assessment of the relative surface area of 
PSDs was first accomplished by analyzing 120 randomly chosen PSDs from each 
preparation.  Histograms of the binned surface areas (Figure 3.11) provide an 
assessment of the size distribution amongst PSDs and show the mode to be 
approximately 0.2 μm2 for all PSD types, similar to the peak surface area of 0.15 μm2 
reported previously for PSDs isolated from adult rat forebrains, which contained PSDs 
from both the cerebral cortices and hippocampi (Swulius et al., 2010).  The mean 
surface area of PSDs from cerebella, hippocampi and cortices were determined to be 
0.37, 0.34 and 0.35 μm2 (all ± 0.02 μm2), respectively and were not significantly 
different from each other. 
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Figure 3.11. Distribution of PSD Surface Areas.  
Histograms depicting surface area distribution for PSDs isolated from cerebella, 
hippocampi and cortices.  The peak for all PSD types was approximately 0.2 μm2. 
 
 
 64 
 
Chapter 4. Morphology of Postsynaptic Densities from Adult Rat Cerebella, 
Hippocampi, and Cerebral Cortices  
4.1. Morphology of Isolated PSDs from Negative Stain Electron Tomography  
Due to its potential to produce relatively high-resolution three-dimensional 
structural information, electron tomography is currently the best imaging option to 
reveal morphological details of individual macromolecular complexes like the PSD 
(Murphy and Jensen, 2007).  Using this technique, a detailed comparative anatomical 
analysis of PSDs isolated from cerebella, hippocampi and cortices was accomplished 
using both negative stain and cryo electron tomography.  Negative stain electron 
tomography provides increased contrast making visualization easier; however the 
application of stain and dehydration of the sample may distort the structure.  These 
distortions are not a limitation with cryo electron tomography and the unique strengths 
of both of these techniques were utilized for the structural morphologic analysis.  These 
distinct PSD preparations are modeled in Figure 2.6.  A total of 49 tilt series of 
cerebellar PSDs (29 negative stained and 20 cryo-preserved), 37 of hippocampal PSDs 
(12 negative stained and 25 cryo-preserved) and 59 of cortical PSDs (14 negative 
stained and 45 cryo-preserved) were reconstructed for morphological and quantitative 
analyses.  
Tilts series of negatively stained isolated PSDs from each region were collected 
and reconstructed in order to obtain higher resolution detail of the three-dimensional 
structure of each PSD.  In Figure 4.1, full projection images of negatively stained PSDs 
from cerebral cortices, hippocampi, and cerebella are shown and compared to 10 nm 
cross-sections through the center of the final tomographic reconstructions for the same 
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PSDs to demonstrate the increased resolution available from the tomographic 
reconstructions.   
From negative stain tomographic reconstructions, cortical PSDs were roughly 
disc-shaped, with well-defined boundaries as shown in the cross-sections through final 
tomographic reconstructions in Figure 4.2, consistent with the negative stain 
micrographs described in Chapter 3.  It was also easily visible from the high contrast 
cross-sections that cortical PSDs were composed of tightly packed protein with few 
areas of low or absent protein density.  In the representative examples in Figure 4.2 
areas of dense protein packing are highlighted with black horizontal arrows and several 
examples of low protein density are indicated with black vertical arrows.  As noted from 
the negative stain micrographs in Chapter 3, another prominent ultrastructural 
component was the presence of detergent resistant lipids intimately attached to the 
protein density of cortical PSDs, as seen in two of the tomographic examples in Figure 
4.2.  The lipids were well integrated into the PSD protein density around the PSD 
edges, as seen in Figure 4.2, and within the PSD volume as shown in the close-up 
cross-section of the cortical PSD in the right panel of Figure 4.7.  Protein particles were 
often associated with the detergent resistant lipids membranes as in the tomographic 
cross-section through a cortical PSD shown in Figure 4.1. 
  From close-up views of the tomographic cross-sections, like shown in Figure 
4.7, it was evident that cortical PSDs were composed of a variety of globular and 
filamentous proteins, highlighted by white vertical and horizontal arrows, respectively.  
Many of the globular proteins within cortical PSDs resembled the structure of CaMKII, 
which is barrel shaped and approximately 20 nm in diameter and height (Kolodziej et 
al., 2000, Swulius and Waxham, 2008).  This was expected as CaMKII is the most 
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abundant protein in cortical PSDs (Dosemeci et al., 2007) and CaMKII has previously 
been identified in tomographic reconstructions of isolated PSDs (Fera et al., 2012, 
Swulius et al., 2012) through comparison with three-dimensional electron microscopic 
structures of purified CaMKII (Kolodziej et al., 2000, Gaertner et al., 2004a).         
Negative stain tomographic reconstructions, like the examples shown in Figure 
4.3, showed that hippocampal PSDs exhibited similar morphology to cortical PSDs.  
Hippocampal PSDs were disc-like in shape with irregular well-defined edges and were 
also composed of densely packed proteins with sparse areas absent of protein density 
(Figure 4.3).  Black horizontal and vertical arrows highlight regions of tightly packed 
protein and areas of low protein density, respectively, within tomographic cross-
sections of hippocampal PSDs. Figure 4.3 also shows examples of detergent lipid 
membranes (white asterisks) which were connected to proteins both on the edges and 
interior of PSDs.  All of the lipid membranes associated with hippocampal PSDs in the 
negative stain tomographic reconstructions appeared to be studded with protein, as 
evident in Figure 4.3, similar to the cortical PSD in Figure 4.1.  Also similar to cortical 
PSDs, hippocampal PSDs were composed of a combination of globular and 
filamentous proteins, as shown in Figure 4.7 where globular CaMKII-like proteins, 
easily visible within the tomographic reconstruction, are indicated with white vertical 
arrows and filamentous proteins are highlighted with white horizontal arrows. 
In contrast to the relatively consistent architecture of cortical and hippocampal 
PSDs, three distinct morphological classes of PSDs isolated from cerebella were 
identified (Figures 4.4-4.6).  Figure 4.4 includes three representative cross-sections 
through cerebellar PSDs that exhibit mostly densely packed protein with small areas 
absent of protein that closely resembles the morphology of cortical and hippocampal 
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PSDs.  This type of dense cerebellar PSD was also disc-like with distinct protein 
boundaries (Figure 4.4) and had lipids associated with the protein density, as indicated 
with asterisks in Figure 4.4 and Figure 4.7.   
Other cerebellar PSDs were identified that exhibited a more granular protein 
substructure (Figure 4.5) or a latticelike substructure (Figure 4.6), both which appeared 
to have smaller areas of dense protein packing.  The granular-like cerebellar PSDs 
lacked larger regions of dense protein and instead had smaller regions of protein 
clusters about 40 nm in diameter with areas of low protein density between clusters 
(Figure 4.5), but were disc-shaped with distinct edges, similar to cortical, hippocampal 
and dense cerebellar PSDs.  Three representative cross-sections through final 
tomographic reconstructions of granular cerebellar PSDs are shown in Figure 4.5, 
where black horizontal arrows highlight several small areas of protein clustering, black 
vertical arrows indicate areas lacking protein density and an asterisk highlights lipid 
material associated with one of the PSDs.  The lacier cerebellar PSDs had a latticelike 
structure, with distinct filamentous proteins connecting regions of protein density 
(Figure 4.6).  There also appeared to be significantly less protein density, evident as 
increased areas absent of protein density within the PSD boundaries, as highlighted by 
black vertical arrows within the representative tomographic cross-sections shown in 
Figure 4.6.  The latticelike cerebellar PSDs were also roughly disc-shaped but in 
contrast to other PSD types their edges were more web-like, lacking a distinct 
boundary or perimeter. 
In contrast to these larger scale differences, close examination of the fine 
structural details of PSDs isolated from cerebella indicated that they were all comprised 
of small filamentous and globular proteins (Figure 4.7), similar to hippocampal and 
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cortical PSDs.  The larger scale differences for all PSD morphologies appeared to arise 
from the ratio and packing density of these smaller substructures as in the examples 
shown in Figure 4.7.  Globular proteins resembling the structure of CaMKII were also 
evident in all cerebellar PSDs and examples are highlighted with white vertical arrows 
within a representative tomographic reconstruction for each cerebellar PSD 
morphologic class (Figure 4.7). 
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Figure 4.1. Negative Stain Tomographic Reconstructions of PSDs Isolated from Adult 
Rat Cortices, Hippocampi, and Cerebella.  
Full projections of entire reconstructions are shown in the left panel while 10 nm cross-
sections through the center of reconstructions are shown in the right panel for 
comparison.  Gold is used as a fiducial marker to align image series during 
reconstruction.  Scale bar = 100 nm. 
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Figure 4.2. Tomographic Reconstructions of Negatively Stained Cortical PSDs. 
Ten-nanometer cross-sections through final tomographic reconstruction of negatively 
stained cortical PSDs.  Horizontal arrows indicate areas of dense protein, vertical 
arrows indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm. 
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Figure 4.3. Tomographic Reconstructions of Negatively Stained Hippocampal PSDs. 
Ten-nanometer cross-sections through final tomographic reconstruction of negatively 
stained hippocampal PSDs. Horizontal arrows indicate areas of dense protein, vertical 
arrows indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm. 
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Figure 4.4. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with 
Dense Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of negatively 
stained cerebellar PSDs categorized as dense in morphology, similar to cortical and 
hippocampal PSDs.  Horizontal arrows indicate areas of dense protein, vertical arrows 
indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm. 
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Figure 4.5. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with 
Granular Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of negatively 
stained cerebellar PSDs categorized as granular in morphology.  Horizontal arrows 
indicate small areas of dense protein, approximately 40 nm in diameter, vertical arrows 
indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm. 
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Figure 4.6. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with 
Lacy Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of negatively 
stained cerebellar PSDs categorized as lacy in morphology.  Vertical arrows indicate 
areas without protein density and asterisks highlight detergent resistant membranes 
attached to the PSDs.  Gold is used as a fiducial marker to align image series during 
reconstruction.  Scale bar = 100 nm. 
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Figure 4.7.  Fine Morphology of Isolated PSDs from Negative Stain Tomographic 
Reconstructions. 
Ten-nanometer cross-sections through final tomographic reconstruction of 
negatively stained PSDs.  The panels include the different morphologies observed 
among A) cortical, B) hippocampal, and C-D) cerebellar PSDs.  Enlargements of each 
image are included, respectively, in the right column of panels illustrating the finer 
structural features of isolated PSDs.  All PSDs were composed of filamentous and 
globular proteins, indicated with white horizontal and vertical arrows, respectively.  Gold 
is used as a fiducial marker to align image series during reconstruction.  Scale bar = 
100 nm. 
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4.2. Morphology of Isolated PSDs from Cryo Electron Tomography 
Tilt series were also collected for cryo-preserved PSDs from each region in 
order to assess their morphological structure without dehydration and negative stain.  
Since the PSDs were preserved in vitreous ice, rather than negatively stained, the 
contrast is reversed from the negative stain tomographic reconstruction and protein 
density is represented by darker voxel intensity in the final tomographic 
reconstructions, like the cross-sections shown in Figures 4.8-4.12.  The morphology of 
PSDs as determined by cryo electron tomography confirmed and extended the findings 
from negative stain electron tomography.   
Cortical PSDs were disc-like in shape with distinctive edges defining the protein 
density, and were composed of densely packed protein with occasional areas absent of 
protein, as shown in the representative cross-sections in Figure 4.8.  Cortical PSDs 
also had lipid-structures attached to the protein density (Figure 4.8), as seen in the 
negative stain tomographic reconstructions (Figure 4.2).  Figure 4.8 nicely illustrates 
the variable size of the associated lipids, indicated with asterisks, present within cortical 
PSDs.  Hippocampal PSDs were morphologically similar to cortical PSDs, confirming 
the results from the negative stain tomography.  As Figure 4.9 illustrates, hippocampal 
PSDs had well-defined boundaries and irregular but disc-like perimeters and were 
composed of dense layers of proteins with holes in the density as highlighted by 
vertical arrows.  Detergent resistant lipids were also associated with the cryo-preserved 
hippocampal PSDs (Figure 4.9).  It was also evident from the morphological analysis of 
cryo-preserved cerebellar PSDs that three separate classes of cerebellar PSDs existed 
with respect to protein texture or protein packing (Figures 4.10-4.12).  The dense 
cerebellar PSDs, as shown in Figure 4.10, were also composed of large regions of 
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densely packed protein, with the occasional area absent of protein density within their 
well-defined perimeter, similar to the dense cerebellar PSDs from negative stain 
tomographic reconstructions (Figure 4.4).  The cryo-preserved granular cerebellar 
PSDs (Figure 4.11) were also morphologically the same as the granular cerebellar 
PSDs imaged by negative stain electron tomography (Figure 4.5), lacking the larger 
regions of dense proteins which comprise cortical, hippocampal, and dense cerebellar 
PSDs and were instead composed of smaller areas of protein approximately 40 nm in 
diameter.  These small protein granules are well represented in the example cross-
sections through final tomographic reconstructions of cryo-preserved granular 
cerebellar PSDs shown in Figure 4.11, and several are highlighted with horizontal 
arrows.  Three representative cross-sections through cryo-preserved lacy cerebellar 
PSDs are included in Figure 4.12.  In these cross-sections, the latticelike structure is 
evident as filamentous proteins connecting much larger regions of densely packed 
protein, just as described from the negative stain tomographic examples (Figure 4.6).  
Lipid-like material was also associated with cryo-preserved cerebellar PSDs from all 
three morphologic classes, and examples of these are indicated with asterisks in 
Figures 4.10-4.12.  
In total, dense cerebellar PSDs (Figures 4.4 and 4.10) represented 20 of 49 
(41%) of the cerebellar PSDs analyzed by both negative stain and cryo electron 
tomography.  Granular cerebellar PSDs (Figures 4.5 and 4.11) represented 12 of 49 
(24%) of cerebellar PSDs, and 17 of 49 (35%) cerebellar PSDs were classified as 
latticelike in morphology (Figures 4.6 and 4.12).  Cerebellar PSDs have previously 
been described as lacy or latticelike and it was postulated that they were from inhibitory 
synapses rather than excitatory synapses (Carlin et al., 1980).  However, the results of 
 78 
 
my immunogold labeling experiments, discussed further in Chapter 5, suggest that the 
PSDs isolated and described in this dissertation were only from excitatory synapses.  
Additionally, not all of the cerebellar PSDs isolated were lacy in morphology, 
suggesting isolation of differential PSD populations.  
The presence of lipid-like structures obvious in the reconstructions was also 
quantified for each of the PSD types, from both the negative stain and cryo 
tomographic reconstructions.  Lipids were associated with 78% (46 of 59) of cortical 
PSDs, while hippocampal PSDs had lipid present in 62% (21 of 37) and cerebellar 
PSDs in 63% (31 of 49).  Within the cerebellar PSD group, lipid membrane structures 
were associated with 60% (12 of 20) of the dense cerebellar PSDs, 50% (6 of 12) of 
the granular cerebellar PSDs and 76% (13 of 17) of the lacy cerebellar PSDs.  Lipid-
like structures associated with PSDs have been described in previous publications 
(Cohen et al., 1977, Matus and Taff-Jones, 1978, Swulius et al., 2010, Swulius et al., 
2012) and are hypothesized to be lipid raft-like (Suzuki et al., 2001, Swulius et al., 
2012) as they are composed of raft-associated lipid GM1 in forebrain PSDs (Swulius et 
al., 2012).    
 
4.3. Protein-to-Volume Ratios of Isolated PSDs  
From the visual assessment of PSD morphology described above from both 
negative stain and cryo electron tomography, differences were evident in the packing 
density of structures within different cerebellar PSDs.  Therefore subsets of cryo-
preserved PSDs were chosen for analysis of protein-to-volume ratios, a measure of 
PSD protein occupancy, in the absence of stain/dehydration artifacts.  Twelve 
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cryotomograms of PSDs from each region were selected for analysis and protein-to-
volume ratios were calculated as described in the methodology, Chapter 2 section 2.6, 
and the results are shown in a whisker plot in Figure 4.13.  The protein-to-volume 
ratios, which were calculated by taking the number of voxels representing protein and 
dividing by the total voxels within each PSD boundary, were more variable for cortical 
PSDs with a range from 0.19 to 0.53, than for hippocampal PSDs which ranged from 
just over 0.2 to 0.34 (Figure 4.13).  As expected, cerebellar PSDs had the largest range 
of protein-to-volume ratios, ranging from 0.15 to over 0.5, and uniquely half (6 of 12) of 
the PSDs evaluated clustered near a protein-to-volume ratio of 0.175 while the others 
cerebellar PSDs ranged from approximately 0.25 to just over 0.5 (Figure 4.13).  This 
suggests that a distinct group of less dense cerebellar PSDs existed with respect to 
protein volume, and consistent with the visual observations, the lower protein-to-
volume ratios corresponded to the lacy cerebellar PSDs.  Most hippocampal PSDs 
clustered around a protein-to-volume ratio of 0.325, while most cortical PSDs clustered 
around a ratio of 0.35 (Figure 4.13), and this was well represented by the calculated 
average protein-to-volume ratios, as reported in Table 4.2.  Figure 4.13 also includes a 
surface rendering of a representative cryo-preserved hippocampal PSD to illustrate a 
PSD with a typical protein-to-volume ratio.  Overall, the mean protein-to-volume ratios 
for cerebellar, hippocampal, and cortical PSDs were 0.29 ± 0.04, 0.31 ± 0.01, and 0.35 
± 0.03, respectively but did not reach statistically significant differences (Table 4.2). 
 
4.4. PSD Thickness from Tomographic Reconstructions 
Average PSD thickness and surface area were also calculated for the same 12 
cryo-preserved PSDs to assess PSD size in the absence of dehydration and staining 
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(Table 4.1).  The mean surface areas were 0.24 ± 0.04 μm2, 0.28 ± 0.04 μm2, and 0.27 
± 0.06 μm2 for cryo-preserved cerebellar, hippocampal and cortical PSDs, respectively 
(Table 4.1).  These values were not statistically different from each other and were well 
within the distribution of surface areas measured from negative stain micrographs 
(Figure 3.11).  The mean thickness of cryo-preserved hippocampal PSDs was 
calculated to be 112 ± 9 nm and was statistically different than both cryo-preserved 
cortical and cerebellar PSDs, which had mean thicknesses of 169 ± 22 nm and 210 ± 
13 nm, respectively (Table 4.2).  This finding cannot be ascribed to differences in the 
isolation procedure as the samples from all three regions were processed 
simultaneously and were imaged under identical conditions, suggesting that cortical 
and cerebellar PSDs are significantly thicker than hippocampal PSDs.  However, these 
thicknesses are significantly larger than historically reported for PSDs (Cohen et al., 
1977, Carlin et al., 1980, Harris et al., 1992), and it is plausible that the discrepancy in 
PSD thickness could be the result of the negative stain and dehydration employed in 
the earlier studies. 
For a direct comparison, I measured the thickness and surface area of PSDs 
from negative stain tomographic reconstructions using the identical procedure to that 
described for the cryo-preserved PSDs, and the values are reported in comparison to 
the measurements of cryo-preserved PSDs in Table 4.2.  The mean surface areas 
calculated for the PSDs imaged by negative stain tomography were statistically the 
same as the average surface areas for cryo-preserved PSDs (Table 4.2), suggesting 
that dehydration and stain do not significantly affect PSD surface area.  In contrast, the 
mean thicknesses for negatively stained cerebellar and cortical PSDs (115 ± 11 nm 
and 94 ± 5 nm, respectively, were significantly thinner, approximately 2-fold, than for 
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cryo-preserved PSDs from the same brain regions (210 ± 13 nm and 169 ± 22 nm, 
respectively) (Table 4.2).  However, negatively stained hippocampal PSDs had a mean 
thickness of 94 ± 7 nm, which was not statistically different than cryo-preserved 
hippocampal PSDs (112 ± 9 nm) (Table 4.2).  These results provide evidence that the 
application of stain and dehydration causes collapse of cortical and cerebellar PSDs 
along their Z dimension, and that PSDs from these brain regions are significantly 
thicker than hippocampal PSDs, extending further into the synaptic compartment.  The 
impact of dehydration and stain on hippocampal PSDs was not significant, suggesting 
that the molecular organization of hippocampal PSDs prevents the structure from 
collapsing under negative stain conditions.  
Morphologic analysis of PSDs by negative stain and cryo electron tomography 
established that there were significant differences in PSD morphology among 
cerebellar PSDs and in the variability of protein-to-volume ratios between PSD types, 
as well as in PSD thickness.  The described differences in PSD structure were believed 
to be most likely due to differences in the molecular composition of the PSDs from the 
different brain regions.  In fact, proteomic approaches already provided evidence to 
support this conclusion (Cheng et al., 2006).  To directly assess whether PSD protein 
composition and organization of specific proteins within individual PSDs was different 
for PSDs from each region, immunogold labeling and EM localization was employed, 
using antibodies to different functional classes of PSD associated proteins and is 
discussed in Chapter 5. 
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Figure 4.8. Tomographic Reconstructions of Cryo-Preserved Cortical PSDs. 
Ten-nanometer cross-sections through final tomographic reconstruction of cryo-
preserved cortical PSDs.  Horizontal arrows indicate areas of dense protein, vertical 
arrows indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm. 
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Figure 4.9. Tomographic Reconstructions of Cryo-Preserved Hippocampal PSDs. 
Ten-nanometer cross-sections through final tomographic reconstruction of cryo-
preserved hippocampal PSDs. Horizontal arrows indicate areas of dense protein, 
vertical arrows indicate areas without protein density and asterisks highlight detergent 
resistant membranes attached to the PSDs.  Gold is used as a fiducial marker to align 
image series during reconstruction.  Scale bar = 100 nm.  
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Figure 4.10. Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with 
Dense Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of cryo-
preserved cerebellar PSDs categorized as dense in morphology, similar to cortical and 
hippocampal PSDs.  Horizontal arrows indicate areas of dense protein, vertical arrows 
indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm.  
 85 
 
 
Figure 4.11. Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with 
Granular Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of cryo-
preserved cerebellar PSDs categorized as granular in morphology.  Horizontal arrows 
indicate small areas of dense protein, approximately 40 nm in diameter, vertical arrows 
indicate areas without protein density and asterisks highlight detergent resistant 
membranes attached to the PSDs.  Gold is used as a fiducial marker to align image 
series during reconstruction.  Scale bar = 100 nm.  
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Figure 4.12.  Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with 
Lacy Morphology. 
Ten-nanometer cross-sections through final tomographic reconstruction of cryo-
preserved cerebellar PSDs categorized as lacy in morphology.  Vertical arrows indicate 
areas without protein density and asterisks highlight detergent resistant membranes 
attached to the PSDs.  Gold is used as a fiducial marker to align image series during 
reconstruction.  Scale bar = 100 nm.  
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Figure 4.13. PSD Protein-to-Volume Ratios Measured from Cryo Tomographic 
Reconstructions. 
A) Histogram of protein-to-volume ratios for PSDs isolated from each region as 
measured from tomographic reconstructions of cryo-preserved PSDs.  N = 12.  B)  
Surface rendering of representative cryo-preserved hippocampal PSD created in 
Amira. Scale bar = 100 nm.  
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Surface Area ± SEM (μm2) Thickness ± SEM (nm) P-to-V Ratio ± SEM 
Cerebellar PSDs 0.24 ± 0.04 210 ± 13 0.29 ± 0.04 
Hippocampal PSDs 0.28 ± 0.04 112 ± 9 0.31 ± 0.01 
Cortical PSDs 0.27 ± 0.06 169 ± 22 0.35 ± 0.03 
 
Table 4.1. PSD Surface Area, Thickness and Protein-to-Volume Ratio Measured from 
Cryo Tomographic Reconstructions.  
Surface Area, Thickness and PSD Protein-to-Volume Ratios (P-to-V) for PSDs isolated 
from each region as measured from tomographic reconstructions of cryo-preserved 
PSDs.  N = 12. 
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  Surface Area ± SEM (μm2) 
  Cryo-Preserved Negative Stain 
Cerebellar PSDs 0.24 ± 0.04 0.32 ± 0.09 
Hippocampal PSDs 0.28 ± 0.04 0.21 ± 0.04 
Cortical PSDs 0.27 ± 0.06 0.37 ± 0.06 
      
  Thickness ± SEM (nm) 
  Cryo-Preserved Negative Stain 
Cerebellar PSDs 210 ± 13 115 ± 11 
Hippocampal PSDs 112 ± 9 94 ± 7 
Cortical PSDs 169 ± 22 93 ± 5 
 
Table 4.2. PSD Surface Area and Thickness Compared from Cryo and Negative Stain 
Tomographic Reconstructions.  
Surface area and thickness for PSDs isolated from each region as measured from 
tomographic reconstructions of cryo-preserved and negatively stained PSDs.  N = 12. 
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Chapter 5. Protein Composition of Postsynaptic Densities from Adult Rat 
Cerebella, Hippocampi, and Cerebral Cortices  
5.1. PSD Protein Staining Patterns 
In order to determine whether PSD protein composition differs across the brain, 
the global protein staining pattern was first compared between PSDs isolated from 
adult rat cortices, hippocampi, and cerebella.  PSD fractions from each region were 
separated by SDS-PAGE and stained using Amersham Deep Purple Stain (GE 
Healthcare) following SDS-PAGE (Figure 5.1).  The PSD protein profiles exhibit similar 
overall staining patterns; however, there were specific differences in band intensity 
between the PSD types, confirming that PSD protein composition does vary across the 
brain.  In Figure 5.1, the protein bands whose intensities were at least twice the 
average band intensity within each sample were considered major bands and are 
identified with asterisks.  A band just above 250 kDa is highlighted for all PSD types, 
while a band at approximately 100 kDa is only highlighted in cortical and hippocampal 
PSDs.  The band above 250 kDa could represent Shank scaffolds which are typically 
between 190 kDa and 220 kDa, while the band around 100 kDa could represent 
scaffold PSD-95, which is abundant in cortical (Cheng et al., 2006) and hippocampal 
PSDs (Dosemeci et al., 2007).  The band at approximately 100 kDa is present in the 
cerebellar PSD fraction; however it was not determined to be a major band within the 
cerebellar PSD fraction.  Cortical and hippocampal PSDs share an additional intense 
band highlighted at 45 kDa, which is the approximate molecular weight of PSD scaffold 
Homer.  There are also unique and intensely stained bands within each individual 
sample; 70 kDa in cortical PSDs, 50 kDa in hippocampal PSDs, and 27 kDa and 47 
kDa in cerebellar PSDs.  These results confirm previous studies which have shown 
 91 
 
compositional differences in PSD fractions from different brain regions identifiable by 
SDS-PAGE (Carlin et al., 1980) and are consistent with more recent proteomic 
approaches (Cheng et al., 2006).  These approaches have been successful in 
determining and quantifying the protein composition of PSD fractions, but not of 
individual PSDs, which as described before are unique heterogeneous structures. 
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Figure 5.1. Comparison of Isolated PSD Protein Profiles.  
 
Amersham Deep Purple stained gel of SDS-PAGE-separated proteins from PSDs 
isolated from cortices, hippocampi, and cerebella.  The major bands in each lane are 
indicated with asterisks and molecular weights (kDa) are indicated to the left of the gel. 
Three micrograms of total protein were loaded into each lane. 
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5.2. Immunogold Labeling of Major PSD Proteins 
To further refine our understanding of PSD composition and structure, and to 
determine how PSD protein composition and organization differ across the brain, 
immunogold labeling was employed.  Immunogold labeling, described in detail in 
Chapter 2.4, combines antibody specific identification of proteins and electron 
microscopy through the use of electron dense gold-conjugated secondary antibodies.  
Briefly, PSDs are applied to grids, proteins of interest are tagged with a protein specific 
primary antibody and gold-conjugated secondary antibody, PSD are then negatively 
stained and individually imaged.  From the resulting micrographs I can measure the 
labeling density and distribution for the protein of interest and determine if there are 
differences across and within PSD groups.  Three distinct protein classes were 
investigated: scaffolds, signaling proteins, and neurotransmitter receptors and the 
results are described in the following sections.  Representative examples of the primary 
data generated from the immunogold labeling protocol are shown in Figures 5.2-5.6.   
The first group of proteins targeted through immunogold labeling were PSD 
scaffolds, which form the core structure of the PSD and serve to anchor 
neurotransmitter receptors and organize signaling proteins (Okabe, 2007).  Antibodies 
against eight major PSD scaffolds were employed, including α-actinin, actin, PSD-95, 
Homer, SAP102, Shank1, Shank2, and Shank3 to test whether the composition and 
organization of the PSD scaffold network differs across brain regions.  PSDs isolated 
from cerebella, hippocampi, and cortices immunogold labeled for scaffolds α-actinin, 
actin, PSD-95, and Homer are shown in Figure 5.2.  PSDs labeled for additional 
scaffolds SAP102, Shank1, Shank2, and Shank3 are shown in Figure 5.3.  
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The second group of proteins targeted in immunogold labeling experiments 
included calcium signaling proteins αCaMKII, βCaMKII, and calmodulin, CaM.  CaM is 
the calcium-transducing molecule of the synapse, which has many targets including 
αCaMKII and βCaMKII.  The αCaMKII and βCaMKII isoforms of CaMKII are the 
neuronal isoforms of the protein, which when activated phosphorylate a variety of 
synaptic and PSD proteins (Dosemeci and Jaffe) and are crucial for learning and 
memory (Lisman et al., 2012).  βCaMKII also binds both monomeric and F-actin, 
regulating actin polymerization in response to calcium influxes.  This suggests that 
βCaMKII plays a role in regulating molecular transport and synaptic architecture 
(Swulius and Waxham, 2008, Sanabria et al., 2009, Hoffman et al., 2013).  Cerebellar, 
hippocampal and cortical PSDs immunogold labeled for αCaMKII, βCaMKII, and CaM 
are presented in Figure 5.4.   
Neurotransmitter receptors were the third group of proteins targeted through 
immunogold labeling experiments.  Antibodies against several postsynaptic 
neurotransmitter receptors, including glutamate receptors: NR1, NR2a, NR2b, GluR1, 
GluR2, GluR1/5, and GluRδ2, and a GABA receptor antibody, were used in an attempt 
to determine labeling densities for these proteins in the PSDs isolated from each brain 
region.  However, I did not detect labeling above background for NR2a, GluR1, GluR2, 
GluR1/5, GluRδ2, or GABA; only the antibodies against NR1 and NR2b positively 
labeled PSDs.  These results may lead one to conclude that these receptors are not 
present in the isolated PSDs due to the two detergent treatments which remove the 
plasma membranes; however, it is also plausible that the epitopes to which the 
antibodies were raised are masked when these proteins are incorporated into the 
native PSD structure, preventing labeling under my experimental conditions.  Figure 5.5 
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includes PSDs isolated from each region immunogold labeled for NMDA receptors 
subunits NR1 and NR2b.   
Lastly, PSDs were also immunogold labeled for the proteasome, which in 
response to synaptic activity, is activated and recruited to synapses (Ehlers, 2003, 
Bingol and Schuman, 2006, Djakovic et al., 2009, Bingol et al., 2010) where it can 
degrade PSD scaffolds PSD-95 (Colledge et al., 2003), GKAP and Shank (Ehlers, 
2003).   This suggests that the ubiquitin proteasome system provides a role in the 
activity-dependent structural reorganization of PSDs underlying synaptic plasticity.  An 
antibody against a subunit of the proteasome lid was used to immunogold PSDs from 
each region (Fig 5.6).  
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Figure 5.2. PSDs Immunogold Labeled for Scaffolds: α-Actinin, Actin, PSD-95 and 
Homer.  
Representative negative stain electron micrographs of PSDs isolated from cerebella, 
hippocampi, or cortices immunogold labeled for PSD scaffolds: α-actinin, actin, PSD-95 
and Homer.   Gold = 12 nm.  Scale bar = 100 nm.  
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Figure 5.3. PSDs Immunogold Labeled for Scaffolds: SAP102, Shank1, Shank2, and 
Shank3. 
Representative negative stain electron micrographs of PSDs isolated from cerebella, 
hippocampi, or cortices immunogold labeled for PSD scaffolds: SAP102, Shank1, 
Shank2, and Shank3.   Gold = 12 nm.  Scale bar = 100 nm.  
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Figure 5.4. PSDs Immunogold Labeled for Ca2+ Signaling Proteins. 
Representative negative stain electron micrographs of PSDs isolated from cerebella, 
hippocampi, or cortices immunogold labeled for calcium signaling proteins: αCaMKII 
βCaMKII, and CaM.   Gold = 12 nm.  Scale bar = 100 nm. 
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Figure 5.5. PSDs Immunogold Labeled for Neurotransmitter Receptors. 
Representative negative stain electron micrographs of PSDs isolated from cerebella, 
hippocampi, or cortices immunogold labeled for neurotransmitter receptor subunits 
NR1 and NR2b.   Gold = 12 nm.  Scale bar = 100 nm. 
  
 100 
 
 
Figure 5.6. PSDs Immunogold Labeled for the Proteasome. 
Representative negative stain electron micrographs of PSDs isolated from cerebella, 
hippocampi, or cortices immunogold labeled for the RPT6 subunit of the proteasome 
lid.  Gold = 12 nm.  Scale bar = 100 nm. 
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The results of the immunogold labeling experiments are presented in Tables 5.1-
5.3 as well as Figures 5.7 and 5.8.  Table 5.1 reports the average labeling density for 
each antibody and each PSD group as the average number of gold per unit of area and 
as the average number of gold per PSD.  Table 5.2 compares the average labeling 
density, measured as gold per unit of area, across the different PSD groups for each 
antibody to assess trends in protein composition.  Each column in Table 5.2 compares 
labeling densities of one PSD group directly to another and reports the ratio of the 
labeling densities.  Table 5.3 reports the percentage of PSDs from each experiment 
with gold labeling density above secondary background control experiments.  Typically 
at least 90% of PSDs from each experiment were measured to have gold labeling well 
above background, however this was not always the case and Table 5.3 provides some 
unique information about the diversity of PSD protein composition within brain regions.  
Figure 5.7 illustrates the data from Table 5.1 in graphical form to provide visualization 
for the average labeling densities, reported as gold per unit area.  Figure 5.8 presents 
three graphs which report labeling for each antibody as the percentage of total labeling 
for that PSD group, giving a better picture for individual protein representation within 
PSDs. 
  
5.2.1. Scaffold Proteins within and across PSD Groups 
As mentioned previously, scaffolds form the core substructure of the PSD, 
anchoring neurotransmitter receptors, and organizing signaling proteins (Okabe, 2007).  
Antibodies against α-actinin, actin, PSD-95, Homer, SAP102, Shank1, Shank2, and 
Shank3 were employed to test whether the composition and organization of the PSD 
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scaffold network differs in PSDs across the brain.  In PSDs isolated from adult rat 
cortices, the most abundant scaffold was PSD-95 which demonstrated a significantly 
greater average labeling density than all other scaffold proteins analyzed (Table 5.1 
and Figure 5.7).  In cerebellar PSDs, labeling densities for α-actinin, Shank1, Shank3, 
and actin were approximately equally abundant, and they were significantly greater 
than the average labeling for PSD-95, Homer, SAP102, and Shank2 (Table 5.1 and 
Figure 5.7).  Labeling for α-actinin was the most abundant of all the scaffolds tested in 
hippocampal PSDs, while actin, Shank1, PSD-95, Shank3, and Homer were 
moderately abundant (Table 5.1 and Figure 5.7).  Labeling for shank2 and SAP102 
was found to be the least abundant of the scaffolds in each PSD group (Table 5.1 and 
Figure 5.8), which was consistent with previous observations that SAP102 is replaced 
with scaffold PSD-95 as PSDs developmentally mature (Sans et al., 2000, Petralia et 
al., 2005, Zheng et al., 2011). 
Labeling densities for each scaffold were also compared across the different 
PSD groups (Table 5.2).  Of the scaffold proteins evaluated, Shank1 was the only 
scaffold that did not change significantly in labeling density between PSDs isolated 
from cerebella, hippocampi and cortices, suggesting a fundamental role for Shank1 in 
PSDs across the brain.  In contrast, PSD-95 and Homer were found to differ 
significantly between all groups (Table 5.2), which was surprising given that PSD-95 is 
thought of as the primary PSD scaffold supporting both NMDA and AMPA receptors in 
the synaptic plasma membrane (Zheng et al., 2011).  Labeling for PSD-95 and Homer 
was most abundant in cortical PSDs and least abundant in cerebellar PSDs (Table 5.1 
and 5.2).  Cortical PSDs also had significantly increased labeling for actin and Shank3 
as compared to hippocampal and cerebellar PSDs (Table 5.2).  Labeling densities for 
 103 
 
Shank2 and α-actinin in hippocampal and cortical PSDs were significantly increased in 
comparison to cerebellar PSDs (Table 5.2).  
Of the cortical and hippocampal PSDs imaged in scaffold immunogold labeling 
experiments, at least 85% were measured with gold labeling densities above 
background (Table 5.3).  With several exceptions, 95% of cerebellar PSDs were found 
to have positive labeling for the scaffolds analyzed (Table 5.3).  Only 45% of cerebellar 
PSDs had positive labeling for Homer, 70% for PSD-95 and 75% for Shank2 (Table 
5.3).  Given the low labeling densities for cerebellar PSDs labeled for Homer, PSD-95 
and Shank2, these percentages were not entirely surprising. However, labeling for 
SAP102 was the second lowest within cerebellar PSDs and yet 100% of cerebellar 
PSDs positively labeled for SAP102 (Table 5.3).  The differential labeling densities for 
scaffolds across the PSD groups and the variability of labeling for scaffolds within 
cerebellar PSDs, compared to both cortical and hippocampal PSDs, suggest that the 
PSD scaffold network changes across the brain even within specific brain areas such 
as the cerebellum.  It is also of interest to note that while scaffolds were targeted by 8 
of the 13 (62%) antibodies used in this analysis, labeling for scaffolds only represented 
47% of total gold labeling for cortical PSDs, 36% for cerebellar PSDs and 27% for 
hippocampal PSDs (Figure 5.8), suggesting that there are other proteins that comprise 
the hippocampal and cerebellar scaffold networks that were not targeted in this 
analysis or it is plausible that PSDs from hippocampi and cerebella have less 
scaffolding than cortical PSDs. 
 
5.2.2. Signaling Molecules within and across PSD Groups 
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Antibodies against the  and  isoforms of CaMKII, the most abundant proteins 
in PSDs, and CaM, the calcium signal transducing activator, were used to determine 
labeling densities in the region specific PSDs.  In PSDs isolated from cerebral cortices, 
the average labeling density for αCaMKII was significantly greater than labeling for 
βCaMKII, while in PSDs isolated from cerebella and hippocampi the average labeling 
densities were reversed with labeling significantly greater for βCaMKII than αCaMKII 
(Table 5.1 and Figure 5.7).  The ratio of αCaMKII to βCaMKII was approximately 3:2 for 
cortical PSDs, 2:3 for hippocampal PSDs and 1:4 for cerebellar PSDs (Table 5.1 and 
Figure 5.7).  βCaMKII was present in PSDs at higher concentrations than expected, 
suggesting stronger interactions between PSDs and the actin network as βCaMKII can 
uniquely bind monomeric and F-actin unlike αCaMKII (Swulius and Waxham, 2008, 
Sanabria et al., 2009, Hoffman et al., 2013).  
Labeling for CaM was present in all PSD groups, although the average labeling 
densities were significantly lower than labeling densities for αCaMKII and βCaMKII 
(Table 5.1 and Figure 5.7) and labeling for CaM was not statistically different between 
the PSD groups (Table 5.2).  Labeling densities for βCaMKII were different between all 
PSD groups, with labeling ratios between PSD types ranging from 1.6 to 2.9 (Table 
5.2).  Cortical and hippocampal PSDs had significantly increased labeling, 11x and 8.4x 
respectively, for αCaMKII as compared to cerebellar PSDs (Table 5.2).  Interestingly, 
40% of cerebellar PSDs did not show labeling for αCaMKII over background, while 
labeling for αCaMKII was above background in 100% of cortical and hippocampal 
PSDs immunogold labeled, further supporting the heterogeneity of PSDs isolated from 
the cerebellum (Table 5.3).   
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Together the average gold labeling densities for both isoforms of CaMKII 
represented 41% of the total labeling within cortical PSDs (Figure 5.8).  Cerebellar 
PSDs had the lowest labeling densities for both αCaMKII and βCaMKII, which together 
represented 26% of the total gold labeling for all proteins targeted within cerebellar 
PSDs (Figure 5.8).  Hippocampal PSDs had the greatest labeling for βCaMKII and the 
labeling for CaMKII represented 50% of the total gold labeling for all proteins targeted 
within hippocampal PSDs (Figure 5.8). When combined, labeling for αCaMKII and 
CaMKII was 2-4 times greater than for all other proteins evaluated, consistent with a 
major role for CaMKII in establishing the structure of PSDs from the three regions 
evaluated.   
 
5.2.3. Neurotransmitter Receptors within and across PSD Groups 
Immunogold labeling for NMDA receptor subunit NR1 was statistically greater 
than the labeling for the NR2b subunit in both cortical and hippocampal PSDs (Table 
5.1 and Figure 5.7), while labeling densities for NR1 and NR2b were not different in 
PSDs isolated from cerebella (Table 5.1 and Figure 5.7).  NR1 is the necessary subunit 
to form ion conducting NMDA receptors (Kumar and Mayer, 2013), therefore these 
results suggest that NR subunits other than NR2b are likely present in cortical and 
hippocampal PSDs to form the obligate heteromeric complexes.  In contrast, the 
majority of NMDA receptors in the cerebellum associated with PSDs may be largely 
composed of NR1/NR2b subunits.  Given that at least 90% of all PSDs labeled above 
background for NR1 and 100% of all PSDs labeled for NR2b, it is likely that the majority 
of the PSDs analyzed in the immunogold analysis were from glutamatergic synapses.  
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Comparing the average labeling densities across PSD types, there were no significant 
differences in NR1 or NR2b labeling with the exception that hippocampal PSDs had 
1.5x more labeling for NR2b when compared to cortical PSDs (Table 5.3).  It is also of 
interest to note that while the labeling densities of NR1 and NR2b did not change 
significantly between most PSD groups, the labeling for both subunits represented 19% 
of total labeling for cerebellar PSDs while only representing 12% and 9% of the total 
labeling for hippocampal and cortical PSDs, respectively.   
 
5.2.4. Proteasome within and across PSD Groups 
Given recent evidence suggesting that the ubiquitin proteasome system (UPS) 
plays a crucial role in activity-dependent plasticity (Ehlers, 2003, Bingol and Schuman, 
2006, Djakovic et al., 2009), I performed immunogold labeling experiments on each 
PSD group with an antibody against the proteasome.  Labeling for the proteasome was 
present in all PSD types (Table 5.1 and Figure 5.7), but the labeling density was 
significantly increased in hippocampal and cerebellar PSDs compared to cortical PSDs 
(Table 5.2).  Interestingly, only 65% of cortical PSDs labeled for the proteasome (Table 
5.3) and labeling for the proteasome represented only 2% of total labeling in cortical 
PSDs as compared to 7% in hippocampal PSDs and 12% in cerebellar PSDs (Figure 
5.8).  These results confirm that proteasomes are present within PSDs across the brain 
and imply that synapses from different regions of the brain may differentially engage 
the UPS for structural modification of the PSD scaffold. 
 
5.2.5. Additional Trends across PSD Groups 
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 Figure 5.8 illustrates the percentage each antibody represents of the total 
immunogold labeling for each PSD group, allowing visualization of the protein 
composition of each PSD type.  In order to further compare the protein composition of 
the PSDs isolated from cortices, hippocampi and cerebella, the four most abundant 
proteins in each PSD group, as determined by Figure 5.8, were compared.  The most 
abundant proteins in cortical PSDs were αCaMKII, βCaMKII, PSD-95 and actin (Figure 
5.8 and Table 5.1), which was consistent with previous work ranking proteins in PSD 
fractions isolated from cerebral cortices (Dosemeci et al., 2007).  The most abundant 
proteins within hippocampal PSDs were βCaMKII, αCaMKII, NR1, and the proteasome, 
while βCaMKII, the proteasome, NR1, and NR2b were the most abundant components 
of cerebellar PSDs (Figure 5.8 and Table 5.1).  Interestingly PSD-95 was not one of the 
four most abundant proteins within hippocampal and cerebellar PSDs, but no other 
scaffolds were within the most abundant proteins either for these PSD types.  The 
proteasome, however, was included in hippocampal and cerebellar PSDs as a major 
component, further suggesting that synapses from these brain areas may differentially 
utilize proteasomal degradation.        
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  Gold/μm2 ± SEM  Gold/PSD ± SEM 
  Cereb. Hippo. Cortical  Cereb. Hippo. Cortical 
α-actinin 27 ± 4 45 ± 7 52 ± 8  10 ± 2 18 ± 4 21 ± 4 
Actin 24 ± 3 30 ± 3 66 ± 11  18 ± 2 18 ± 3 31 ± 7 
PSD-95 12 ± 4 27 ± 5 87 ± 11  4 ± 1 9 ± 3 32 ± 4 
Homer 9 ± 3 24 ± 5 49 ± 7  2 ± 1 5 ± 1 14 ± 3 
SAP102 8 ± 2 17 ± 3 10 ± 2  3 ± 1 6 ± 2 4 ± 1 
Shank1 25 ± 5 30 ± 5 33 ± 6  10 ± 2 9 ± 2 11 ± 2 
Shank2 5 ± 2 13 ± 3 16 ± 4  1 ± 1 3 ± 1 3 ± 1 
Shank3 25 ± 4 26 ± 5 59 ± 11  9 ± 2 8 ± 2 17 ± 4 
αCaMKII 18 ± 7 153 ± 17 199 ± 21  5 ± 2 41 ± 10 52 ± 9 
βCaMKII 80 ± 17 232 ± 21 127 ± 12  18 ± 3 59 ± 8 39 ± 6 
CaM 12 ± 3 17 ± 3 9 ± 3  3 ± 1 8 ± 3 3 ± 2 
NR1 39 ± 8 56 ± 5 45 ± 8  11 ± 2 23 ± 4 14 ± 3 
NR2b 32 ± 4 40 ± 4 26 ± 3  9 ± 2 13 ± 2 11 ± 2 
Proteasome 46 ± 9 54 ± 9 13 ± 7  15 ± 3  20 ± 5 4 ± 2 
 
Table 5.1. Summary of Immunogold labeling Experiments. 
Average labeling densities reported as gold/μm2 and gold/PSD for all immunogold 
labeling experiments.  Antibodies were used against a subset of PSD scaffolds, 
calcium signaling proteins, neurotransmitters and the proteasome.  N = 20 for each 
PSD group and antibody combination. 
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Figure 5.7.  Bar Graph of Immunogold Labeling Results. 
Bar graph illustrating the average labeling densities reported as gold/μm2 ± SEM for all 
immunogold labeling experiments.  Antibodies were used against a subset of PSD 
scaffolds, calcium signaling proteins, neurotransmitters and the proteasome.  N = 20 
for each PSD group and antibody combination. 
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CX vs. CB CX vs. Hippo Hippo vs. CB 
  Labeling Density (CX ÷ CB) Labeling Density (CX ÷ H) Labeling Density (H ÷ CB) 
α-actinin 1.9 ↑* 1.1 1.7 ↑* 
Actin 2.7 ↑** 2.2 ↑* 1.2 
PSD-95 7.3 ↑** 3.2 ↑** 2.3 ↑** 
Homer 5.6 ↑** 2.1 ↑* 2.7 ↑* 
SAP102 1.2 0.6 2.3 ↑* 
Shank1 1.3 1.1 1.2 
Shank2 3.5 ↑* 1.3 2.8 ↑* 
Shank3 2.3 ↑* 2.3 ↑* 1 
αCaMKII 11 ↑** 1.3 8.4 ↑** 
βCaMKII 1.6 ↑* 0.6 ↓** 2.9 ↑** 
CaM 0.7 0.5 1.4 
NR1 1.2 0.8 1.4 
NR2b 0.8 0.7 ↓* 1.2 
Proteasome 0.3 ↓* 0.2 ↓* 1.2 
 
Table 5.2. Immunogold Labeling Densities Compared Across Regions. 
Comparisons of immunogold labeling across PSD groups. Ratios were considered 
significant if P < 0.05 in a 2-tailed t test, indicated with a single asterisk (*); boldface 
and double asterisks (**) indicated a P ≤ 0.001.  Arrows indicated whether the ratios 
represented increased (↑) or decreased (↓) immunogold labeling. N = 20 for each PSD 
group and antibody combination.  
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PSDs with Gold above Background 
  Cerebellar PSDs Hippocampal PSDs Cortical PSDs 
α-actinin 100% 100% 100% 
Actin 95% 100% 100% 
PSD-95 70% 95% 100% 
Homer 45% 85% 100% 
SAP102 100% 90% 90% 
Shank1 95% 95% 95% 
Shank2 75% 90% 85% 
Shank3 100% 100% 100% 
2D5 60% 100% 100% 
CBβ1 95% 100% 100% 
CaM 85% 95% 80% 
NR1 90% 100% 100% 
NR2b 100% 100% 100% 
RPT6 90% 100% 65% 
 
Table 5.3. Fractions of PSDs with Gold Labeling above Background. 
Percentage of PSDs included in the immunogold labeling experiments with gold 
labeling above background gold measurements.  N = 20 for each PSD group and 
antibody combination. 
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Figure 5.8.  Percentage of Total Immunogold Labeling. 
Bar graphs illustrating the percentage of total immunogold labeling each antibody 
represented for the different PSD groups. 
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5.3. Spatial Analysis of Gold Labeling 
While measuring labeling densities for PSDs immunogold labeled for scaffold 
PSD-95, it was observed that gold appeared clustered on cerebellar PSDs, a pattern 
not observed with cortical or hippocampal PSDs (Fig. 5.9).  A Ripley’s K-function based 
spatial analysis was employed to test whether the spatial distribution of PSD-95 in 
cerebellar PSDs was statistically non-random.  A description of the analysis can be 
found in Chapter 2, section 2.4, and examples of random and non-random gold labeling 
are illustrated in Figure 5.10.  Included in Figure 5.10 are two micrographs of 
immunogold labeled PSDs (Fig. 5.10.A), one with random gold distribution and the 
other with non-random distribution, the 2D models of the same PSDs (Fig. 5.10.B) and 
the H-functions which result from the Ripley’s K-function analysis (Fig. 5.10.C).  In 
Figure 5.10.C, the horizontal black lines through 0 on the y-axis represents complete 
spatial randomness, the black traces represent the minimum and maximum envelopes 
for random distribution based on the simulated data of complete spatial randomness, 
and the red traces represent the distribution of the gold from the data.  If the red trace 
falls outside of the minimum or maximum envelope, the distribution is non-random, as 
shown in the right column of Figure 5.10. If the red trace stays within the min and max 
envelopes, the gold is distribution is considered random as shown in the left column of 
Figure 5.10.  The PSD with non-random distribution in Figure 5.10 is a cerebellar PSD 
immunogold labeled for PSD-95, and the distribution of PSD-95 labeling is clearly non-
random at both short (~ 200 nm) and long (~ 800 nm) distances, consistent with 
statistically significant clustering.   
Spatial analysis for PSD-95 labeling was assessed for 21 cerebellar PSDs, of 
which 20 PSDs (95%) were determined to have non-random distribution for gold 
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labeling PSD-95 (Table 5.4).  Seventeen of the cerebellar PSDs with non-random 
distribution deviated from random at larger distances suggesting clustering (Table 5.4) 
as opposed to non-random dispersed points, indicating that PSD-95 is typically 
organized in clusters within cerebellar PSDs, when present, as labeling for PSD-95 was 
below controls in approximately 30% of cerebellar PSDs.  For comparison, spatial 
analysis of the gold labeling of PSD-95 in hippocampal and cortical PSDs was also 
determined (Table 5.4).  In total, 71% (12 of 17) of hippocampal PSDs and only 54% 
(13 of 24) of cortical PSDs were categorized as having non-random gold distribution 
compared to the 95% (20 of 21) of cerebellar (Table 5.4).  The number of hippocampal 
(7 of 17, 41%) and cortical PSDs (11 of 24, 46%) with gold distribution categorized as 
clustering was also significantly less than cerebellar PSDs (17 of 21, 81%) (Table 5.4), 
confirming the visual observation that gold labeling PSD-95 clustered more often in 
cerebellar PSDs.   
Spatial analysis was also performed on cerebellar, hippocampal, and cortical 
PSDs immunogold labeled against βCaMKII, to determine if cerebellar PSDs display 
increased non-random distribution for proteins other than PSD-95 as compared to other 
PSD types (Table 5.4).  Gold distribution for βCaMKII, which was the most abundant 
protein in cerebellar and hippocampal PSDs and the second most abundant in cortical 
PSDs (Table 5.1), was found to have similar levels of non-random distribution between 
the different PSD groups, approximately 64%.  Hippocampal PSDs had the highest 
percentage of PSDs with clustering of gold targeting βCaMKII (11 of 25, 44%), followed 
by cerebellar PSDs (7 of 20, 35%) and cortical (10 of 25, 25%), suggesting that 
increased non-random distribution and clustering in cerebellar PSDs is possibly limited 
to PSD-95 (Table 5.4).  To test this, the spatial distribution of gold targeting the NR1 
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subunit of the NMDA receptor complex, which is anchored in the synaptic plasma 
membrane by PSD-95, was also analyzed by Ripley’s K-function analysis.  
Interestingly, the level of non-random distribution for NR1 followed the same trend as 
PSD-95, with 70% (7 of 10) of cerebellar PSDs having gold distribution categorized as 
non-random, while only 53% (8 of 15) of hippocampal PSDs and 45% (5 of 11) of 
cortical PSDs were categorized as having non-random gold distribution (Table 5.4).  
The same trend was also evident for gold distribution consistent with clustering; gold 
distribution for NR1 was clustered in 50% of cerebellar PSDs, 33% of hippocampal and 
only 18% of cortical PSDs (Table 5.4).  These results first illustrate that a threshold 
exists for non-random distribution and second suggest that organization of proteins 
within cerebellar PSDs deviates from random more often than the organization of 
proteins from cortical and hippocampal PSDs.  Future work will be required to 
determine the full functional significance of non-random distribution and clustered 
distribution.  However, given that the trend for both non-random and clustered NR1 
gold distribution was consistent with although not as robust as PSD-95, it is plausible 
that NR1 clustering may be in part the result of interactions between the NMDA 
receptor complex and PSD-95. 
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Figure 5.9. PSDs Immunogold Labeled for PSD-95. 
Representative electron micrographs of negatively stained cerebellar, hippocampal and 
cortical PSDs immunogold labeled for PSD scaffold PSD-95.  Gold = 12 nm. Scale Bar 
= 100 nm.  
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Figure 5.10. Ripley’s K-Function Analysis of Random and Non-Random Gold 
Distribution. 
A) Electron micrographs are representative immunogold labeled and negatively stained 
PSDs with either random or non-random gold distribution.  B) Corresponding 
coordinate models for the PSD boundary and gold distribution from the micrographs in 
A.  C) The H-functions are the result of the Ripley’s K-function analysis comparing 
examples of complete spatial randomness to the actual gold distribution.  When the red 
trace, which represents the distribution of gold from A, deviates outside of the minimum 
or maximum envelopes, the black traces, the distribution deviates from random.  See 
Chapter 2.5 for more information. Scale bar = 100 nm.   
 118 
 
Number of PSDs with Non-Random Gold Distribution 
  βCaMKII PSD-95 NR1 
Cerebellar 13 of 20 (65%) 20 of 21 (95%) 7 of 10 (70%) 
Hippocampal 16 of 25 (64%) 12 of 17 (71%) 8 of 15 (53%) 
Cortical 16 of 25 (64%) 13 of 24 (54%) 5 of 11 (45%) 
Number of PSDs with Gold Clustering 
βCaMKII PSD-95 NR1 
Cerebellar 7 of 20 (35%) 17 of 21 (81%) 5 of 10 (50%) 
Hippocampal 11 of 25 (44%) 7 of 17 (41%) 5 of 15 (33%) 
Cortical 10 of 25 (25%) 11 of 24 (46%) 2 of 11 (18%) 
 
Table 5.4. Summary of Gold Distribution Data by Ripley’s K-Function Analysis.  
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Chapter 6. Discussion 
For decades, numerous studies have focused on unraveling the composition 
and structure of PSDs, as they play an essential role in establishing and modulating 
synaptic transmission (Okabe, 2007, Sheng and Hoogenraad, 2007).  Despite these 
efforts, there remain significant gaps in the understanding of the detailed anatomical 
structure of the PSD and the spatial distribution of the proteins from which it is 
composed.  This dissertation presents the first study to employ stain and cryo electron 
tomography to directly compare PSDs isolated from cerebella, hippocampi and cortices 
and couple that analysis with immunogold labeling to advance the understanding of the 
fine morphology and protein composition of the PSD.   
Biochemical isolation of PSDs, as first established in the 1970’s (Cotman et al., 
1974, Cohen et al., 1977), produces an enriched PSD fraction, that is morphologically 
and compositionally similar to PSDs in situ (Kennedy, 1997) and allows for analysis of 
individual PSDs which is crucial given that PSDs are heterogeneous in nature 
(Petersen et al., 2003, Swulius et al., 2012).  PSDs were isolated from adult rat 
cerebella, hippocampi and cortices because these brain regions contain unique 
populations of neuronal cells and are amenable to straightforward isolation.  Neuronal 
cells within cerebral cortices and hippocampi are primarily pyramidal cells, while 
purkinje cells and granule cells are the major neuronal cells of the cerebellum (Cotman 
et al., 1974, Rollenhagen and Lubke, 2006). Therefore, it is believed that the vast 
majorities of PSDs isolated were derived from these neuronal cell types and are from 
excitatory glutamatergic synapses as confirmed by immunogold labeling experiments.  
However, it is possible that PSDs from other neuronal cell populations were enriched 
during the PSD isolation procedure, although they are likely a minor contribution.   
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Final PSD fractions, produced by first enriching for synaptosomes and then 
removing all detergent soluble membrane and presynaptic material through detergent 
treatments and centrifugations on discontinuous sucrose gradients, were all enriched 
for PSD scaffold PSD-95 and depleted of synaptic marker SV2 (Figure 3.2) as 
previously shown by Western blot analysis (Swulius et al., 2010).  Enrichment of PSD-
95 was expected as PSD-95 is a known component of forebrain (Dosemeci et al., 
2007) and hippocampal PSDs (Dosemeci et al., 2006).  Depletion of SV2 was also 
anticipated since presynaptic terminals are removed in the isolation procedure as 
shown in the negative stain micrographs of synaptic junctions (Figure 3.3), which were 
morphologically similar to synaptic junction fractions previously described (Cotman et 
al., 1974, Matus and Taff-Jones, 1978).  For each region, SDS-PAGE protein profiles 
were similar between homogenate and synaptosome fractions (Figure 3.4) as 
previously reported for forebrain tissue (Swulius et al., 2010).  PSD protein profiles also 
shared many of the same bands as homogenate and synaptosomal fractions but 
contained protein bands significantly enriched from previous fractions, especially in the 
higher molecular weight range (Figure 3.4) which likely represent PSD scaffolds 
including PSD-95 (100 kDa) and Shank (~120-240 kDa) (Sheng and Kim, 2011).  The 
protein profiles for the individual PSD fractions from cerebella, hippocampi and cortices 
were also different (Figure 3.4) confirming that the protein composition of PSDs is 
varied across brain regions (Carlin et al., 1980, Cheng et al., 2006). 
Initial morphologic comparisons of PSDs from negative stain micrographs 
revealed both similarities and differences (Figures 3.8-3.10).  Overall, they appeared 
similar in dimensions and texture, yet some cerebellar PSDs qualitatively appeared to 
have less protein density than other cerebellar PSDs and were distinct from both 
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hippocampal and cortical PSDs.  A quantitative assessment of surface area determined 
that PSDs from cerebella, hippocampi and cortices are similar in size with the average 
surface areas equivalent at approximately 0.35 μm2 with a peak surface area of 0.2 
μm2 (Figure 3.11), comparable to surface areas measured for isolated forebrain PSDs 
(Swulius et al., 2010).  This was unexpected as PSD areas have been reported to vary 
greatly, as measured through serial electron microscopy of fixed tissue sections, 
between adult rat hippocampi, 0.069 μm2, (Harris and Stevens, 1989) and cerebella, 
0.15 μm2, (Harris and Stevens, 1988), reviewed in (Harris and Weinberg, 2012).  Note 
that the average PSD areas reported in this dissertation, similar to previously published 
PSD areas from this lab (Swulius et al., 2010), are larger than the values reported from 
serial sectioning of fixed tissue (Harris and Stevens, 1988, 1989, Harris and Weinberg, 
2012) and this will be discussed in more detail later in the discussion.  
Negative stain and cryo electron tomographic reconstructions of isolated PSDs 
were used to resolve the morphologic structures of PSDs isolated from cerebella, 
hippocampi and cortices, and revealed both similarities and differences (Figures 4.2-
4.12).  Overall, the majority of PSDs were similar in texture but there were clear 
distinctions in the organization of protein modules within PSDs from the different 
regions.  Cortical and hippocampal PSDs were disc-shaped and generally displayed 
densely packed areas of protein with occasional areas of low or absent protein density.  
These morphological features are consistent with previous descriptions of PSDs 
isolated from hippocampi (Wu and Siekevitz, 1988) and cerebral cortices (Cohen et al., 
1977, Carlin et al., 1980) where the authors noted the cup or disc-shaped morphology 
and also described PSD substructure as being composed of both particles (13-28 nm) 
and filaments.  Areas of less protein density in the PSD center (Cohen et al., 1977, 
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Cohen and Siekevitz, 1978, Carlin et al., 1980) or openings in the PSD mesh (Petersen 
et al., 2003) have also been described previously and are consistent with the findings 
reported here.   
Most striking was comparison of PSDs from the cerebellum.  Three distinct types 
of morphology were apparent, which could be categorized by the packing and 
organization of protein substructures.  One type, similar to the morphological features 
of PSDs from cortices and hippocampi, showed a relatively high protein packing 
density obscuring some of the fine detail.  This dense type of cerebellar PSD 
represented ~ 41% of cerebellar PSDs.  Cerebellar PSDs more granular in texture 
represented ~ 24% of cerebellar PSDs and were composed of smaller (~ 40nm) protein 
regions than dense cerebellar PSDs, while latticelike cerebellar PSDs composed ~ 
35% of all cerebellar PSDs and exhibited less dense packing of the protein 
substructure.  My description of the latticelike cerebellar PSDs is mostly consistent with 
a previous morphologic description of cerebellar PSDs as disc-shaped and latticelike 
(Carlin et al., 1980).  The previously described latticelike cerebellar PSDs were 
postulated to be inhibitory PSDs (Carlin et al., 1980), however the immunogold labeling 
experiments presented here indicate that the vast majority of PSDs isolated using our 
protocol were from glutamatergic synapses.  Future work will be required to relate 
these morphologically distinct PSDs to both their neuronal type of origin and the 
functional significance of their structural differences. 
I also determined that a high proportion, 62%, 63% and 78% respectively, of 
hippocampal, cerebellar and cortical PSDs had tightly associated lipids.  The presence 
of lipids associated with PSDs was previously noted (Cohen et al., 1977, Petersen et 
al., 2003, Swulius et al., 2010, Swulius et al., 2012).  These tightly associated lipids are 
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hypothesized to be lipid raft-like (Suzuki, 2002, Petersen et al., 2003, Swulius et al., 
2012) as they are composed of GM1, a raft-associated lipid, in forebrain PSD fractions 
(Swulius et al., 2012) and therefore may well play an important role in organizing the 
overlying synaptic plasma membrane.  Interestingly, immunogold labeling of synaptic 
membranes found a significant fraction of AMPARs co-localized with GM1 (Cole et al., 
2010), while another study concluded that ~ 40% of synaptic NMDARs are associated 
with synaptic lipid rafts (Delint-Ramirez et al., 2010).  These results suggest that 
synaptic lipid rafts are crucial for synaptic organization of glutamate receptors and 
therefore synaptic transmission.  Additionally, PSD-95, a PSD scaffold, is a known 
component of synaptic lipid rafts (Delint-Ramirez et al., 2010) which associates with 
cell membranes when palmitoylated (Topinka and Bredt, 1998).  Ring-like structures, 
approximately 15-20 nm in diameter resembling CaMKII, were also evident in 
tomographic reconstructions of PSDs from all brain regions.  This was expected, as 
CaMKII holoenzymes have previously been visually identified in tomographic 
reconstructions of PSDs (Fera et al., 2012) and as my immunogold labeling results 
(Table 5.1), discussed in further detail later, confirm that CaMKII is the most abundant 
protein in PSDs from cerebella, hippocampi, and cortices. 
Additional insights into the morphology of regional PSDs was provided by 
quantifying the protein-to-volume ratios and thickness of PSDs imaged through electron 
cryotomography.  As expected based on cerebellar PSD morphology, cerebellar PSDs 
had the largest range of protein-to-volume ratios with half of the PSDs evaluated 
uniquely clustered near a ratio much smaller than the calculated average (Figure 4.13).  
This suggested that a distinct group of less dense cerebellar PSDs exist with respect to 
protein volume, consistent with the visual observations.  I expect that increasing the 
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pool of cerebellar PSDs analyzed for protein-to-volume ratios to allow separation by 
morphologic type would confirm that separate populations of cerebellar PSDs exist with 
respect to protein packing, with the lower protein ratios corresponding to the latticelike 
cerebellar PSDs.  With respect to PSD thickness, hippocampal PSDs were determined 
to be significantly thinner (~ 110 nm) than cerebellar (~ 170 nm) and cortical PSDs (~ 
210 nm) from cryo-preserved tomographic reconstruction.  This lab has previously 
reported a disparity in thickness between traditionally prepared and cryo-preserved 
forebrain PSDs (Swulius et al., 2012) and a similar increase in thickness was found in 
PSDs across the three brain regions analyzed in this dissertation.  Cerebellar, 
hippocampal and cortical PSDs were six, two and three times thicker than those 
reported previously in serial sections of fixed and plastic embedded isolated PSDs 
(Carlin et al., 1980, Wu and Siekevitz, 1988) or from thin sections of fixed, plastic 
embedded neuropil isolated from the same brain regions (Harris et al., 1992).  
Interestingly, the thickness of PSDs from these earlier studies (~60-80 nm) was quite 
similar even though the studies analyzed PSDs prepared in different ways.  Two 
studies (Carlin et al., 1980, Wu and Siekevitz, 1988) used isolated PSDs prepared 
using a nearly identical protocol to that employed in the present study, while the other 
(Harris et al., 1992) analyzed PSD thickness in serial sections of fixed neuropil.  
Therefore, isolating the PSDs from the brain does not appear to cause significant 
distortions in their overall morphology.   
I favor the explanation that the discrepancy in thickness is due to differences in 
methods employed to preserve and image the PSDs.  The use of electron 
cryotomography to assess the dimensions and morphology of PSDs does not require 
dehydration, fixation or heavy metal staining and has advantages in retaining a more 
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accurate representation of the structure of macromolecular assemblies (Murphy and 
Jensen, 2007, Koning and Koster, 2009).  Consistent with this idea, I showed that 
negatively stained PSDs, from cerebella and cerebral cortices, were approximately half 
as thick as when cryo-preserved and significantly closer to the values historically 
reported for thickness of fixed or negative stained PSDs.  Additionally PSD surface 
areas were consistent between negative stain and cryotomography suggesting that 
staining and dehydrating isolated PSDs selectively compresses the structure in the z-
dimension.  Fixation embedding of tissue may cause underestimation of PSD size in all 
three dimensions, and this could account for the differences in surface area mentioned 
previously between this work and published studies reporting PSD surface area from 
serial sectioned fixed neuronal tissue (Harris and Stevens, 1988, 1989).  For these 
reasons, I conclude that PSDs may be significantly thicker and extend farther into the 
spine compartment than previously recognized, potentially facilitating interactions with 
the cytoskeleton and/or spine apparatus that reside more deeply in the spine head.  
This idea is supported by tomographic reconstructions of sectioned neuronal tissue 
where filamentous structures appear to be directly contacting the PSD bridging it with 
the cytoskeletal network (Rostaing et al., 2006).  Additionally, another group 
investigated the laminar organization of PSD proteins through immunogold labeling of 
sectioned neuronal tissue (Tao-Cheng et al., 2010, Yang et al., 2011) and defined the 
core of the PSD to be the area approximately 40 nm under the postsynaptic membrane 
and the area 40-120 nm under the postsynaptic membrane to be the PSD contiguous 
network which labels for the PSD proteins synGAP and Shank (Tao-Cheng et al., 2010, 
Yang et al., 2011).  Together, these results strongly suggest that PSDs extend 
significantly farther into the spine compartment, presumably interacting directly with the 
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cytoskeletal network through Shank and cortactin.  The difference in hippocampal PSD 
thickness, compared to cortical and cerebellar PSDs, is also intriguing and suggests 
that differences exist in the interactions between integral PSD components that 
maintain their three-dimensional architecture. 
To compliment the morphological analyses, I investigated the composition and 
spatial organization of a set of the major PSD associated proteins within individual 
morphologically identified PSD by employing immunogold labeling.  Such an approach 
has been strategically used in past studies to analyze the presence and distribution of 
PSD associated proteins (Dosemeci et al., 2001, Valtschanoff and Weinberg, 2001, 
Petersen et al., 2003, DeGiorgis et al., 2006, Swulius et al., 2010).  In interpreting the 
previous work and the results presented here, it is important to acknowledge that 
antibodies to individual proteins each bind with a different affinity and epitopes could be 
inaccessible within the PSD structure.  Nevertheless, the amount and patterns of 
distribution of labeling in PSDs across the different regions provided unique 
comparative insights into the roles played by each protein.  
PSD-95 was the most abundant scaffold in cortical PSDs, consistent with earlier 
studies (Cheng 2006, Dosemeci 2007), but interestingly was found to differ significantly 
between all groups and was not the most abundant scaffold in hippocampal or 
cerebellar PSDs.  This is surprising given that PSD-95 is thought of as the primary 
scaffold supporting glutamate receptors in the synaptic plasma membrane (Zheng et 
al., 2011).   In fact, 30% of cerebellar showed no significant labeling for PSD-95 and 
when present, spatial analysis showed PSD-95 was clustered.  PSD-95 clustering was 
not prominent in either hippocampal or cortical PSDs, consistent with previous 
descriptions of homogenous labeling for PSD-95 within forebrain PSDs (Petersen et al., 
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2003, DeGiorgis et al., 2006).  This suggests that PSD-95 plays a unique role in 
forming structural/functional subdomains in cerebellar PSDs.  Perhaps the PSD-95 rich 
domains function to cluster AMPA receptors as it has been shown by super resolution 
fluorescence microscopy that PSD-95 rich domains were associated with increased 
AMPA receptor presence, rather than NMDA receptors in hippocampal neurons 
(MacGillavry et al., 2013).  However, this idea conflicts with my conclusions from the 
Ripley’s K-function analysis of cerebellar PSDs.  Future experiments will be required to 
determine the function of PSD-95 clusters in cerebellar PSDs.  Additionally, the 
antibody used against PSD-95 is known to cross-react with PSD-93 (Sans et al., 2000), 
thus it is plausible that PSD-93 represents a portion of the labeling seen with the PSD-
95 antibody.  Unfortunately, labeling experiments with a specific PSD-93 antibody did 
not yield labeling above background, which was somewhat surprising since PSD-93 is 
believed to be the only member of the PSD-95 family in cerebellar purkinje cells, as 
determined by immunohistochemistry (McGee et al., 2001).  This could well be the 
result of the epitope this antibody recognizes being inaccessible for labeling.  
Ultimately, the differential labeling for PSD-95 across each PSD group indicates that 
PSD-95 may play distinct roles in the synapses from each of these regions.   
Interestingly, the most abundant scaffolds in cerebellar PSDs: α-actinin, Shank1, 
Shank3, and actin, all suggested that cerebellar PSDs are integrally connected with the 
actin cytoskeletal network, as both α-actinin and Shanks bind actin (Sheng and Kim, 
2011), confirming the conclusions from the morphologic analysis.  Cerebellar PSDs 
were also quite variable in scaffold composition; only 45% of cerebellar PSDs had 
positive labeling for Homer, 70% for PSD-95 and 75% for Shank2.  Given this variability 
within cerebellar PSDs and the differential labeling densities for scaffolds across the 
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PSD groups, my findings indicate that the PSD scaffold network changes across the 
brain even within specific brain areas such as the cerebellum.  Figure 6.1 includes my 
hypothesized models for the core organization of PSDs from each region based on my 
immunogold labeling results and known protein-interactions.  The cortical organization 
is similar to the “traditional” model of PSD organization as others have predicted 
(Sheng and Kim, 2011), while the models of hippocampal and cerebellar PSD 
organization rely more heavily on βCaMKII and actin binding proteins (Figure 6.1).  It is 
also of interest to note that while scaffolds were targeted by 62% of the antibodies used 
in this analysis, labeling for scaffolds represented 47% of total gold labeling for cortical 
PSDs, and only represented 36% for cerebellar PSDs and 27% for hippocampal PSDs.  
This suggests that there are other proteins that make up the hippocampal and 
cerebellar scaffold networks that were not targeted in this analysis and it is also 
plausible that PSDs from hippocampi and cerebella have less traditional PSD 
scaffolding than cortical PSDs.   
I hypothesize that the core structure of hippocampal PSDs is composed 
primarily of βCaMKII, the most abundant molecule measured in hippocampal PSDs, 
and α-actinin, the most abundant scaffold measured in hippocampal PSDs which 
interacts with βCaMKII.  Through its interactions with actin, βCaMKII is thought to act 
more as a structural molecule within PSDs, and given that βCaMKII, α-actinin and actin 
can all bind one another to form a multi-protein assembly.  It is easy to visualize this 
complex functioning as the primary core of hippocampal PSDs (Figure 6.1).  Supporting 
this idea, hippocampal PSDs had the least labeling for scaffold molecules and were 
significantly thinner than cortical and cerebellar PSDs when measured from cryo 
tomographic reconstructions; hippocampal PSDs were also resistant to collapse by 
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negative staining, perhaps through stabilization by the βCaMKII, α-actinin and actin 
complex.  I think it would be of interest to further investigate this possibility by treating 
hippocampal PSDs with detergents known to strip away additional PSD proteins (Matus 
and Taff-Jones, 1978) to visualize and determine through dual immunogold labeling the 
composition of hippocampal PSD substructure.  Labeling for scaffolds and CaMKII 
molecules within cerebellar PSDs was also much lower than in cortical PSDs, and I 
suspect that given that cerebellar PSDs are thicker, there are cerebellar scaffolds not 
yet identified.  One study employed a proteomic approach to quantify the proteins in 
cerebellar PSD and cortical PSD fractions and, of the 287 proteins identified, 43 
proteins differed in quantity between the two samples and several novel proteins were 
identified within cerebellar PSDs relating to the protein kinase C pathway (Cheng et al., 
2006).  Close inspection of such proteomic studies should provide insights into the 
most likely candidates for additional scaffold molecules that would be priorities for 
future investigations. 
Shank1 was the only scaffold for which immunogold labeling did not differ 
significantly across all PSD groups in either amount or spatial distribution, suggesting 
that it might play a functionally similar role fundamental to all PSDs.  Shank1 interacts 
with the actin cytoskeleton and ionotropic and metabotropic glutamate receptors 
through scaffolds GKAP and Homer (Naisbitt et al., 1999, Tu et al., 1999, Grabrucker et 
al., 2011c).  Furthermore, Shank1 is also known to bind to neuroligin, an adhesion 
molecule involved in aligning the presynaptic and postsynaptic membranes (Meyer et 
al., 2004).  These results are consistent with a ubiquitous role for Shank1 as a scaffold 
to create local domains of glutamate receptors as well as bridging the PSD scaffold to 
the cytoskeletal network.  
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CaMKII is the most abundant protein in the PSD (Kennedy et al., 1983, Cheng et 
al., 2006, Dosemeci et al., 2007) and is an important molecule regulating synaptic 
plasticity (Lisman et al., 2002, Colbran and Brown, 2004).  From the immunogold 
labeling experiments, I calculated the ratio of αCaMKII and βCaMKII isoforms to be 3:2 
in cortical PSDs, which is relatively consistent with previous findings from forebrain 
PSDs (ranging from 3:1-6:1) (McGuinness et al., 1985, Miller and Kennedy, 1985, 
Cheng et al., 2006). The smaller α/β CaMKII ratio calculated in this study is likely due in 
part to the fact that I determined the amounts of CaMKII in morphologically identified 
PSDs and not the bulk PSD fraction, which includes variable amounts of non-PSD 
material.  Additionally, great care was taken to ensure rapid isolation and cooling of the 
brains in order to minimize αCaMKII aggregation (Hudmon et al., 2005) and recruitment 
to the PSD (Aronowski et al., 1992, Suzuki et al., 1994, Kolb et al., 1995).  This is a 
known consequence of ischemia unavoidable during brain isolation and αCaMKII 
enriched aggregates could contribute to the increased ratio of αCaMKII to βCaMKII in 
fractions analyzed previously by Western blot (McGuinness et al., 1985, Miller and 
Kennedy, 1985) and proteomics (Cheng et al., 2006).  Interestingly, my results showed 
an even greater amount of αCaMKII vs. βCaMKII in hippocampal PSDs (2:3 α/β ratio), 
so discrepancies with past reports and those presented here cannot be explained by 
the fact that separate analyses on hippocampal and cortical PSDs were performed.  My 
ratio for cerebellar PSDs also favored βCaMKII over aCaMKII (4:1) and was consistent 
with previous work (Miller and Kennedy, 1985).  Interestingly, when analyzed by 
immunocytochemistry αCaMKII was only present within purkinje cells of the 
cerebellum, with βCaMKII being present throughout the cerebellum (Walaas et al., 
1988).  From my immunogold labeling experiments, approximately 60% of the isolated 
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cerebellar PSDs were labeled for αCaMKII.  It is possible that the subset of isolated 
cerebellar PSDs that labeled for αCaMKII were PSDs from purkinje cells while the 
PSDs that did not label for αCaMKII were from other cells types, such as granule cells 
(Voogd and Glickstein, 1998, Rollenhagen and Lubke, 2006).  Overall, the α/β-CaMKII 
ratios, which are presumably representative of the isoform composition of the average 
PSD CaMKII holoenzyme, suggested that βCaMKII subunit plays a more integral role 
in the PSD and is present at higher concentration in cortical and hippocampal PSDs 
than previously appreciated.  One possibility for the increased amount of βCaMKII over 
αCaMKII in hippocampal and cerebellar PSDs is to provide additional interactions with 
the spine actin network.  βCaMKII can bind actin and actin filaments in a Ca2+/CaM 
reversible manner (Shen et al., 1998, Colbran and Brown, 2004, Sanabria et al., 2009) 
and has proposed structural roles as a scaffold to integrate Ca2+ signals with 
modifications of actin associated with PSDs and the actin cytoskeleton in spines.  
Additionally, αCaMKII and βCaMKII have different affinities for Ca2+/CaM (Miller and 
Kennedy, 1985, Gaertner et al., 2004a) and different frequency-dependent activation 
curves (De Koninck and Schulman, 1998).  The results showing that PSDs from 
different regions vary in their CaMKII holoenzyme subunit ratios suggests that 
differential recruitment of the enzyme could help distinctively tune the ability of a 
synapse to respond to the varying frequencies of Ca2+ signals.  The high relative 
concentration of βCaMKII compared to αCaMKII in cerebellar PSDs also further 
confirms conclusions drawn by the morphologic descriptions and scaffold composition 
of cerebellar PSDs in that cerebellar PSDs are likely well-connected to the actin 
network.  Additionally, labeling for αCaMKII and βCaMKII was 2-4 times greater than 
for all other proteins evaluated in all PSD types, consistent with a major role for CaMKII 
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in establishing the structure of PSDs from the three regions evaluated.  Supporting this 
idea, labeling for both αCaMKII and βCaMKII represented 50% of the total labeling for 
hippocampal PSD, further suggesting that CaMKII may act as both the major signaling 
molecule and as the major scaffold within hippocampal PSDs. 
AMPA, NMDA and metabotropic glutamate receptor subunits have been 
identified in proteomic studies of forebrain (Jordan et al., 2004, Li et al., 2004, Peng et 
al., 2004, Yoshimura et al., 2004, Cheng et al., 2006) and cerebellar PSD fractions 
(Cheng et al., 2006), and I expected to detect these receptors in the immunogold 
analysis.  Additionally I expected to detect GluRδ2, which is thought to be present at 
cerebellar parallel fiber-purkinje cell synapses (Takumi et al., 1999) and has been 
detected in isolated cerebellar PSDs (Cheng et al., 2006).  In the analyses of 
morphologically identified PSDs, significant immunogold labeling was detected for only 
the NMDA receptor (NR1 and NR2b subunits) whose levels were consistent between 
cerebellar, hippocampal and cortical PSDs.  Perhaps there were minor subcellular 
contaminants in the fractions used for the proteomic analyses that contained AMPA 
and metabotropic receptors that were avoided in this analysis of morphologically 
identified PSDs.  Alternatively, these negative results could be due to epitopes on the 
receptors being obscured from antibody labeling by their incorporation into PSDs.  
Remarkably, despite the double Triton X-100 extraction during PSD isolation, the 
NMDA receptor remains tightly anchored, presumably through interactions with scaffold 
and signaling proteins.  Along with PSD-95, NR2b also binds CaMKII and both NR1 
and NR2b can bind α-actinin, creating a multi-protein complex that likely stabilizes the 
NMDA receptor in the PSD and prevents its extraction (Strack and Colbran, 1998, 
Inoue and Okabe, 2003, Robison et al., 2005, Okabe, 2007, Sheng and Hoogenraad, 
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2007).  These results suggest that the mobility of the NMDA receptor is restricted, 
consistent with work that has demonstrated that a portion (~50%) of NMDA receptors 
are immobile at synapses (Groc et al., 2004, Triller and Choquet, 2005).   
Finally, I determined that the proteasome is a component of isolated PSDs and 
while all cerebellar and hippocampal PSDs were positively labeled, only 65% of cortical 
PSDs were labeled.  Since the proteasome plays a role in activity-dependent changes 
to PSD composition (Ehlers, 2003), it is interesting to propose that some PSDs might 
utilize the proteasome pathway while others do not.  In response to synaptic activity, 
the proteasome was found to be recruited into hippocampal dendritic spines (Bingol 
and Schuman, 2006) where it can bind to and be phosphorylated by αCaMKII, thereby 
increasing proteasomal activity, (Djakovic et al., 2009, Bingol et al., 2010, Djakovic et 
al., 2012).  Once activated, several PSD proteins are targeted for degradation, 
including PSD-95 (Colledge et al., 2003), Shank, and GKAP (Ehlers, 2003). From these 
results, one can speculate that the increased labeling of hippocampal and cerebellar 
PSDs for the proteasome indicates that a higher percentage of synapses in these brain 
areas are undergoing active proteasomal remodeling than in cortex.  This finding raises 
the additional possibility that a population of cortical PSDs is not susceptible to 
proteasome-mediated plasticity, although activity-dependent changes in cortical PSD 
composition, as determined by Western blot, have been shown to be mediated by 
proteasomal activity (Ehlers, 2003).  This is an excellent example of the type of unique 
information that comes from analyzing individual PSDs.  If proteasomal degradation is 
a hallmark of plasticity at synapses, one can speculate that a population of synapses in 
the cortex are resistant to plasticity and perhaps are the specific sites of long-term 
memory storage, as has recently been proposed (Osada et al., 2008, Fuster, 2009, 
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Hasan et al., 2013).  Future experiments focusing on the proteasomal remodeling of 
individual PSDs will be required to determine if there is a population of cortical PSDs 
resistant to proteasomal degradation.  It is also intriguing that cortical PSDs with the 
greatest abundance of αCaMKII, which is the presumed proteasome scaffold within 
PSDs, had the lowest labeling for the proteasome, while hippocampal and cerebellar 
PSDs, with more βCaMKII than αCaMKII, had significant labeling for the proteasome; 
cerebellar PSDs labeled for twice as much proteasome as αCaMKII.  While it is 
possible that in response to synaptic activity the additional αCaMKII molecules which 
translocate to PSDs act as scaffolds for incoming proteasome molecules, this suggests 
that the proteasome may also be binding to other PSD proteins within hippocampal and 
cerebellar PSDs.  Dual labeling experiments should be employed in the future to 
determine the fraction of CaMKII molecules co-localizing with the proteasome. 
Future work will be required to unfold the mechanism of proteasomal 
degradation of PSD scaffolds and preliminary work addressing this is presented in 
Appendix 1.  To begin to understand the level of proteasomal remodeling in PSDs 
isolated from hippocampi, cerebella, and cortices, western blotting should be employed 
to assess the level of ubiquitin and ubiquitin specific for proteasomal degradation.  Dual 
labeling experiments or dual Western blotting between ubiquitin and PSD scaffolds 
could determine whether PSD scaffolds are being tagged for proteasomal degradation.  
Additionally, proteasome activity assays could also be performed to test whether the 
proteasomes present in the different PSD fractions are functional.  It is also interesting 
that PSD populations with lower labeling for two of the proteasome-targeted PSD 
scaffolds, PSD-95 and shank, were the PSDs with the most labeling for the 
proteasome.  While is it plausible that PSD-95 and Shank family members are just less 
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abundant in hippocampal and cerebellar derived PSDs, it is interesting to speculate 
that their concentration at PSDs is more heavily regulated by proteasomal degradation 
in hippocampal and cerebellar PSDs.  
Future work will also be required to relate the morphologically distinct cerebellar 
PSDs to both their neuronal type of origin and the functional significance of their 
structural differences.  Intriguingly, from my immunogold labeling results, 75% of 
cerebellar PSDs immunogold labeled positively for Shank2, which is thought to be 
specific for purkinje cells, as determined by in situ hybridization (Boeckers et al., 
1999b), and 60% of cerebellar PSDs labeled for αCaMKII, the dominant CaMKII 
isoform in purkinje cells as determined by immunocytochemistry (Walaas et al., 1988).  
These results suggested that 60-75% of the cerebellar PSDs were isolated from 
purkinje cells.  However, 100% of cerebellar PSDs labeled for shank3, which is 
believed to be specific for granule cells as determined by in situ hybridization (Boeckers 
et al., 1999b), and only 45% of cerebellar PSDs labeled positively for scaffold homer, 
which is enriched selectively in purkinje cells as determined by immunohistochemistry 
(Xiao et al., 1998, Okabe, 2007), thereby confusing the issue.  These conflicting results 
suggest that expression of these proteins, especially specific isoforms of the same 
protein, may not be as distinctly separate within cerebellar tissue.  Future experiments 
will be required to further clarify the synaptic molecular composition of the different 
populations of cerebellar cells.  I also suggest that antibodies specific against PSD-93 
and PSD-95, which successfully label PSDs and do not cross-react, be acquired in 
order to parse out PSDs from specific cerebellar neurons, as PSD-93 is believed to be 
the only member of the PSD-95 family within purkinje cells as previously determined by 
immunohistochemistry (McGee et al., 2001).  Once a pattern of labeling is consistent 
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and suggests that separate identifiable populations of cerebellar PSDs exist, it would 
be fascinating to combine immunogold labeling and electron tomography to connect 
differences in protein composition to detailed morphologic distinctions in cerebellar 
PSD texture.  Additionally cerebellar synaptic junction fractions (a fraction one step 
preceding the final PSD fraction) could be immunogold labeled for GluRδ2, as the 
postsynaptic membrane and presumably neurotransmitter receptors are still attached to 
PSDs within this fraction and GluRδ2 is again believed to only be present within 
purkinje cells of the cerebellum (Takumi et al., 1999). 
Tomographic analysis of synaptic junctions could also prove to be a fruitful 
endeavor.  Synaptic junctions are composed of PSDs with residual presynaptic and 
postsynaptic membranes still attached, as they have only been once treated with 
detergent.  Tomographic analysis of synaptic junctions combined with immunogold 
labeling could provide valuable information about the organization of proteins in 
individual morphologically identified PSDs with respect to the postsynaptic plasma 
membrane.  For example, synaptic junctions could be dual immunogold labeled with 
antibodies against palmitate or scaffold PSD-95 and other markers of lipids rafts in 
order to determine how synaptic lipid rafts and the PSD might interact, addressing the 
hypothesis that PSDs play a role in organizing the synaptic membrane.  Additionally, to 
more specifically address PSD dynamics, synaptic junctions could be isolated from 
chemically activated hippocampal slices, as the yield is also greater for synaptic 
junctions than for PSDs, and the fine morphologic and compositional changes 
associated with synaptic activity could be addressed with a combined tomographic and 
immunogold approach.  
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Overall, my results indicate that there are unique structural and compositional 
differences between PSDs isolated from different brain regions. Despite sharing similar 
morphology, PSDs were diverse in molecular composition, implying functional 
distinctions. The differential labeling for PSD scaffolds and clustering of PSD-95, 
suggested that the underlying PSD scaffold varies across the brain, even within brain 
regions, a question I am actively investigating.  It is quite remarkable to me that PSDs 
of similar morphology can have such variable protein compositions and that within the 
cerebellum similar protein composition is observed across PSDs with such varying 
morphologies.  I speculate that the overall structure of the PSD depends more heavily 
on protein organization than on protein composition, meaning that the PSD structure is 
largely determined by assembling similar smaller modules of proteins in unique ways.  
These issues will need to be addressed by identifying the structure of individual 
modules within the PSD along with higher resolution structural information about their 
organization and binding interactions within PSDs.  Lastly, I propose that the differential 
ratios of CaMKII isoforms and varying presence of the proteasome suggest that the 
regulation of synaptic plasticity might vary significantly at different synapses across the 
brain, thereby increasing the complexity of the rules for how specific synapse types 
respond to synaptic activity. 
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Figure 6.1.  Proposed Organization of PSD Scaffolds from Cortical, Hippocampal and 
Cerebellar PSDs. 
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Appendix 1: Insights into the Dynamic PSD Structure  
A.1.1. Introduction 
Investigations into the PSD have determined that the protein composition and 
structure of PSDs change through development (Petralia et al., 2005, Swulius et al., 
2010, Swulius et al., 2012) and with synaptic activity (Ehlers, 2003, Tao-Cheng et al., 
2010, Yang et al., 2011).  The activity-dependent changes to the molecular composition 
and organization of the PSD are postulated to mediate the long-term changes in 
synaptic strength underlying learning and memory (Swulius et al., Tao-Cheng et al., 
Yang et al., Swulius et al., 2012), although the exact molecular organization of the PSD 
as well as how synaptic activity alters PSD organization and architecture remain 
unclear.  It is reasonable to hypothesize that regulated degradation of key organizing 
molecules within PSDs could lead to remodeling, and the ubiquitin proteasome system 
(UPS) has recently been shown to mediate activity-dependent changes in PSD 
composition (Ehlers, 2003, Sheng and Hoogenraad, 2007).  Whether these changes in 
PSD composition result in structural changes to the PSD is unknown, as are the 
mechanisms in which the UPS alters PSD composition.   
The UPS is a highly regulated protein degradation system, where proteins 
tagged with polyubiquitin lysine-48 chains are specifically targeted by the proteasome 
and degraded (Miller and Gordon, 2005).  In 2003, it was demonstrated that several 
PSD scaffold proteins are ubiquitinated in response to activity, including Shank, GKAP 
(Ehlers, 2003) and PSD-95 (Colledge et al., 2003).  Other groups have shown that in 
response to activity the level of both ubiquitinated proteins and the proteasome 
increases in dendritic spines (Bingol and Schuman, 2006, Djakovic et al., 2009).  
Additionally, the activity-induced recruitment of the proteasome to spines was 
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dependent on prior translocation of CaMKII (Djakovic et al., 2009, Bingol et al., 2010).  
It is also of interest to note that mutations in and/or dysregulation of PSD-95 (Roselli et 
al., 2005) and Shank (Roselli et al., 2009, Grabrucker et al., 2011c, Grabrucker et al., 
2011d) have been associated with neurologic disorders and diseases, characterized by 
synaptic dysfunction, such as Autism, the Autism Spectrum Disorders and Alzheimer’s 
Disease.  These findings strengthen the idea that the structure of the PSD plays an 
important role in synaptic function and developing a dynamic molecular model of the 
PSD will be crucial in understanding mechanisms underlying synaptic function. 
My hypothesis for activity-induced structural reorganization of the PSD by the 
ubiquitin proteasome system is modeled in Figure A.1.1., where in response to synaptic 
activation, there is initial recruitment of CaMKII into the spine and to the PSD 
(Dosemeci et al., 2001, Sheng and Hoogenraad, 2007), along with increased 
ubiquitination of PSD scaffolds (Ehlers, 2003).  The 12 subunit CaMKII holoenzyme is 
known to phosphorylate the proteasome (Djakovic et al., 2009), and act as a target 
providing binding sites for the proteasome within the PSD (Figure A.1.1.).  The arrival 
of the proteasome at the PSD allows for targeted degradation of ubiquitinated PSD 
scaffold proteins including Shank, GKAP and PSD-95 (Figure A.1.1.).  Loss of these 
scaffold proteins allows for molecular rearrangement within the PSD as Shank, GKAP 
and PSD-95 have multiple protein-interaction domains forming multiprotein complexes 
(Kennedy, 2000, Kim and Sheng, 2004). 
Shank molecules can interact with themselves and are hypothesized to 
construct the frame of the PSD (Kim and Sheng, 2004) (Figure A.1.1.).  Shank and 
PSD-95 form receptor modules as Shank is believed to indirectly support metabotropic 
glutamate receptors in the membrane, whereas PSD-95 is believed to support both 
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NMDA and AMPA receptors in the postsynaptic membrane (Kennedy, 2000, Colledge 
et al., 2003, Kim and Sheng, 2004).  Interestingly, GKAP binds both PSD-95 and 
Shank bringing the two scaffold modules together (Kennedy, 2000), and loss of GKAP 
could directly impact the organization of synaptic receptors.  Therefore targeted 
proteasomal degradation of PSD scaffolds could result in the removal of receptors from 
the synapse or could rearrange the PSD scaffold in order to support the recruitment of 
additional receptors, altering the physiological properties of the synapse.  To begin to 
test this hypothesis, preliminary experiments were performed in order to investigate 
how the composition of PSDs change in response to activity and whether the 
proteasome plays a role in PSD structural remodeling throughout development. 
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Figure A.1.1. Model for Activity-Induced Structural Reorganization of the PSD by the 
Ubiquitin Proteasome System 
A) Calcium influx through NMDA receptors triggers immediate activation and 
translocation of CaMKII into the PSD.  B) Ubiquitination of PSD scaffold proteins 
increases.  C) In the PSD, CaMKII acts as a scaffold recruiting proteasome molecules 
localizing proteasomal degradation within the PSD. 
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A.1.2. Additional Methodology 
A.1.2.1. Preparation of Hippocampal Slices and Chemical Induction of Neuronal Activity 
To prepare hippocampal slices, adult Sprague-Dawley rats were decapitated 
immediately after being anesthetized with isoflurane.  Brains were removed, placed in 
oxygenated ringer’s solution, and hemissected.  Hippocampi were isolated and 
transverse 400 μm slices were prepared with a McIlwain tissue chopper.  Slices were 
then placed in continuously oxygenated ringer’s solution at room temperature to 
recover for 1 hr.  Since the goal of this proposal was to study the activity-induced 
changes to PSD structure, hippocampal slices were synaptically activated with the 
potassium channel blocker TEA (Enzo Life Sciences).  After the recovery period, slices 
were incubated for 10 min in modified oxygenated ringer’s solution either with or 
without 25 mM TEA (Lengyel et al., 2004) and returned to ringer’s solution to allow 
activity-induced changes to develop, before being immediately frozen in liquid nitrogen 
and then homogenized for PSD isolation.  PSDs were isolated from hippocampal slices 
following the PSD isolation protocol described in Chapter 2, section 2.1, scaled for 
starting material. 
 
A.1.2.2. Isolation of Postsynaptic Densities from Forebrains at Postnatal Days 2, 7, 14, 
21, and 60 
 The protocol to isolate forebrain PSDs from Sprague-Dawley rats at postnatal 
days 2, 7, 14, 21, and 60 (denoted as P2, P7, P14, P21, and P60 respectively) was 
adapted from a widely used PSD enrichment procedure (Cohen et al., 1977) modified 
to increase PSD yield (Figure A.1.2).  Forebrains were removed within 30 seconds of 
decapitation and placed in ice-cold buffer A.  For each preparation, a total of 9 
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forebrains from P60, 12 from P21, 14 from P14, 30 from P7, or 40 from P2 were 
homogenized in 108 ml of buffer A with a motor-driven glass/Teflon homogenizer (0.2 
mm clearance).  All steps of the following protocol were accomplished at 4˚C.  
Homogenates were spun at 3600 g for 10 minutes in a RTH-750 rotor, supernatants 
saved.  Pellets were resuspended in original volume of buffer A, hand homogenized, 
and spun again at 3600 x g for 10 minutes in a RTH-750 rotor.  Supernatants were 
combined and spun at 10,000 x g in a JA-20 rotor for 10 minutes.  Pellets were 
resuspended in original volume of buffer A by hand homogenizing and spun again at 
10,000 x g for 10 minutes in a JA-20 rotor.  Pellets were resuspended in 28 ml of buffer 
B and applied to a sucrose gradient (7 ml sample, 9.5 ml 0.85 M sucrose, 10.5 ml 1.0 
M sucrose, 10.5 ml 1.4 M sucrose) which was spun for 2 hours at 125,800 x g in a 
SW32 rotor.  The band between 1.0 M and 1.4 M sucrose, containing the synaptosome 
fraction, was collected and diluted in half with buffer B.  An equal volume of triton 
extraction buffer was added and the samples rotated for 15 minutes prior to being spun 
at 30,000 x g for 20 minutes in the SW32 rotor.  Pellets were resuspended in 2.5 ml of 
buffer B and applied to a second sucrose gradient (2.5 ml sample, 5 ml 1.0 M sucrose, 
5 ml 1.2 M sucrose).  The gradient was spun at 167,000 x g for 2 hours in a SW41 
rotor.  The pellet was resuspended in 1 ml 5 mM HEPES/KOH pH 7.4, 1 ml triton 
extraction buffer was added, and the sample was mixed on ice for 15 minutes.  Finally 
the sample was spun at 38,000 x g for 15 minutes in a SW55 rotor and the resulting 
pellet was suspended in 300-500 μl of 20% glycerol in 5 mM HEPES/KOH pH 7.4 and 
stored as aliquots at -80˚C.  Spins were performed in a Sorvall® RT7 plus centrifuge, 
Avanti® J-E Centrifuge and Optima XPN-80 Ultracentrifuge.  Gradients were spun with 
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acceleration and deceleration program 1, resulting in a 2 minute acceleration to and 
deceleration from 170 RPM, respectively. 
 
A.1.2.3. Western Blotting and Immunogold Labeling 
Western blotting and immunogold labeling were performed as previously 
described in Chapter 2, sections 2.2 and 2.3.  Additional primary antibodies included: 
pan-Shank (mouse, Neuromab, 75-089), GKAP (mouse, Neuromab, 75-156), CaMKII 
(rabbit, Millipore, 04-1079), pT286 (Rabbit, Phosphosolutions, p1005-286), pT286 
(mouse, Thermo, MA1-047), pT305 (rabbit, produced in house), and 20S (mouse, Enzo 
Life Sciences, PW8195).  Antibody information including Western blot and immunogold 
labeling dilutions not included in Table 2.1 are listed in Table A.1.1. 
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Figure A.1.2. Isolation of PSDs from Forebrains throughout Development. 
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Antibody Species Manufacturer Catalog Number WB Dilution IG Dilution 
pan-Shank mouse Neuromab 75-089 1:2500 1:20 
GKAP mouse Neuromab 75-156 1:2500 1:20 
CaMKII rabbit Millipore 04-1079 1:1000 1:20 
pT286 rabbit Phosphosolutions p1005-386 1:1000 1:20 
pT286 mouse Thermo MA1-047 1:2000 1:20 
pT305 rabbit Waxham Lab -- 1:1000 1:20 
20S mouse Enzo Life Science PW8195 1:1000 1:20 
 
Table A.1.1. Antibody Information for all Primary Antibodies Used. 
Information includes: the species in which antibody was raised, manufacturer, catalog 
number, Western blot dilution and immunogold labeling dilution. 
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A.1.3. Results 
A.1.3.1. Hippocampal Slice PSDs 
In preliminary experiments to address activity-induced changes in PSD 
composition and structure, hippocampal slices were prepared, activated with potassium 
channel blocker TEA, and PSDs isolated, as described in the methodology section 
A.1.2.3.  Hippocampal slices were frozen with liquid nitrogen immediately after the 10 
min TEA treatment or control treatment, homogenized and PSDs isolated.  Negative 
stain micrographs of control and TEA treated PSDs were collected to determine if there 
were gross morphologic differences associated with activation.  As no obvious 
differences were evident in the gross morphology, the surface area was measured for 
120 control and TEA treated hippocampal PSDs and average surface area calculated 
(Figure A.1.3).  The mean surface area was 0.27 ± 0.02 μm2 for control hippocampal 
PSDs and 0.18 ± 0.01 μm2 for TEA treated, which was a statistically significant 
difference from the control PSDs.  The peak surfaces areas, or mode, were also 
different with control hippocampal PSD surface area peaking at 0.15 μm2 while the 
surface area for TEA treated hippocampal PSDs peaked at 0.10 μm2 (Figure A.1.3).  
This trend is evident in the histograms of PSD surface area shown in Figure A.1.3, 
where the surface areas for TEA treated hippocampal PSDs were less variable, tending 
toward smaller surface areas.  These results suggested that PSDs are smaller as a 
result of inducing neuronal activity, further supporting the idea that structural 
remodeling of PSDs underlies synaptic plasticity. 
Immunogold labeling experiments were performed on the TEA treated and 
control hippocampal slice PSDs to directly test how PSD protein composition changes 
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in response to synaptic activity.  Antibodies against αCaMKII, βCaMKII, CaMKII 
phosphorylated at T286 (pT286), CaMKII phosphorylated at T305 (pT305), and a pan 
antibody against the Shank isoforms (pan-Shank) were employed in immunogold 
labeling experiments.  The results of the immunogold labeling experiments are shown 
as gold/μm2 and gold/PSD in Table A.1.2.  Secondary controls were included for the 
αCaMKII immunogold labeling experiment.  Sample size was 20 PSDs for each 
experiment, with the exception of pan-Shank, where 15 non-TEA treated PSDs and 8 
TEA treated PSDs were imaged.  There were no significant differences in labeling 
density when results were reported as gold over surface area; however when labeling 
densities were reported as gold per PSD there were statistical differences (Table 
A.1.2).  These results are easily explained as the average surface areas of TEA treated 
PSDs were smaller than controls (Figure A.1.3).   
Labeling densities for βCaMKII and pT305 were significantly different and 
greater for control non-treated PSDs than for TEA-treated PSDs (Table A.1.2).  These 
results, while preliminary, were in part not expected; it is known that activation of 
synapses results in translocation of CaMKII to PSDs (Strack et al., 1997, Shen and 
Meyer, 1999, Dosemeci et al., 2001) and yet there was lower labeling for βCaMKII in 
TEA treated hippocampal slice PSDs compared to control and there was no difference 
in the level of αCaMKII between groups (Table A.1.2).  Additionally, it was expected 
that TEA treatment of hippocampal slices would result in increased phosphorylation of 
CaMKII at T286, suggesting activation of CaMKII (Miller and Kennedy, 1986), and yet 
the labeling densities for pT286 were the same in the control and TEA treated groups, 
while phosphorlyation at T305 was increased in control PSDs (Table A.1.2).  
Phosphorlyation of CaMKII at T305 is inhibitory autophosphorylation which prevents 
 150 
 
CaMKII activation by Ca2+/CaM (Hanson and Schulman, 1992) and is believed to be 
important in targeting CaMKII to the PSD (Elgersma et al., 2002).  Therefore, while less 
inhibitory CaMKII phosphorlyation was evident in PSDs which had been treated with 
potassium channel blocking TEA, translocation and activation of CaMKII was not 
evident as expected.  The scaffold Shank is also thought to translocate to PSDs in an 
activity-dependent manner (Tao-Cheng et al., 2010), although the labeling of Shank 
between TEA treated PSDs and control PSDs was the same.   
Additional PSDs were isolated from TEA treated hippocampal slices and control 
hippocampal slices, in order to assess the time course of molecular events occurring 
after TEA treatment.  Hippocampal slices were homogenized either immediately after 
or 20 minutes after TEA or control treatment, and PSDs were then isolated and 
immunogold labeled (Table A.1.3).  The first PSD preparation, termed A, was prepared 
20 min after TEA treatment following the same isolation procedure as the hippocampal 
slice PSDs previously discussed, to test whether CaMKII translocation and recruitment 
of the proteasome could be detected 20 minute after synaptic activation.  The results of 
the immunogold labeling experiments are shown in Table A.1.3.  There were no 
differences in labeling densities of the proteasome between TEA-treated and control 
PSDs, however there was significantly more gold targeting βCaMKII per PSD in the 
TEA-treated group as compared to the control group (Table A.1.3), suggesting that 
activity-dependent CaMKII recruitment to the PSD can be detected within 20 min of 
activity induction.   
Due to low PSD yields when isolating hippocampal slice PSD through three 
separate discontinuous sucrose gradients, the PSD isolation protocol for hippocampal 
slices was changed to a two sucrose gradient protocol, as described in section A.1.2.2.  
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Hippocampal slice PSD preps B and C were isolated through the two sucrose gradient 
protocol to increase yield and thus increasing the number of preliminary experiments 
possible.  Slices from prep B were homogenized immediately after TEA treatment, 
while slices for prep C were homogenized 20 minutes after treatment.  Preliminary 
immunogold assessment of protein density in the resulting PSDs is shown in Table 
A.1.3.  Labeling for the lid of the proteasome was determined to be the same in control 
and TEA-treated hippocampal slice PSDs from prep B, the immediate time point.  
However, labeling for the proteasome lid was increased in TEA-treated hippocampal 
slice PSDs, as compared to control PSDs, isolated 20 minutes after activity induction 
(Table A.1.3).  This result contradicts the proteasome labeling densities calculated for 
prep A which was also isolated 20 minutes after TEA-treatment, although the sample 
size for prep C was double the sample size for prep A (Table A.1.3).  Labeling densities 
for αCaMKII were calculated for preps B and C to test whether recruitment of CaMKII 
could be detected immediately after or 20 minutes after activity induction, and 
surprisingly there were no statistical differences in labeling for αCaMKII between 
control and TEA-treated PSDs at either time point, also contradicting the increased 
labeling for βCaMKII measured in TEA-treated PSDs from prep A (Table A.1.3).  Two 
immediate issues should be addressed before continuing this line of investigation.  
First, activity induction in hippocampal slices by TEA, although well documented 
(Lengyel et al., 2004), will need to be verified by electrophysiology, to ensure the 
efficacy of TEA-induced activity.  Second, protocols will need adapted/optimized in 
order to increase the PSD yield.  This is presently the major factor limiting this 
potentially revealing line of investigation.  By increasing the yields, the time course of 
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molecular events related to activity-dependent PSD modification can be assessed by 
Western blots analysis in addition to immunogold labeling experiments.   
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Figure A.1.3. Histograms of Control and TEA Treated Hippocampal Slice PSD 
Surface Areas.   
The mean surface are for TEA PSDs was statistically smaller than control PSDs as 
determined if P < 0.05 in two-tailed t tests.  The peak surface areas for control and 
TEA treated PSDs were also different, 0.15 μm2 and 0.10 μm2 respectively.   
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Gold/μm2 Gold/PSD 
  Control TEA Control TEA 
αCaMKII 446 ± 45 472 ± 48 113 ± 18 103 ± 13 
βCaMKII 238 ± 36 257 ± 57 71 ± 13 31 ± 9 
pT286 188 ± 32 227 ± 49 62 ± 12 35 ± 8 
pT305 283 ± 35 346 ± 91 93 ± 15 47 ± 13 
pan-Shank 41 ± 7 45 ± 5 13 ± 3 12 ± 1 
 
Table A.1.2.  Preliminary Immunogold Labeling for Hippocampal Slice PSDs treated 
with TEA and Controls.   
Secondary controls were only included for αCaMKII experiment.  Sample size was 
20 PSDs for each experiment, with the exception of pan-Shank, where 15 non-TEA 
treated PSDs and 8 TEA treated PSDs were imaged. 
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  Slice Prep PSD Group Gold/um2 Gold/PSD Sample Size 
RPT6 
A (20 min) Control 56 ± 6 23 ± 4 10 
TEA 55 ± 3 15 ± 3 10 
B (0 min) Control 54 ± 8 14 ± 2 20 
TEA 60 ± 8 15 ± 2 20 
C (20 min) Control 55 ± 9 9 ± 4 20 
TEA 69 ± 12 22 ± 4 20 
αCaMKII 
B (0 min) Control 126 ± 21 35 ± 8 20 
  TEA 174 ± 21 59 ± 20 20 
C (20 min) Control 134 ± 13 28 ± 4 20 
  TEA 127 ± 11 29 ± 4 20 
βCaMKII A (20 min) Control 65 ± 9 25 ± 4 5 
TEA 121 ± 29 47 ± 7 5 
 
Table A.1.3. Preliminary Immunogold Labeling for Control and TEA Treated PSDs 
Isolated from Hippocampal Slices.   
Statistical significance, indicated in bold, was defined as a p-value < 0.05, as 
determined through two-tailed t tests in Excel.  TEA treatment was 10 minutes long for 
each preparation.  Hippocampal Slices were homogenized 20 min after TEA treatment 
for preparations A and C while slices were homogenized immediately following TEA 
treatment for preparation B.  Preparation A included the typical 3 gradients, while preps 
B and C were shortened to 2 gradients to increase PSD yield. 
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A.1.3.2. PSDs during Development 
To continue investigating how the composition of PSDs changes and to 
investigate the potential role of the proteasome in PSD modifications, a developmental 
model was employed as the Waxham Lab has previously done (Swulius et al., 2010, 
Swulius et al., 2012).  As a preliminary experiment PSDs isolated from rat forebrain at 
embryonic day 19 (E19), postnatal day 2 (P2), postnatal day 21 (P21) and postnatal 
day 60 (P60) were immunogold labeled for the lid of the proteasome to assess for its 
presence and differences in amount over development (Table A.1.4).  A bar graph of 
the immunogold labeling results from Table A.1.4 is shown in Figure A.1.4 and 
developmental regulation of the proteasome at PSDs is clearly evident.  Not only was 
the proteasome present within PSDs from all ages, labeling densities for the 
proteasome were significantly higher in PSDs from early development, peaking at P2, 
compared to PSDs isolated from P21 and adult, P60 animals, where the labeling was 
lowest.   
Given this preliminary result, PSDs were also isolated from rat forebrains at two 
additional time points: P7 and P14, in order to further investigate the developmental 
profile of the proteasome system.  Initial experiments focused on Western blotting to 
examine the developmental profile of CaMKII, the proteasome, and scaffolds targeted 
by the proteasome (Figure A.1.5).  Western blots illustrated that PSD-95 increases in 
concentration as PSDs matured (Figure A.1.5), as previously shown by Western blot 
(Petralia et al., 2005) and immunogold labeling (Swulius et al., 2010).  Scaffolds Shank 
and GKAP were also determined to increase in concentration within PSDs through 
development (Figure A.1.5) confirming published work (Petralia et al., 2005).  However 
a subunit of the proteasome lid, RPT6, decreased in concentration within PSDs 
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throughout development (Figure A.1.5), confirming the preliminary immunogold labeling 
results (Table A.1.4).  PSDs isolated at P2 contained 315% more proteasome lid 
subunits than PSDs isolated at P60, as quantified in ImageQuant (GE Healthcare).  
The 20S proteasome core was also found to be developmentally regulated in PSDs, 
and decreased in amount from P2 to P60 similar to RPT6 (Figure A.1.5).  These results 
confirm that the proteasome is present in PSDs and that the presence of the 
proteasome within PSDs is developmentally regulated, supporting that the ubiquitin 
proteasome system plays a role in structural remodeling of the PSD during 
development and plausibly in response to synaptic activity.  
CaMKII, the hypothesized target for the proteasome in PSDs, was also probed 
by Western blot and both αCaMKII and βCaMKII increased from P2 to P60, with 
βCaMKII as the dominant isoform until P60, as previously reported (Sahyoun et al., 
1985, Swulius et al., 2010). The blots in Figure A.1.5 demonstrate that at P2, 
phosphorlyation of T286 is mainly on βCaMKII (the abundant isoform at that age), and 
interestingly decreases from P2 to P60, even though the abundance of βCaMKII 
increases through this time frame.  Phosphorylation of αCaMKII at Thr286 increases 
from P2 to P60, as does abundance of αCaMKII (Figure A.1.5).  Of all the known PSD 
associated proteins, the only ones identified to decrease through development are 
NR2B, SAP102 (Petralia et al., 2005), and CaM (Swulius et al., 2010).  Therefore the 
decreases seen by Western blot for the proteasome lid (RPT6), core (20s), and 
phosphorlyation of βCaMKII at T286 is novel and suggests that the proteasome and 
phosphorylation of βCaMKII are correlated with the structural maturation of PSD.   
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  Gold/μm2 ± SEM Gold/PSD ± SEM 
E19 56 ± 17 29 ± 9 
P2 86 ± 15 52 ± 11 
P21 19 ± 3 10 ± 2 
P60 10 ± 3 5 ± 1 
 
Table A.1.4. Preliminary Immunogold Labeling for RPT6 on Developmental PSDs.  
Labeling densities for the proteasome significantly drop between P2 and P21.  
Statistical significance, indicated in bold, was defined as a p-value < 0.05, as 
determined through two-tailed t tests in Excel. N = 10. No secondary controls were 
performed.   
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Figure A.1.4. Preliminary Average Labeling Densities for RPT6 on Developmental 
PSDs.  
No secondary controls were performed.  Labeling densities for the proteasome 
significantly drop between P2 and P21.  Statistical significance, indicated with 
asterisks, was defined as a p-value < 0.05, as determined through two-tailed t tests in 
Excel. N = 10. 
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Figure A.1.5. Western Blots Illustrating the Developmental Profiles for Select PSD 
Proteins. 
Lanes for each blot were loaded with equal protein, between 5 and 10 μg, using 8%, 
10% or 15% polyacrylamide gels.  Multiple bands are expected to be detected by the 
primary antibodies against Shank, GKAP, 20S, CaMKII and pT286.  The pan-Shank 
antibody recognizes the entire family of Shank proteins which range in from 120-240 
kDa (Sheng and Kim, 2000).  The GKAP antibody also recognizes multiple isoforms of 
the protein at 110 kDa and 120 kDa; others have reported this as well (Petralia et al., 
2005).  The 20S antibody against the core of the proteasome recognizes multiple 
subunits which compose the 2000 kDa catalytic core of the proteasome, as shown by 
others (Djakovic et al., 2012).  The CaMKII antibody and the pT286 antibody recognize 
both αCaMKII (55 kDa) and βCaMKII (60 kda).   
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A.1.4. Discussion 
While some of the preliminary experiments described above were inconclusive, 
they have contributed forward progress toward the goal of building a dynamic structural 
model for the PSD.  PSDs were isolated from chemically activated hippocampal slices 
to investigate how PSD composition changes in response to activity and whether the 
proteasome is recruited to PSDs in an activity-dependent manner.  The ubiquitin 
proteasome system is predicted to degrade PSD proteins in response to activity 
providing structural flexibility for reorganization within PSDs supporting synaptic 
plasticity.  The results of the preliminary hippocampal slice work are inconclusive; while 
there were some statistically significant differences between TEA-treated hippocampal 
slice PSDs and control hippocampal PSDs, activity induction by TEA requires 
verification and a consistent PSD isolation protocol that produces sufficient PSD yield 
for Western blotting.   
As an alternative preparation to assess the potential role of the UPS in PSD 
structural remodeling, PSDs were isolated from different developmental time points.  
Western blots showed that both the proteasome lid and core were present at highest 
concentrations in PSDs isolated early in development and decreased as PSDs 
matured.  This suggests that the proteasome plays an important role in the structural 
maturation of PSDs early in development, but its role diminishes as synapses mature.  
Interestingly the PSD scaffolds targeted by the proteasome including; PSD-95 
(Colledge et al., 2003), Shank and GKAP (Ehlers, 2003), increase in concentration 
within PSDs through development, as shown here and as previously published (Sans 
et al., 2000, Petralia et al., 2005, Swulius et al., 2010) while the proteasome decreases 
in concentration.  While is it possible that these trends are unrelated, it is interesting to 
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speculate that early in postnatal development while the concentrations of PSD 
scaffolds Shank, GKAP and PSD-95 are increasing there is steady proteasomal 
turnover of the scaffolds providing flexibility for the maturing PSD structure.  To begin to 
test this hypothesis proteasome activity assays could be performed on PSD fractions 
from each developmental age to determine the level of proteasome activity in PSDs 
throughout development.  Western blotting of PSD fractions could also be probed for 
monomeric ubiquitin and polyubiquitin chains specific for proteasomal degradation to 
test whether a subset of PSD components are being tagged for proteasomal 
degradation.  Western blots dually probed for polyubiquitin K48, specific for 
proteasomal degradation (Miller and Gordon, 2005), and Shank, GKAP or PSD-95 
could also determine which scaffolds are specifically targeted by the ubiquitin chains.   
Phosphorlyation of βCaMKII at T286 decreased within PSDs as animals 
matured, in contrast to the increasing concentration of βCaMKII.  This is a novel result 
suggesting that the activation of βCaMKII is crucial for the structural maturation of PSD.  
This result makes sense in that early in development βCaMKII is the primary isoform of 
CaMKII expressed (Sahyoun et al., 1985), therefore the majority of phosphorylated 
CaMKII would be on βCaMKII.  However the intensities of the pT286 band for βCaMKII 
at postnatal day 2 and 7 were significantly more intense than the pT286 bands for both 
αCaMKII and βCaMKII together at any other age.  This suggested that the majority of 
the CaMKII present within PSDs at P2 and P7 are in the autophosphorylated form.  It is 
intriguing at such early postnatal time points that the majority of βCaMKII is active and 
very little αCaMKII is present in PSDs, especially when translocation of αCaMKII, not 
βCaMKII, is proposed to be required for activity-dependent recruitment of the 
proteasome to the PSD (Djakovic et al., 2009, Bingol et al., 2010).  Additionally it is 
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believed that αCaMKII acts as the anchoring protein for the proteasome into PSDs 
(Bingol et al., 2010) and phosphorlyation of RPT6 by αCaMKII increases proteasomal 
activity (Djakovic et al., 2012).  Likely, the noted βCaMKII activation is crucial for other 
synaptic functions at these stages in development through its interactions with F-actin 
(Lin and Redmond, 2008, Sanabria et al., 2009, Hoffman et al., 2013), such as the 
formation and expansion of neurites (Fink et al., 2003) although these results suggest a 
further investigation of phosphorylated βCaMKII and the proteasome may be 
warranted.  However, the low levels of αCaMKII measured at P2 and P7 and the idea 
that βCaMKII is not acting as the proteasome scaffold suggests that CaMKII is 
plausibly not the primary proteasome scaffold molecule early in development.  It would 
be of interest to affinity-purify proteasomes out of PSDs isolated from P2 and P7 rats 
and determine what PSD proteins precipitate alongside the proteasome. 
In the future it will also be of interest to investigate the postsynaptic 
developmental profiles of deubiquitinases CLYD and UCH-L1.  CLYD accumulates in 
PSDs in a manner that is dependent on synaptic translocation of CaMKII (Thein et al., 
2014), similar to the proteasome.  CaMKII can also phosphorylate CYLD promoting 
CYLD’s deubiquitinase activity which preferentially removes ubiquitin from polyubiquitin 
lysine-63 chains, which target proteins for non-proteasomal pathways (Thein et al., 
2014).  The additional free ubiquitin is then available to form lysine-48 chains, specific 
for proteasomal degradation (Miller and Gordon, 2005).  It is easy to visualize a model 
where in response to synaptic activity CaMKII enzymes translocate to PSDs, followed 
by the proteasome and CYLD, active CaMKII then phosphorylates CYLD, resulting in 
deubiquitination of lysine-63 chains, providing additionally ubiquitin for formation of 
lysine-48 chains, which are specific for proteasomal degradation. CaMKII also 
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phosphorylates proteasomes, increasing their activity, which then degrade PSD 
scaffolds tagged with lysine-48 chains.  Ubiquitin carboxyl-terminal hydrolase L1, UCH-
L1 also increases levels of free ubiquitin in response to synaptic activation (Cartier et 
al., 2009).  Inhibition of UCH-L1 resulted in decreased free ubiquitin, changes in spine 
morphology and density (Cartier et al., 2009), and increased levels of PSD-95 (Xie et 
al., 2014).  Additionally it is believed that α-synuclein accumulation results from 
oxidative damage of UCH-L1 in both Alzheimer’s disease and Parkinson’s disease (Liu 
et al., 2002, Choi et al., 2004).  A more thorough understanding of how these 
deubiquitinases are organized within PSDs, as well how they may influence PSD 
structure and function in response to activity and through development is warranted.
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Appendix 2. CaMKII Isoforms Differentially Impact the Structure of Actin 
Cytoskeleton 
A.2.1. Introduction 
This chapter of the appendix is based on previously published work which I 
contributed to. The methods, figures and figure legends, pertaining to my contribution, 
were taken directly, with permission, from the published work (Hoffman et al., 2013).  
The introduction, results and discussion are rewritten and focused on experiments to 
which I contributed. 
αCaMKII and βCaMKII, the major PSD proteins, are well known for their role 
converting variable synaptic calcium signals into enzymatic activity crucial for learning 
and memory (Lisman et al., 2002, Colbran and Brown, 2004, Swulius and Waxham, 
2008).  There are four isoforms of the enzyme, produced from four separate genes 
(Hudmon and Schulman, 2002).  The α and β isoforms are present within neuronal 
tissue, comprising 1-2% of the total protein in the brain (Erondu and Kennedy, 1985), 
while the other isoforms of CaMKII, γ and δ are present alongside the α and β isoforms 
in cells across the body (Tobimatsu and Fujisawa, 1989, Swulius and Waxham, 2008).  
The structures of the isoforms are highly conserved with exception of a variable linker 
region, located on the C-terminal side of the shared regulatory domain (Gaertner et al., 
2004a, Swulius and Waxham, 2008), as shown in Figure A.2.1. 
This variable region is hypothesized to provide βCaMKII the unique ability to 
bind actin and regulate actin polymerization (Fink and Meyer, 2002, O'Leary et al., 
2006, Okamoto et al., 2007, Lin and Redmond, 2009), which is important for molecular 
transport throughout cells and establishing cellular structure (Pollard and Cooper, 2009, 
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Michelot and Drubin, 2011, Schoenenberger et al., 2011).  βCaMKII, unlike αCaMKII, 
can bind monomeric G-actin, polymerized F-actin, and can bundle F-actin filaments 
due to the dodecameric structure (Ohta et al., 1986, Shen and Meyer, 1999, O'Leary et 
al., 2006, Okamoto et al., 2007, Sanabria et al., 2009).  CaMKII exists as a mixed 
holoenzyme composed of 12 subunits of CaMKII isoforms in two stacked rings of 6 
subunits each (Kolb et al., 1998, Brocke et al., 1999, Gaertner et al., 2004a).  Therefore 
a holoenzyme composed entirely of βCaMKII could presumably bind up to 12 actin 
molecules, allowing the kinase to simultaneously bind F-actin and sequester G-actin, 
both regulating the rate of polymerization and providing a pool of G-actin available for 
polymerization (Hoffman et al., 2013).  While many studies have analyzed the 
interactions of βCaMKII and actin (O'Leary et al., 2006, Okamoto et al., 2007, Sanabria 
et al., 2009), not much work has evaluated the interactions of the other CaMKII 
isoforms and actin.  This is an important step in understanding how mixed CaMKII 
holoenzymes in neural and non-neural cells interact with and regulate the actin 
network.  
The goal of the work, which is summarized in this appendix, was to investigate 
CaMKII isoform specific interactions with actin (for a full description see Hoffman et al., 
2013).  As described in the paper and performed by Dr. Laurel Hoffman, 
cosedimentation experiments between CaMKII isoforms and F-actin suggested that 
binding of F-actin is isoform specific with βCaMKII most avidly binding actin followed by 
δ, γ, and α (Hoffman et al., 2013).  All isoforms also inhibited actin polymerization and 
Ca2+/CaM activation of each isoforms resulted in increased polymerization by freeing 
monomeric actin from binding to the kinase (Hoffman et al., 2013).  In order to visualize 
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the interaction of each isoform with actin, I produced negative stain tomographic tilt 
series of the actin/CaMKII complexes and these results are described in this appendix. 
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Figure A.2.1. Domain map of CaMKII isoforms 
 
The domain structures of all CaMKII isoforms used in these studies are highly 
conserved in sequence in the catalytic, regulatory, and association domains. The only 
noteworthy differences are found in the variable linker region where alternative splicing 
results in inclusion or omission of various exons denoted by Roman numerals.  Figure 
adapted from (Hoffman et al., 2013). 
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A.2.2. Methodology 
Tomographic tilt series were collected on a 300 kV FEI Polara F30 electron 
microscope equipped with a 4000 × 4000 pixel Tietz CCD camera. Series were 
collected at 39000x magnification with a 5 to 10 μm defocus under a dose of ∼400 
electrons/Å2. Images were collected at 2° tilt increments from −60° to 60° with 2x 
binning that generated a final pixel size of 4.6 Å. Tilt series were aligned and 
tomographic reconstructions produced using Etomo, part of the IMOD software 
package (Mastronarde, 1997).   Protein preparation, F-actin–CaMKII binding reactions, 
and grid preparation were completed by Dr. Laurel Hoffman, as published (Hoffman et 
al., 2013). 
 
A.2.3. Results 
A.2.3.1. Actin Filaments are Bundled Similarly by δCaMKII and βCaMKII 
 From negative stain micrographs it was evident that there were differences in 
the interaction of the CaMKII isoforms and F-actin (Figure A.2.2.A and Figure A.2.3.A), 
however the F-actin bundles formed by δCaMKII were structurally indistinguishable 
from those formed by βCaMKII (Figure A.2.2.A), which have been described previously 
(Okamoto et al., 2007, Sanabria et al., 2009).  The F-actin bundles produced by both 
δCaMKII and βCaMKII were approximately 100 nm wide and composed of tightly 
packed slightly twisting parallel actin filaments (Figure A.2.2.A).  The bundles were also 
quite variable in length with some extending up to 15 μm in length.   
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 Negative stain electron tomography was employed to further investigate the 
structure of the F-actin bundles.  Cross-sections, approximately 10 nm thick, through 
final tomographic reconstructions of actin bundles are shown for βCaMKII and δCaMKII 
in Figure A.2.2.B, and individual holoenzymes are easily visible within the tightly 
packed actin bundles.  For both βCaMKII and δCaMKII, the actin filaments were 
organized in a fairly parallel manner, with some twisting, and bundles were 
approximately 50-100 nm thick.  Close-up views of the same reconstructions shown in 
Figure A.2.2.B are shown in C of Figure A.2.2 to highlight individual CaMKII 
holoenzymes bridging actin filaments.  Interestingly, bundles formed by both βCaMKII 
and δCaMKII also appeared to have blunt ends rather than tapered ends (Figure 
A.2.2.D), suggesting that the manner of packing produced by both isoforms did not 
support extension of individual filaments beyond a certain length.  Presumably the 
kinase provided stability for the individual filaments; therefore the individual filaments 
could only extend so far past the last kinase, although it is possible that filaments 
extending past the end of the bundle were severed during grid preparation. 
 
A.2.3.2. γCaMKII Uniquely Bundles Actin Filaments 
 The F-actin bundles formed by γCaMKII deviated in structure from the bundles 
produced by both δCaMKII and βCaMKII (Figure A.2.2.A and Figure A.2.3.A).  The left 
panel in Figure A.2.3.A shows a negative stain micrograph of a typical γCaMKII actin 
bundle, which were less consistent in width and 2-3 times wider than the βCaMKII and 
δCaMKII bundles.  The γCaMKII bundles were wide and flat with branching in both the 
x and y dimensions (Figure A.2.3.), and a layered structure was evident from the 
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tomographic reconstructions (Figure A.2.3).  Individual holoenzymes were visibly 
interacting with actin (Figure A.2.3.A right panel) in the γCaMKII bundles, which 
appeared to be composed of a single layer of filamentous actin sandwiched between 
two layers of CaMKII (Figure A.2.3), roughly 40 nm thick compared to the 50-100 nm 
thickness of the βCaMKII and δCaMKII bundles.  Representative tomographic slices 
through the layers of one bundle are shown in Figure A.2.3.C and a cartoon illustration 
comparing the layered γCaMKII bundle to the rod-like δ and βCaMKII in included in 
Figure A.2.3.B.  
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Figure A.2.2. Structural Analysis of Actin Bundles Formed in the Presence of the β and 
δ Isoforms of CaMKII (Hoffman et al., 2013). 
A) Left panels illustrate representative 2D projections of low power electron 
micrographs of negative stained F-actin in the presence of β (upper) and δ (lower) 
isoforms (n > 5). B) Panels show ~10 nm thick slices of two tomographic 
reconstructions to illustrate packing of β and δ CaMKII holoenzyme molecules within 
bundles. C) Several CaMKII holoenzyme molecules are highlighted by red circles in a 
zoomed in region of a representative slice from the same reconstructions shown in 
Panel B. D) The right panels show ~ 10 nm slices through two different tomographic 
reconstructions that illustrate examples of blunt ended bundles formed with β or δ 
CaMKII (Hoffman et al., 2013). 
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Figure A.2.3. Structure of Layered γCaMKII Bundle (Hoffman et al., 2013). 
 
A) Left and center panels show representative electron micrographs of F-actin bundles 
in the presence of γCaMKII (n = 6). The right panel illustrates a ~10 nm slice from a 
tomographic reconstruction where several CaMKII holoenzyme molecules are 
highlighted in red circles. B) A cartoon illustrates structural differences between the 
layered bundles observed in the presence of the γ isoform (orange spheres) and the 
rod-like bundles observed in the presence of the β or δ isoforms (red spheres). C) ~ 10 
nm slices from tomograms illustrate the top, center, and bottom z sections of the 
layered bundle in the left, center, and right panels, respectively (Hoffman et al., 2013). 
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A.2.4. Discussion 
 The low resolution structure of the different CaMKII isoforms was similar as 
previously published (Gaertner et al., 2004a), however the differential actin bundle 
structures indicate that there are isoform-specific differences in the interactions 
between CaMKII and actin.  The electron microscopic and cosedimentation results 
suggest that there is a correlation between actin bundle structure and actin binding 
capacity.  Each of the CaMKII isoforms did indeed bind actin, with the β, δ, and γ 
isoforms forming higher ordered structures with F-actin.  αCaMKII showed the lowest 
actin binding capacity and did not form detectable actin bundles.  Interestingly, the 
bundles formed by F-actin and γCaMKII structurally diverged from the bundles formed 
by βCaMKII and δCaMKII.  The wide and flat bundles produced by γCaMKII appeared 
limited in the z dimension, while the bundles formed by βCaMKII and δCaMKII bundles 
appeared limited in the x and y dimensions, as they were very consistent in width and 
thickness.  It is plausible that flexibility of the variable linker region constrains the three-
dimensional organization of the actin bundles and identification of the actin binding 
domain will be crucial for fully understanding the isoform specific differences in actin 
binding and bundling.  These results are significant step toward our understanding the 
complex multifaceted regulation of the actin network by CaMKII holoenzymes 
composed of varying ratios of CaMKII isoforms. 
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